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RESUMO 
As citocinas são proteínas do sistema imunitário inato que estão envolvidas 
em vários processos da resposta imunológica. De forma a diversificar e adaptar-
se rapidamente a mudanças nas condições normais, as citocinas podem sofrer 
alterações. Até à data, a descrição de interleucinas e de ligandos das quimiocinas 
em lagomorfos está quase unicamente restringida ao coelho-bravo. De forma a 
complementar a informação disponível para os lagomorfos, caracterizou-se a 
organização genómica, a diversidade genética e a evolução das interleucinas 
(ILs) e dos ligandos das quimiocinas com importância biológica nos lagomorfos. 
Estes genes foram analisados para diversos géneros de lagomorfos pertencentes 
às famílias Ochotonidae e Leporidae. 
De forma a compreender as alterações que têm acompanhado a evolução 
destes genes nos lagomorfos, as sequências obtidas neste trabalho foram 
comparadas com as sequências publicamente disponíveis para outros mamíferos. 
A deteção de assinaturas de seleção positiva com recurso a métodos de máxima 
verosimilhança em 46 ILs de diferentes mamíferos revelou que 60% destas 
proteínas têm codões sob seleção positiva. Porém, o número e a percentagem de 
codões sob seleção positiva variaram entre as diferentes ILs. Dada a importância 
destas proteínas na ativação da resposta imunitária, era esperado que a sua 
estrutura e função fossem mantidas ao longo de diferentes linhagens evolutivas e, 
consequentemente, seriam observados padrões de seleção negativa. No entanto, 
os resultados obtidos neste trabalho contradizem esta previsão, o que pode ser 
explicado pela multiplicidade de processos biológicos em que as interleucinas 
estão envolvidas. 
Das ILs estudadas neste trabalho, destaca-se a IL6, com um padrão 
evolutivo único. Estudos anteriores demonstraram que a IL6 do coelho-bravo 
difere de outros mamíferos, nomeadamente de outros dois géneros de leporídeos 
(Sylvilagus spp. e Lepus spp.) cuja divergência ocorreu há aproximadamente 12 
milhões de anos. Esta diferença consiste na extensão desta proteína em mais 27 
aminoácidos. Neste trabalho, estudámos esta proteína em outros quatro géneros 
de leporídeos (coelho-pigmeu, coelho-bosquímano, coelho-de-Amami e coelho-
zacatuche) e na pika-americana. No coelho-de-Amami, detetou-se uma deleção 
do codão stop que provoca uma extensão da IL6 em 17 aminoácidos. Estes 
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resultados indicam que a extensão da IL6 ocorreu de forma independente no 
coelho-bravo e no coelho-de-Amami: uma aconteceu entre 2 a 8 milhões de anos 
atrás no ancestral do coelho-bravo, e a outra ocorreu no ancestral do coelho-de-
Amami há um máximo de 9 milhões de anos. A ausência desta extensão na IL6 
no coelho-bosquímano, género mais próximo do coelho-bravo, mostra que este 
evento aconteceu por convergência, sugerindo alguma relevância funcional. Esta 
hipótese é reforçada pela presença de quatro cisteínas extra na extensão do 
coelho-europeu que, de acordo com as nossas previsões de modelação, alteram 
significativamente a estrutura da IL6. 
As populações naturais de coelho-bravo têm sido afetadas por duas 
doenças virais, a doença hemorrágica do coelho, causada pelo vírus da doença 
hemorrágica do coelho (VDHC), e a mixomatose causada pelo vírus do mixoma 
(VM). Estudos anteriores com coelhos infetados com VDHC detetaram alterações 
na expressão das interleucinas IL1, IL2, IL6, IL8 e IL10. Alterações na expressão 
da IL4, IL12, IL15 e IL18 foram relacionadas com a infeção pelo vírus do mixoma. 
Neste contexto, caracterizamos estas ILs em seis espécies de lagomorfos: 
coelho-bravo, coelho-pigmeu, coelho-do-chaparral, coelho-da-Flórida, lebre-
europeia e pika-americana. Em geral, estas ILs são conservadas entre os 
lagomorfos. No entanto, para a pika-americana verificámos algumas diferenças, 
nomeadamente na localização do codão stop na IL1α e na IL2, na existência de 
um transcrito diferente na IL8 e num elevado número de cisteínas na IL1β. 
Adicionalmente, foram também detetadas alterações em locais de N-glicosilação 
na IL1, IL10, IL12B e IL15. 
O coelho-bravo e a lebre-europeia são afetados por uma doença 
bacteriana, a tularemia, cujo agente etiológico é a bactéria Francisella tularensis. 
Anteriormente, encontrou-se uma associação entre a IL17A e a defesa do 
hospedeiro contra esta bactéria. O estudo da IL17A em cinco géneros de 
lagomorfos mostrou uma similaridade de 97-99% entre leporídeos e ~88% entre 
os leporídeos e a pika-americana. Em geral, a estrutura da IL17A é muito 
conservada nos lagomorfos. No entanto, no codão 88, um dos locais de interação 
entre a IL17A e o seu recetor IL17RA, existe uma mutação Arg>Pro que só ocorre 
em coelhos e lebres-europeias, as duas espécies infetadas pela F. tularensis. 
Esta mutação pode induzir alterações críticas na estrutura e conformação da 
IL17A e consequentemente modificar a sua função. 
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A conversão génica entre os receptores das quimiocinas CCR5 e CCR2 
descrita para o coelho-bravo, o coelho-de-Amami e o coelho-bosquímano, está 
ausente em Sylvilagus spp. e Lepus spp., o que sugere que este evento 
aconteceu há aproximadamente 9 milhões de anos no ancestral do coelho-bravo, 
coelho-de-Amami e coelho-bosquímano. Posteriormente, estudos realizados nos 
ligandos do CCR5 demonstraram que as quimiocinas CCL3, CCL4 e CCL5 são 
funcionais em leporídeos e evoluíram sob seleção negativa. Curiosamente, a 
evolução do CCL8 tem um padrão consistente com a conversão génica 
observada para o CCR5. O CCL8 é um pseudogene nas espécies em que a 
conversão génica CCR5-CCR2 ocorreu, sendo funcional em espécies em que 
este evento não se verificou. Esta relação de causa-efeito levou ao estudo dos 
restantes ligandos do CCR5, nomeadamente o CCL11, o CCL14 e o CCL16. 
Todos os lagomorfos têm um CCL11 potencialmente funcional. Contudo, o 
coelho-pigmeu tem uma mutação no codão stop codificando uma proteína mais 
longa. Através de abordagens de máxima verosimilhança, foram detetadas 
assinaturas de seleção negativa e de seleção positiva. A seleção negativa foi 
detetada em locais importantes para a ligação e ativação dos recetores e pode 
resultar das restrições funcionais da proteína. A seleção positiva, ao resultar num 
aumento da frequência de mutações vantajosas para a proteína, poderá estar 
associada com uma melhoria da resposta do hospedeiro contra vários agentes. 
Os leporídeos têm um CCL14 funcional, enquanto em algumas espécies de 
pika este gene é um pseudogene. De facto, para a pika-americana, pika-alpina, 
pika-de-pallas e pika-de-turuchan, o CCL14 é um pseudogene devido a uma 
mutação Met>Thr no codão de iniciação. A pika-do-Norte apresenta dois alelos 
(um funcional e um pseudogene) e na pika-da-estepe o CCL14 é um pseudogene 
devido a uma inserção de 7 pares de bases. Adicionalmente, a análise das 
sequências de CCL14 de vários mamíferos revelou seis codões sob seleção 
positiva em regiões cruciais para a ativação do CCL14 e a ligação a recetores. 
Isto sugere que o CCL14 tem um importante papel biológico nos mamíferos que 
se perdeu na família Ochotonidae, nomeadamente nos subgéneros Pika e 
Lagotona. 
O gene CCL16 foi identificado como pseudogene no coelho-bravo e em 
alguns roedores como rato, ratinho e porquinho-da-Índia, enquanto no esquilo 
parece ser funcional. Para clarificar a evolução deste gene na superordem Glires, 
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composta por roedores e lagomorfos, foram sequenciados seis géneros de 
leporídeos e nove espécies de pikas. Adicionalmente, recuperamos as 
sequências de CCL16 de roedores disponíveis em bases de dados públicas. Os 
resultados da análises dessas sequências sugerem que na superordem Glires o 
CCL16 sofreu vários eventos independentes de pseudogenização. Nos 
lagomorfos, em todos os leporídeos, com a exceção dos Sylvilagus spp., o CCL16 
é um pseudogene devido a uma mutação não-sinónima no codão 45, o que 
conduz a um codão stop prematuro. Isto sugere que o gene sofreu a 
pseudogenização no ancestral dos leporídeos há cerca de 14 milhões de anos. 
Curiosamente, no coelho-mexicano, no coelho-brasileiro e no coelho-da-Flórida, o 
CCL16 não possui esta mutação. Nestas espécies, a cisteína 45 também sofreu 
uma mutação, codificando uma lisina. Apesar de codificar uma proteína 
putativamente funcional, o CCL16 não é expresso no coelho-da-Flórida. A 
alteração de uma das cisteínas características do CCL16 para uma lisina pode ter 
levado à perda de função da proteína. Em todas as espécies de pika, com a 
exceção de um alelo da pika-de-pallas, o CCL16 está intacto, sendo expresso na 
pika-americana. Nos roedores, em alguns membros das famílias Muridae (rato e 
ratinho), Heteromyidae (rato-canguru) e Caviidae (porquinho-da-Índia) o CCL16 é 
um pseudogene, enquanto em membros das famílias Sciuridae (esquilo de treze 
linhas e a marmota), Cricetidae (hamster chinês e dourado), Dipodidae (gerbo), 
Bathyergidae (rato-toupeira-nu e o rato-toupeira-de-damaraland), Chinchilloidea 
(chinchila) e Octodontidae (degu), o CCL16 está intacto. Isso pode indicar que, 
embora o CCL16 esteja presente e seja funcional no ancestral dos Glires, este foi 
posteriormente inativado em algumas espécies. Isto pode ter ocorrido 
estocasticamente ou em linhagens específicas em momentos diferentes durante a 
evolução do CCL16. 
Estes trabalhos são os primeiros estudos centrados na caracterização 
genómica e na diversidade genética de genes do sistema imunitário inato 
(interleucinas e ligandos de quimiocinas) na ordem Lagomorfa. Além disso, os 
resultados obtidos levantam novas questões que poderão conduzir a novos 
estudos para a compreensão das funções destas proteínas. Assim, os trabalhos 
futuros deverão ser direcionados para o estudo da função e determinação da 
estrutura cristalográfica, de forma a compreender o impacto das mutações 
detetadas nestas proteínas. 
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SUMMARY 
Cytokines are innate immune modulators involved in several processes of 
the immune response that diversify and quickly adapt to alterations in normal 
conditions. Knowledge on interleukins and chemokine ligands in lagomorphs was 
mostly restricted to the European rabbit. To fill in this gap we characterize the 
genomic organization, genetic diversity and evolution of interleukins and 
chemokine ligands with biological relevance in lagomorphs. Indeed, we analyzed 
these genes for several Lagomorphs belonging to the Ochotonidae and Leporidae 
families. 
In order to understand the changes associated with the evolutionary 
patterns of these genes in lagomorphs, the sequences obtained in this work were 
compared with sequences available for other mammals. The search of signatures 
of positive selection by using maximum-likelihood (ML) methods in 46 mammalian 
ILs revealed that 60% of these makers have codons under positive selection. The 
number and percentage of codons positively selected varied between the ILs. 
Given the relevance of these proteins in the early activation of the immune 
response, we expected that their structure and function would be maintained along 
evolutionary lineages and thus, signatures of purifying selection would be 
detected. However, our results contradict this prediction, which may be explained 
by the multitude of biological processes in which ILs are enrolled. 
From the ILs studied in this work, IL6 showed a unique evolutionary pattern. 
The IL6 from the European rabbit had been previously shown to differ from other 
mammals, including two other leporids (Sylvilagus spp. and Lepus spp.) that 
diverged ~12 million years ago, by extending for 27 additional amino acids. We 
further studied this protein for more four leporids (pygmy rabbit, riverine rabbit, 
Amami rabbit and volcano rabbit) and also in the American pika. Remarkably, in 
the Amami rabbit we detected a deletion of the stop codon causing an extension of 
IL6 for 17 extra amino acids. Our results indicate that this extension occurred 
independently in these species. Indeed, one occurred between 2 and 8 million 
years ago in the ancestor of the European rabbit, and the other occurred in the 
ancestor of the Amami rabbit less than 9 million years ago. The absence of this 
extension in Bunolagus, a sister genus of Oryctolagus, indicates evolution by 
convergence, suggesting some functional relevance. This is reinforced by the 
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presence of four extra cysteines in the European rabbit extension that, according 
to our modelling predictions, significantly alter the IL6 structure. 
The European rabbit populations have been affected by two viral diseases, 
the rabbit hemorrhagic disease caused by the rabbit hemorrhagic disease virus 
(RHDV), and myxomatosis caused by the myxoma virus (MYXV). Previous studies 
on RHDV-infected rabbits identified alterations in the expression of IL1, IL2, IL6, 
IL8 and IL10. IL4, IL12, IL15 and IL18 expression was also altered following 
myxoma virus infection. We characterized these ILs in six Lagomorpha species 
(European rabbit, pygmy rabbit, two cottontail rabbit species, European brown 
hare and American pika). Overall, these ILs are conserved between lagomorphs. 
However, for the American pika, an altered location of the stop codon in IL1α and 
IL2, a different transcript in IL8 and a high number of cysteine residues in IL1β 
were observed. Additionally, changes at N-glycosylation motifs were also detected 
in IL1, IL10, IL12B and IL15. 
The European rabbit and Lepus spp. are affected by a tularemia, a disease 
whose etiological agent is the bacteria Francisella tularensis. IL17A had been 
implicated in the host defense against this pathogen. The study of IL17A in five 
lagomorphs showed a similarity between 97–99% in leporids and ∼88% between 
leporids and American pika. Overall, the IL17A structure is very well conserved. 
However, at codon 88, one of the interaction sites between IL17A and its receptor 
IL17RA, there is an Arg>Pro mutation that only occurs in the European rabbit and 
in the European brown hare. Interestingly, these two species are infected by F. 
tularensis. This mutation may induce critical alterations in the IL17A structure and 
conformation and consequently modify its function. 
A CCR5-CCR2 gene conversion was observed in the European rabbit, 
Amami rabbit and riverine rabbit, but it was not detected in cottontails or Lepus 
spp., suggesting that this event occurred at approximately 9 million years ago in 
the ancestor of the European, Amami and riverine rabbits. Further studies on 
CCR5 ligands demonstrated that CCL3, CCL4 and CCL5 are functional in leporids 
and evolved under purifying selection. Interestingly, the evolution of CCL8 in 
lagomorphs is consistent with the gene conversion event observed. Indeed, CCL8 
is pseudogenized in species with the CCR5-CCR2 gene conversion while it is 
functional in species without this gene conversion. This prompted us to study the 
remaining CCR5 ligands, CCL11, CCL14 and CCL16. All lagomorphs have a 
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potentially functional CCL11. However, the pygmy rabbit has a mutation in the 
stop codon leading to a longer protein. By using maximum likelihood approaches, 
we detected both signatures of purifying and positive selection. While purifying 
selection is detected in sites important for receptor binding and activation and may 
result from the proteins’ functional constraints, positive selection might result from 
an increase in frequency of advantageous mutations that probably enhance the 
host response against several agents. 
CCL14 seems to be functional in leporids while in some Ochotona species it 
is a pseudogene. Indeed, the CCL14 of American, alpine, palla’s and turuchan 
pikas is a pseudogene due to a Met>Thr mutation at the start codon, while 
Northern pika presents one functional and one non-functional allelle and steppe 
pika is pseudogenized due to an insertion of 7 base pairs. Analysis of the CCL14 
sequences of several mammals reveals six codons under positive selection in 
regions crucial for CCL14 activation and binding to receptors. This suggests that 
CCL14 has an important biological role in mammals that was lost in the 
Ochotonidae family, namely in Pika and Lagotona subgenera. 
CCL16 gene was previously identified as a pseudogene in the European 
rabbit and in some rodents, such as mouse, rat and guinea pig, while in the 
squirrel it seems to be functional. To elucidate the evolution of this gene in the 
superorder Glires (Rodents and Lagomorphs), we sequenced six leporids and nine 
species of Ochotona. Additionally we retrieved all the CCL16 sequences of 
rodents available in public databases. Our results suggest that in this superorder 
CCL16 suffered several independent pseudogenization events. In the order 
Lagomorpha, all Leporid species, with the exception of cottontails (Sylvilagus 
spp.), showed that pseudogenization is due to a non-synonymous mutation at 
codon 45 that leads to a premature stop codon. This suggests that the gene 
became pseudogenized in the Leporids ancestor at around 14 million years ago. 
Interestingly, the cottontail rabbits (Mexican, forest and Eastern cottontail) do not 
present this mutation. In cottontails, the Cys45 from the typical Cys-Cys motif also 
suffered a mutation and encodes a Lysine. Despite encoding a putatively 
functional protein, CCL16 is not expressed in the Eastern cottontail. The exchange 
of one of the CCL16 characteristic Cysteines for a Lysine may have caused the 
loss of the protein function. In all species of Pika, except for one allele of 
Hoffmann’s pika, CCL16 is intact, and is expressed in the American Pika. In 
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Rodentia, some members of the Muridae (mouse and rat), Heteromyidae 
(kangoroo rat) and Cavioidea (guinea pig) have a pseudogenized CCL16 gene 
while in members of the Sciuroidea (thirteen lined ground squirrel and alpine 
marmot), Cricetidae (Chinese and golden hamsters), Dipodidae (lesser Egyptian 
jerboa), Bathyergidae (naked mole-rat and damaraland mole-rat), Chinchilloidea 
(long tailed chinchilla), and Octodontoidea (degu), CCL16 is intact. This may 
indicate that although CCL16 is present and functional in the ancestor of the Glires 
clade, it was later inactivated in some species. This may have occurred 
stochastically at different moments in the CCL16 evolution. 
This work is the first study on the genomic characterization and genetic 
diversity of innate immune system genes (Interleukins and Chemokine ligands) in 
the order Lagomorpha. The results obtained raise new questions and may lead to 
a set of future studies that could help to fully understand these proteins’ functions. 
Thus, future works should rely on functional and crystallographic studies to fully 
understand the impact of the mutations detected in these proteins.  
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1.  THE LAGOMORPHA ORDER 
1.1. Phylogeny 
Lagomorphs were first classified as rodents (Duplicidentata) (Vaughan et 
al., 2011). The order Lagomorpha was only proposed in 1912 by Gidley (Gidley, 
1912) in order to distinguish lagomorphs from rodents. Nowadays, and despite 
some controversy, lagomorphs and rodents are clustered in the Glires clade 
(Douzery and Huchon, 2004). The order Lagomorpha includes rabbits, hares and 
pikas, which are adapted to a wide range of environments, from deserts to the 
artic (Chapman and Flux, 2008). Comprising a total of 91 living species, the order 
Lagomorpha has two families, Ochotonidae and Leporidae that diverged 
approximately 30 million years ago (Fontanesi et al., 2016; Lopez-Martinez, 2008; 
Matthee et al., 2004). With a common origin in Asia and the first fossils dating from 
the early Eocene, these families became differentiated in their routes and sizes, 
probably due to climatic changes (Ge et al., 2013; Lopez-Martinez, 2008).  
 
1.1.1. The Ochotonidae family 
The Ochotonidae family includes a single genus (Ochotona) divided in four 
subgenera (Pika, Ochotona, Conothoa and Lagotona) (Figure 1.1) (Lissovsky, 
2014). The radiation of these subgenera occurred at approximately 7 million years 
ago (Melo-Ferreira et al., 2015). The first records of pikas date back to the 
Eocene, in Asia, spreading to Europe and North America during the Oligocene 
(Lopez-Martinez, 2008). Pikas are small-sized (70-300 grams) with short round 
ears and concealed tail and tend to vocalize (Chapman et al., 1990). Currently, 
there are 30 living species, well-adapted to extreme climates, being found mostly 
in alpine or meadow environments, such as in high mountains of North America 
and Asia (Chapman and Flux, 2008; Fontanesi et al., 2016; Fostowicz-Frelik et al., 
2010; Lissovsky, 2014; Melo-Ferreira et al., 2015; Smith, 2008; Vaughan et al., 
2011). In the past few years, many pika subspecies have been considered 
threatened and some have already became extinct (Fontanesi et al., 2016; Smith, 
2008). 
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Figure 1. 1. Evolutionary relationships within the Ochotonidae family. The divergence time (in million years) is 
given for each node (phylogeny based on data from Melo-Ferreira et al. 2015). 
 
1.1.2. The Leporidae family 
The Leporidae family includes rabbits and hares in a total of 11 genera (Poelagus, 
Pronolagus, Nesolagus, Oryctolagus, Bunolagus, Caprolagus, Pentalagus, Brachylagus, 
Sylvilagus, Lepus and Romerolagus) with 61 extant species (29 species of rabbits and 32 
species of hares) widely distributed (Figure 1.2). From these, seven genera are 
monotypic: Poelagus (Bunyoro rabbit), Oryctolagus (European rabbit), Bunolagus (riverine 
rabbit), Caprolagus (hispid hare), Pentalagus (Amami rabbit), Brachylagus (pygmy rabbit) 
and Romerolagus (volcano rabbit) (Alves and Hacklander, 2008; Fontanesi et al., 2016). 
Despite some species being referred as hares, e.g. the hispid hare, only one genus 
represents the true hares (Lepus), with the remaining genera corresponding to true 
rabbits. Morphologically, leporids present larger body size (1-5 kilograms), with long, large 
and tubular ears, long tails and long hind legs (Chapman and Flux, 2008; Fontanesi et al., 
2016; Vaughan et al., 2011). 
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Figure 1. 2. Evolutionary relationships in the Leporidae family. The divergence time (in million years) is given 
for each node (phylogeny based on data from Matthee et al. 2004). The number of species per genus is 
indicated in brackets. 
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2. IMMUNE SYSTEM 
The immune system uses a broad array of mechanisms in order to 
recognize specific features of foreign organisms that distinguish them from the 
host and to consequently develop an immune response towards their elimination 
(Chaplin, 2010). Innate immunity is the first line of defense and is present in all 
multicellular organisms, while adaptive immunity is characteristic of jawed 
vertebrates. Lagomorphs are affected by several diseases that have distinct 
repercussions according to the species/genera. This is probably due to specific 
differences in genes of the immune system, both innate and adaptive. 
 
2.1. Innate Immunity 
This first line of defense prevents pathogen entry through several physical 
(skin and mucosal surfaces), chemical (pH and soluble factors) and 
microbiological (phagocytic cells) barriers (Figure 1.3). Encoded by genes of the 
host’s germline, innate immunity is able to distinguish between “self” and “non-self” 
antigens (Chaplin, 2010; Thaiss et al., 2016; Turvey and Broide, 2010). When a 
pathogen invades the innate immune system acts immediately through pattern 
recognition receptors (PRRs) that detect conserved pathogen-associated 
molecular patterns (PAMPs) such as pathogen specific lipoproteins and 
carbohydrates. The host is also capable to detect damage-associated molecular 
patterns (DAMPs) released from broken cells, and quickly eliminate them. PRRs 
include the Toll-like receptors (TLRs), peptidoglycan recognition proteins (PGRPs) 
and NOD-like receptors (NLRs), among others (Deng et al., 2013; Thaiss et al., 
2016). The outcome from the activation of these PRRs is an inflammatory 
response through the activation of innate immune cells such as macrophages and 
dendritic cells that produce several types of cytokines and chemokines, crucial to 
regulate the nature of the immune responses (Deng et al., 2013; Kasamatsu, 
2013; Newton and Dixit, 2012; Thaiss et al., 2016). Despite being originally 
defined as unable to develop immunological memory, recent findings showed that 
innate immunity is able to exhibit “trained immunity”, i.e., cells of the innate 
immune system like monocytes and natural killer (NK) cells are able to recognize 
pathogens and protect the host against re-infections. Indeed, this is observed in 
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lower organisms as plants and invertebrates (Netea et al., 2016). In vertebrates, 
this “trained immunity” acts in line with the adaptive immunity (Netea et al., 2016; 
Netea et al., 2011; Sun et al., 2014; van der Meer et al., 2015). 
 
 
Figure 1. 3. Schematic representation of the innate imune response. Adapted from (Fontes et al., 2015). 
 
2.1.1. Cytokines 
  Cytokines are small cell-signaling glycoproteins that include a group of 
chemotactic cytokines also known as chemokines. Cytokines and chemokines are 
secreted by a variety of cells in response to different stimuli and can act in other 
cells affecting their activities in order to define and control the nature of the 
immune responses. These proteins are also important to regulate immune cell 
trafficking and the cellular arrangement of the immune organs (Akdis et al., 2011; 
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Borish and Steinke, 2003; Commins et al., 2010). When these cytokines are 
secreted by leukocytes and act on other leukocytes they are named interleukins 
(ILs) (Beadling and Slifka, 2006; Kaiser et al., 2004; Schrader, 2003). 
Interleukins are proteins of low molecular weight that participate in several 
different biological activities, such as immunity, inflammation, hematopoiesis, 
oncogenesis, neurogenesis, fertility, etc (Afzal et al., 2012; Heinrich et al., 2003; 
Ishihara and Hirano, 2002). Despite being molecules of the innate immune 
system, they may influence the result and nature of the adaptive immune 
response, being crucial for growth, differentiation and survival of immune cells 
(Brocker et al., 2010; Kaiser et al., 2004; O'Connell and McInerney, 2005; Zelus et 
al., 2000; Zhang and Nei, 2000). In order to exert their functions, interlukins bind to 
specific cell-surface receptors that are able to transmit an intracellular signal 
through different signaling pathways (Afzal et al., 2012; Fumagalli et al., 2009; 
Ishihara and Hirano, 2002; O'Connell and McInerney, 2005). Currently, there are 
38 interleukins known in the human genome, which are classified according to 
their numeric order of discovery (IL1-IL38). In other mammals this number varies 
between species. 
IL1 is mainly produced by mononuclear phagocytes and is a strong 
proinflammatory cytokine and an endogenous pyrogen. It includes two proteins 
(IL1α and IL1β) with similar biological activities. With an essential role in T helper 
17 (Th17) cells differentiation, it is also a major mediator of inflammation, 
contributing to an increase of B cells proliferation and immunoglobulin (Ig) 
synthesis (Garlanda et al., 2013; Sims and Smith, 2010). IL1 may also be 
important for viral clearance through interferon alpha (IFNα) production (Zhu and 
Liu, 2003). 
 IL2, also known as T cell growth factor, is produced by CD4 T cells and has 
a central role in T cell dependent immune responses. This pleiotropic cytokine is a 
potent pyrogen with a key role in CD4 and CD8 differentiation and T regulatory 
(Treg) cells maintenance (Boyman and Sprent, 2012; Liao et al., 2013; Malek, 
2008). 
IL3 is a Th2 cytokine mainly produced by T lymphocytes, essential for 
eosinophil development and survival, being associated with allergic inflammation 
(Borish and Steinke, 2003; Commins et al., 2010; Tomaki et al., 2002). 
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IL4 is also a Th2 cytokine secreted by several cells such as Th2, NK, mast 
cells, eosinophils and basophils, being important for the immune response against 
parasitic worms. This anti-inflammatory cytokine is also able to inhibit 
proinflammatory cytokine production, being associated with allergy, asthma and 
autoimmunity (Koyanagi et al., 2010; Luzina et al., 2012; Paul, 2015; Pillai and Bix, 
2011). 
IL5 is a Th2 cytokine derived from T lymphocytes with major roles in allergic 
inflammation through eosinophil production, maturation, recruitment, 
differentiation, survival and activation (Borish and Steinke, 2003; Levine and 
Wenzel, 2010; Patterson et al., 2015). 
IL6, also known as B cell differentiation factor is produced after stimulation 
of several different cells, mainly mononuclear phagocytes. With a large array of 
biological activities in humoral and cellular defense, it is responsible for the 
initiation of acute-phase response in hepatocytes, favoring Th1, Th2 and Th17 
differentiation and suppressing Treg responses (Neurath and Finotto, 2011; 
Nishimoto and Kishimoto, 2006; Scheller et al., 2011). 
IL7, also named lymphopoietin-1, is important for B lymphocyte maturation 
in bone marrow and for proliferation, differentiation and survival of B and T 
lymphocytes (Akdis et al., 2011; Fry and Mackall, 2002, 2005). 
IL8, also called C-X-C chemokine ligand 8 (CXCL8), is a potent 
chemoattractant of neutrophils and T cells being associated with several chronic 
inflammatory conditions (Akdis et al., 2011; Harada et al., 1994; Qazi et al., 2011). 
IL9 is produced by T cells and is an important stimulator of mast cells. This 
Th9 cytokine is essential for immunity and inflammation development and acts as 
both positive and negative regulator of immune responses, with unfavorable 
functions in allergy and autoimmunity and beneficial roles in parasitic infections 
(Goswami and Kaplan, 2011; Kaplan et al., 2015; Noelle and Nowak, 2010). 
IL10 is a central player in the inflammatory response, protecting the host 
from excessive immune responses to microbial infections and in autoimmune 
diseases. This anti-inflammatory protein is able to inhibit the production and 
expression of several important cytokines, chemokines and receptors. IL10 has 
been shown to be important for the control of inflammatory reactions in viral 
infections (Couper et al., 2008; Sabat et al., 2010; Saraiva and O'Garra, 2010). 
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IL11, initially described as a stimulator factor for hematopoietic cells, plays a 
significant regulatory role in immunoglobulin and acute phase proteins production 
and also in lymphoid cell differentiation (Akdis et al., 2011; Curfs et al., 1997; Du 
and Williams, 1997). 
 IL12 and IL23 are heterodimers mostly produced by dendritic cells (DC) that 
share a common subunit (IL12p40). Both immunoregulatory proteins are important 
in T cell activation and influence the Th1 and Th17 responses, respectively (Akdis 
et al., 2011; Langrish et al., 2004; Teng et al., 2015; Watford et al., 2004). Along 
with IL18, IL12 induces IFNγ, and both present synergistic effects in the 
development of Th1 cells and antiviral activity. Furthermore, IL18 is important in 
the innate response against pathogens, establishing a link between the innate and 
the adaptive immune systems (Arend et al., 2008; Gasteiger and Rudensky, 2014; 
Hamza et al., 2010). 
IL13 is mainly produced by Th2 CD4 cells and shares with IL4 all its 
functions and 25% of homology. In addition, IL13 is important for mucus secretion 
(Bao and Reinhardt, 2015; Gordon, 2003; Wills-Karp, 2004; Zhu, 2015). 
Also known as alpha taxilin, IL14 is derived from normal T and B cells, 
inhibits Ig secretion of activated B cells and controls growth and proliferation of 
normal and abnormal B cells (Akdis et al., 2011; Shen et al., 2006). 
IL15 is a T cell growth factor with important roles in defense against 
microorganisms and tumors. Produced by mononuclear phagocytes, this 
proinflammatory protein is crucial for the development, survival and differentiation 
of, for example, CD8 memory T cells, NK cells and Th2 cells (Akdis et al., 2011; 
Commins et al., 2010; Fehniger and Caligiuri, 2001; Stonier and Schluns, 2010). 
 IL16, also known as lymphocyte chemoattractant factor, is a 
proinflammatory cytokine secreted as a precursor (pro-IL16) that needs cleavage 
to acquire its mature form. Both forms are biological active, but with different 
functions. While pro-IL16 is a regulator of the cell cycle progression, the mature 
form is a chemoattractant and growth/differentiation factor for several 
hematopoietic cells (Commins et al., 2010; Cruikshank and Little, 2008; Richmond 
et al., 2014; Wilson et al., 2004). Studies on human IL16 revealed that its 
expression is associated with apoptosis, autoimmune and allergic diseases 
(Bowler et al., 2013; Elssner et al., 2004). 
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 Mainly produced by Th17 cells, the IL17 family comprises six different 
structurally related proteins, IL17A-F, with IL17E renamed IL25 due to its specific 
functions. With distinct cellular sources, they are important regulators in host 
defense and inflammatory diseases with the ability to induce proinflammatory 
cytokines. IL17, also known as IL17A, is associated with progression of allergic 
and autoimmune diseases and with defense against external pathogens such as 
bacteria and fungi (Iwakura et al., 2011; Jin and Dong, 2013; Onishi and Gaffen, 
2010; Witowski et al., 2004). 
IL19 can be produced by both tissue and immune cells, being associated 
with antimicrobial immunity and tissue repair (Akdis et al., 2011; Fielding, 2012; 
Sabat, 2010). 
IL20 shares with IL19 many of its sources and functions. Furthermore, it 
regulates keratinocyte functions, and contributes to the formation of lymphatic 
vessels (Akdis et al., 2011; Rutz et al., 2014). 
IL21 is produced by CD4 cells and plays a role in Ig production, in T and NK 
cells stimulation, being also important for B cells proliferation, survival and 
differentiation. In addition, it has a crucial role on inflammatory responses 
associated with autoimmune and inflammatory diseases, assisting innate and 
adaptive responses regulation (Croce et al., 2015; Spolski and Leonard, 2008, 
2014). 
Produced by cells of the innate and adaptive immune systems, IL22 has 
both tissue protection and proinflammatory functions. Moreover, it is also essential 
for induction of acute-phase proteins by hepatocytes and protection against 
extracellular pathogens, participating in intestinal homeostasis and the regulation 
of commensal communities (Dudakov et al., 2015; Rutz et al., 2014). 
IL24 is a proinflammatory cytokine produced by different immune cells and 
is a strong and specific inhibitor of cancer cell proliferation (Akdis et al., 2011; 
Sabat, 2010). 
IL25, also known as IL17E, is a member of the IL17 family, associated with 
initiation, promotion and increase of Th2 cell-mediated immune response, mainly 
in helminthic infections and allergic inflammation (Iwakura et al., 2011; Jin and 
Dong, 2013; Monteleone et al., 2010). 
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IL26 is a Th17 cytokine important for elimination of extracellular bacteria 
and may also play a role in antiviral defense and inflammation (Donnelly et al., 
2010; Tengvall et al., 2016). 
IL27 is a heterodimeric cytokine composed by two subunits (IL27p28 – also 
known as IL30; and Epstein-Barr virus induced gene 3 - Ebi3) with important roles 
in development of NK and T cells and Th1 immunity. This immunosuppressive 
cytokine also promotes IFN-γ production and is an antagonist of different 
inflammatory cells with inhibitory effects on Th2 and Th17 responses (Hunter and 
Kastelein, 2012; Iwasaki et al., 2015; Yoshida and Hunter, 2015). 
IL31 is predominantly produced by Th2 cells and is associated with 
proliferation of B and T cells. This protein is relevant for innate and adaptive 
immunity, being involved mostly in skin and allergic disorders (Castellani et al., 
2010; Cornelissen et al., 2012; Zhang et al., 2008). 
 IL32, initially named NK cell transcript 4, is mainly found in NK and T cells. 
This proinflammatory protein has six variants (α, β, γ, δ, ε, ζ) and is important for 
the induction of other proinflammatory proteins. It has also been associated with 
infection, chronic inflammation and cancer (Dinarello and Kim, 2006; Heinhuis et 
al., 2012; Joosten et al., 2013; Kundu and Basu, 2006; Zhou and Zhu, 2015). 
IL33 is an inducer of several chemokines and cytokines of the innate and 
adaptive immune systems and also of the Th2 response. Mostly expressed by 
cells with direct contact with the environment, it acts in the early inflammatory 
response, playing a role in cell activation, differentiation, polarization and 
chemotaxis (Martin and Martin, 2016; Miller, 2011; Palmer and Gabay, 2011). 
 IL34 increases monocyte viability and promotes macrophage colony 
formation from bone marrow cells, being expressed in a large number of tissues 
(Akdis et al., 2011; Commins et al., 2010; Masteller and Wong, 2014). 
IL35 is a heterodimer composed by two subunits (IL12p35 and Ebi3) with 
immunosuppressive functions, mostly produced by Treg cells (Egwuagu et al., 
2015; Olson et al., 2013; Sawant et al., 2015). 
 IL36 includes three agonistic cytokines: IL36α (IL1F6), IL36β (IL1F8) and 
IL36γ (IL1F9). Despite being expressed and activated by different cells, they share 
the same activities, being important for stimulation of both innate and adaptive 
immune responses (Gabay and Towne, 2015; Gresnigt and van de Veerdonk, 
2013). 
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IL37, also known as IL1F7, is a suppressor of innate immune responses 
inhibiting the production of proinflammatory cytokines (Banchereau et al., 2012; 
Garlanda et al., 2013). 
Firstly identified as IL1F10, IL38 is considered a negative regulator with 
activities in human inflammation and autoimmunity (Garlanda et al., 2013; Yuan et 
al., 2015). 
Interferons (IFNs) are inducible cytokines that are able to protect cells from 
viral infections and may also regulate other processes of the immune response. 
There are three major classes of IFNs (type I, II and III). Type I IFN includes IFNα, 
β, ε, τ, κ, ω, δ and ζ, while type II and type III only include one protein, IFNγ and 
IFNλ, respectively. Type I IFNs are expressed in several different tissues with 
antiviral, antiproliferative and immunomodulatory effects. IFNγ is widely 
expressed, with important roles in regulation of the immune response, linking both 
innate and adaptive responses. Type III IFN includes IFNλ1 (IL29), IFNλ2 (IL28A), 
IFNλ3 (IL28B) and IFNλ4 and has antiviral activity (Ivashkiv and Donlin, 2014; 
McNab et al., 2015; Schneider et al., 2014). 
Tumor necrosis factor (TNF) is a superfamily of cytokines with several 
functions in antimicrobial immunity. TNFα, the most well known member of this 
superfamily, is expressed by monocytes and T cells and is important for tumor 
growth control being a strong mediator of inflammation (Sedger and McDermott, 
2014). 
 
 The European rabbit interleukins 
From the proteins described above, only 32 are described for the European 
rabbit (Table 1.1). Some of these interleukins have been associated with rabbit 
immunity, namely in microbial infections and viral diseases such as rabbit 
hemorrhagic disease (RHD) and myxomatosis. The IL17 and IL22 are highly up-
regulated in rabbit microbial infections (Schnupf and Sansonetti, 2012; Skyberg et 
al., 2013). In rabbit hemorrhagic disease virus (RHDV)-infected rabbits, different 
patterns of proinflammatory and anti-inflammatory proteins were observed at 
different time points post-infection and in different cells. The major differences 
were observed in IL1, IL2, IL6, IL8, IL10, TNFα and IFNα (Garcia-Lastra et al., 
2010; Marques et al., 2012; Marques et al., 2014; Trzeciak-Ryczek et al., 2016; 
Tunon et al., 2011b). 
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Regarding myxoma virus infections, it has been shown that: IL4 enhances 
virus efficiency and virulence by inhibiting host viral clearance and decreasing 
genetic resistance (Kerr et al., 2004; Stanford and McFadden, 2005); IL12 may be 
useful as oncolytic virus, counteracting the myxoma virus infection in rabbits 
(Stanford et al., 2007); IL15 was able to stimulate the immune response leading to 
the elimination of the infection (Liu et al., 2009; Tosic et al., 2014); and IL18 was 
indirectly affected by poxviruses due to their ability to inhibit proteins important for 
IL18 activation (Johnston and McFadden, 2004; Vande Walle and Lamkanfi, 
2011). 
Furthermore, IL2 was associated with rabbit inflammatory processes 
(Perkins et al., 2000) while IL16 down-regulation leads to T cell activation and 
proliferation (Jacquier et al., 2015). Two transcripts have been described for rabbit 
IL7, one presents similar functions to human IL7, while the other has an opposite 
function being able to inhibit B lymphopoiesis (Siewe et al., 2010). 
The list of functions described above is not exhaustive, as these proteins 
may have other roles. Indeed, they can have different functions depending on 
several factors such as target cells, cells where they are expressed, site of 
infection, pathogen, disease, etc. Moreover, many of these cytokines present 
complementary and conflicting roles in induction, regulation and function of the 
immune system and they can interact between themselves in order to obtain an 
optimal immune response. 
 
2.1.2. Chemokines 
Chemokines are cytokines capable to induce chemotaxis. Produced upon 
stimulation, these proteins only exert their roles by binding to specific 
transmembrane G protein-coupled receptors or extracellular matrix-associated 
glycosaminoglycans (Bryant and Slade, 2015). Biological roles associated with 
these proteins include coordination of leucocyte recruitment and trafficking, 
mediation of homeostatic migration and homing of several cells, mediation in 
vascular injury, antimicrobial activities, among others (Zlotnik and Yoshie, 2012). 
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Currently, there are approximately 46 chemokines described that according 
to their N-terminus cysteine residues are classified into CC, CXC, CX3C, XC and 
CX (Bryant and Slade, 2015; Nomiyama et al., 2013). C-C chemokines present 
two adjacent cysteines, include 28 ligands and the encoding genes are located in 
different regions of genome. Indeed, C-C chemokine ligand 1 (CCL1), CCL2, 
CCL7, CCL8 and CCL11-CCL13 are located in the monocyte chemoattractant 
protein (MCP) region, while CCL3-CCL6, CCL9/CCL10, CCL14-CCL17 and 
CCL23 are located in the macrophage inflammatory protein (MIP) region (Figure 
1.4). The remaining ligands (CCL18-CCL22 and CCL24-CCL28) are scattered 
throughout the genome (Nomiyama et al., 2013; Shibata et al., 2013; Zlotnik and 
Yoshie, 2012). CXC ligands have one amino acid between the cysteine residues 
and are encoded by 17 genes clustered in different regions (Nomiyama et al., 
2013; Shibata et al., 2013; Zlotnik and Yoshie, 2012). CXCL1-CXCL8 are located 
in the growth related oncogene (GRO) region while CXCL9-CXCL11 and CXCL13 
are found in the IFNγ-inducible protein 10 (IP10) region (Nomiyama et al., 2013; 
Shibata et al., 2013; Zlotnik and Yoshie, 2012). The CX3C family presents three 
residues between the first and the second cysteines and is composed by only one 
ligand (CX3CL1), also known as fractalkine (Nomiyama et al., 2013; Shibata et al., 
2013; Zlotnik and Yoshie, 2012). In turn, in the XC subfamily the first and third 
cysteines are absent and it is composed by two ligands (XCL1 and XCL2) 
(Nomiyama et al., 2013; Shibata et al., 2013; Zlotnik and Yoshie, 2012). The last 
group of chemokines (CX) was recently described in zebrafish and includes only 
one ligand (CXL1) (Nomiyama et al., 2008). The number of chemokines varies 
between species: mouse – 46; human – 44 and rabbit – 35 (Shibata et al., 2013). 
Chemokines belong to a multigene family with high diversity and 
promiscuity (Nomiyama et al., 2013). Besides their important roles in immunity and 
pathogen entry, the study of chemokines gained notoriety when chemokine 
receptors CCR5 and CXCR4 were described as co-receptors for human 
immunodeficiency virus (HIV) (Wilen et al., 2012). The interaction between these 
receptors and their ligands prevents HIV-1 entry into host cells (Munch et al., 
2014). As for other mammals, in some leporid species CCR5 presents a gene 
conversion event with CCR2, at the second extracellular loop (Abrantes et al., 
2011; Carmo et al., 2006; Esteves et al., 2007; Perelygin et al., 2008; Vazquez-
Salat et al., 2007). Indeed, this gene conversion is present in the European, 
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riverine and Amami rabbits but not in the European brown hare (Lepus europaeus) 
or in the eastern cottontail (Sylvilagus floridanus) (Abrantes et al., 2011; Carmo et 
al., 2006), suggesting that the CCR5/CCR2 gene conversion occurred in the 
ancestor of the European, riverine and Amami rabbits, approximately 9 million 
years ago. CCR5 ligands include CCL3, CCL4, CCL5, CCL8, CCL11, CCL14 and 
CCL16 (Zlotnik and Yoshie, 2012). CCL3, CCL4 and CCL5 are functional genes in 
lagomorphs and present sites with signatures of purifying selection in regions 
important for receptor binding (de Matos et al., 2014). In mouse, rat and rabbit 
there is only one copy of CCL3 and CCL4, but in other rodents such as squirrel 
and guinea pig, as well as in humans, there are more (functional or inactivated) 
copies of these genes (Shibata et al., 2013; Zlotnik et al., 2006). In turn, CCL8 is 
pseudogenized in the European, Amami and riverine rabbits, whilst intact in hares 
and eastern cottontail (van der Loo et al., 2012; van der Loo et al., 2016). CXCR4 
has only one ligand (CXCL2) (Zlotnik and Yoshie, 2012) and presents low genetic 
diversity. Indeed, only two amino acid mutations had been described in the 
European rabbit (Abrantes et al., 2008). 
 
 
 
Figure 1. 4. Genomic organization of the C-C chemokine major cluster. The maps shown are adapted from 
Shibata et al, 2013. 
 
2.2. Host-pathogen co-evolution 
The main function of the immune system is to ensure host integrity in face 
of invading pathogens. Although there are several types of invaders, they all tend 
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to diminish host fitness (Muraille, 2013). The pathogen depends on the host to 
survive and consequently the host recognizes the pathogen antigens and 
develops an immune response to eliminate it. This leads to the development of 
new mechanisms by the pathogen in order to maintain this interaction with the 
host and to promote its own survival. In addition, advantageous mutations present 
in the host and pathogen populations that make them more able to survive and 
breed are likely to be selected and tend to be fixed in the populations. From this 
interaction there are three possible outcomes: i) the pathogen overcomes the host 
immune system leading to disease or death; ii) the host is able to develop new 
strategies and eliminate the pathogen; and iii) a cyclical process of adaptation and 
counter-adaptation that benefits some traits through evolutionary selective 
pressures, allowing the equilibrium between the host and the pathogen (Barreiro 
and Quintana-Murci, 2010). In 1973, Van Valen proposed the “Red Queen 
hypothesis” to describe this balance, stating that the species need to evolve 
continuously to keep up with the competition (Van Valen L., 1973). A good 
example of this host-pathogen co-evolution in natural conditions is the system 
myxoma virus and the European rabbit in Australia (Best and Kerr, 2000; Fenner, 
1956). 
The mammalian immune system genes are widely studied and are among 
the genes with faster evolution. Indeed, some of these genes show signatures of 
strong positive selection probably due to a constant need to adapt in this co-
evolution process (Arbiza et al., 2006; Areal et al., 2011; Kosiol et al., 2008; 
O'Connell and McInerney, 2005; Vallender and Lahn, 2004; Zhang and Nei, 2000). 
At the sequence level, this might result in an increase of non-synonymous 
substitutions (dN) over synonymous substitutions (dS). Non-synonymous 
substitutions occur mainly at the first and second positions of the codon and lead 
to amino acid (aa) alteration, while synonymous substitutions involve the third 
position of the codon and do not change the aa. When the ratio (ω) dN/dS is 
significantly higher than 1, we assume that the codon is under positive (adaptive, 
Darwin or diversifying) selection (Kimura, 1977), as the frequency of mutations is 
high and they are rapidly fixed in the population providing a fitness advantage 
(Kelley and Swanson, 2008). 
Genes of the immune system are examples of multigene families, i.e., a 
group of genes that have originated from a common ancestral gene. These genes 
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encode proteins with similar sequences and functions. The “birth and death” model 
is the most accepted model for the evolution of multigene families (Nei and 
Rooney, 2005) and proposes that new genes arise by gene duplication creating 
differentiated family members (Kaessmann, 2010; Ohno, 1970). This mechanism 
is also an evolutionary strategy by giving to the host the flexibility to rapidly evolve 
and adapt to invading pathogens (Duggal and Emerman, 2012). Genes resulting 
from duplication can be maintained in the genome through subfunctionalization 
and neofunctionalization or lost by pseudogenization. Pseudogenization leads to 
non-functional genes as a result of nucleotide mutations that disrupt the coding 
region. When subfunctionalization occurs, the two copies of the gene are 
maintained in the genome and share the ancestral functions. In 
neofunctionalization one copy retains the ancestral function while the other 
acquires new functions (Kaessmann, 2010; Levasseur and Pontarotti, 2011; 
Zhang, 2003). 
 
3. THE EUROPEAN RABBIT 
The European rabbit (Oryctolagus cuniculus – Linnaeus 1758) belongs to 
the Leporidae family of the order Lagomorpha, which along with rodents 
constitutes the Glires clade. It originated in the Iberian Peninsula in the middle 
Pleistocene period (7.8-1.3 Million years ago) (Lopez-Martinez, 2008) and 
nowadays it is spread worldwide. In Australia, the European rabbit is considered a 
pest since it has a severe negative impact in the Australian ecosystems (Cooke, 
2012). In contrast, in the Iberian Peninsula it is considered a keystone species, 
crucial for conservation of highly endangered species (Iberian lynx and the 
Imperial eagle) (Delibes-Mateos et al., 2008; Monterroso et al., 2016). In addition, 
it is also considered a relevant game species and it is important for meat, wool and 
fur production and also for different biotechnological applications.  
The European rabbit natural history, biology and the richly documented past 
of anthropogenic introductions, have made it a good model for several biological 
questions. Indeed, this species has been extensively used to study hybridization 
due to the existence of a narrow contact between two genetically and 
morphologically distinct subspecies, the domestication process and the adaptation 
to colonization of more than 800 islands. The European rabbit is also a good 
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model to understand the co-evolution between host and pathogens with two viral 
diseases affecting the natural populations, the myxomatosis and the rabbit 
hemorrhagic disease. Furthermore, the pioneer studies in basic immunology, 
rabies and syphilis, conducted in rabbits contributed for some of the major 
advances in biomedicine. Although replaced as a model by mouse in the 1980s, 
the European rabbit is still widely used as model in biomedical research. Recently 
it has been shown that the rabbit could be the elected model to study viral 
diseases that affect the humans, like HIV, hepatitis C and viral fulminant hepatic 
failure. 
 
Hybridization model 
The European rabbit is native to the Iberian Peninsula where two 
subspecies exist, O. c. cuniculus and O. c. algirus (Cabrera, 1914). These 
subspecies diverged between 1.8 and 2 million years ago (Branco et al., 2000; 
Carneiro et al., 2009) and while O. c. algirus originated in the southwest of the 
Iberian Peninsula with stony habitats and scrubs, the O. c. cuniculus originated in 
the northeast peninsula with open pasture and burrows for shelters (Biju-Duval et 
al., 1991; Branco et al., 2000; Carneiro et al., 2009). First described by 
Phoenicians during their navigations in the Mediterranean (Ferrand, 2008; 
Suckow, 2012), these subspecies have phenotypic (body size and cranial 
measurements) and genetic differences (Ferrand and Branco, 2007; Ferreira, 
2012; Sharples et al., 1996; Villafuerte, 2002). They evolved allopatrically during 
the Pleistocene glaciation, however after this period, both expanded establishing a 
contact zone, along a northwest-southeast direction in the Iberian Peninsula (Alda 
and Doadrio, 2014; Branco et al., 2000; Branco et al., 2002; Carneiro et al., 2013). 
Furthermore, there is evidence of high rates of gene flow between the two 
subspecies (Carneiro et al., 2009). This hybrid zone constitutes a good model to 
study gene flow between subspecies and evaluate the hybrids fitness, as 
illustrated by the contrasting patterns observed in the mitochondrial DNA, Y 
chromosome and nuclear genes (Branco et al., 2000; Campos et al., 2007; 
Carneiro et al., 2013; Geraldes et al., 2008; Geraldes and Ferrand, 2006; 
Geraldes et al., 2005). 
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Island colonization 
The majority of the European rabbit population expansions were human-
mediated and the first records are associated with the Phoenicians during their 
path through the Mediterranean Sea. In the 13th and 14th centuries navigators 
were responsible for the introduction of the O. cuniculus spp. in several islands. 
The main objective was to obtain a source of meat. During 1300-1400 B.C., 
Portuguese and Spanish settlers released O. c. cuniculus in Balearics (Seixas et 
al., 2014) and in the Tunisian island of Zembra (Hardy et al., 1994). On the other 
hand, the O. c. algirus was introduced during the 15th century in the archipelagos 
of Azores, Madeira and Canary where a strong bottleneck effect is described 
(Ferrand, 2008). The introduction of the European rabbit into Australia is the most 
emblematic and well-documented introduction. Indeed, from a release of 20 
individuals in 1890 in the Southwest of Australia, the absence of predators and 
competitors allowed the establishment and expansion of the European rabbits to 
all Australia. This colonization was so successful that nowadays the European 
rabbit is considered a major pest in Australia. Furthermore, the European rabbit is 
present in more than 800 islands all over the world which points out the success of 
this species in the colonization of new environments (Flux, 1994). The reasons for 
this success are particular features such as high growth and reproduction rate, an 
efficient food utilization (associated with coprophagy, i.e. the capacity to eat the 
faeces to increase nutritional efficiency), and the ability to shift between growth 
strategies ("r" or "K - selection") according to the carrying capacity of the 
environment. Other aspects are also fundamental in its success in islands, like the 
absence of competitors, the existence of few predators and the inexistence of 
diseases. These European rabbit populations could be seen as natural 
populations in nearly "laboratory" conditions, which can be very useful in 
conservational genetics issues, because they represent the ideal situation where 
consequences of an extreme bottleneck event can be studied. Indeed, the study of 
founder effects has become increasingly important in population genetics, 
speciation theory and conservation biology (reviewed in (Pinheiro et al., 2016)).  
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Domestication 
The European rabbit is the only mammal species that has been 
domesticated in Western Europe (Monnerot et al., 1994), the species for which 
wild populations and domestic animals are more closely related (Carneiro et al., 
2011). The first records that describe rabbits in captivity are associated with 
Romans during their occupation of the Iberian Peninsula in the first century BC. 
The main goal was to obtain rabbit meat and fur (Clutton-Brock et al., 1999). The 
true domestication process, however, with taming and selective breeding, is recent 
and was initiated in monasteries on the Champagne region in the northeast of 
France in the 16th century (Carneiro et al., 2014). Currently, there are more than 
45 breeds recognized by the American Rabbit Breeders Association. In addition, 
the European rabbit is also frequently found as a pet animal. 
All domestic rabbit breeds belong to the subspecies O. c. cuniculus 
(Carneiro et al., 2011). The expansion of wild populations belonging to the 
subspecies O. c. cuniculus from Iberia to France across the French Pyrenees 
occurred with a bottleneck that originated a reduction in the genetic diversity of the 
French populations. Then, when the domestication event occurred in France, an 
additional bottleneck affected the gene pool of domesticated European rabbits 
(Abrantes et al., 2013a; Alves et al., 2015; Carneiro et al., 2011; Esteves et al., 
2004; Ferrand and Branco, 2007; Queney et al., 2001; Surridge et al., 2008; van 
der Loo et al., 1999). Indeed, the domestic breeds lost more than 70% of all the 
diversity observed in the Iberian Peninsula and 25% of the diversity observed in 
the wild French rabbit populations (Alves et al., 2015). The recent and 
geographically defined origin, resulting in the close relatedness between wild and 
domestic animals, makes the European rabbit a very good model to study the 
genetic changes that accompanied domestication. Several genetic studies showed 
associations between specific traits in the European rabbit breeds and genetic 
variability. For example, Fontanesi et al., 2006, demonstrated that different alleles 
of the melanocortin 1 receptor (MC1R) gene are associated with different coat 
colors (Fontanesi et al., 2006). Carneiro and co-workers (2014) showed that genes 
affecting brain and neuronal development have often been targeted during 
domestication and the tame behavior evolved by shifts in allele frequencies at 
many loci, rather than by critical changes at only a few domestication loci 
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(Carneiro et al., 2014). Candidate genes underlying heritable differences in 
reproductive seasonality between wild and domestic rabbits have been identified 
(Carneiro et al., 2016) and it was recently shown that Dwarfism and altered 
craniofacial development in the domestic rabbits is caused by a 12.1 kb deletion at 
the HMGA2 locus (Carneiro et al., 2016). 
 
The European rabbit in biomedicine 
The rabbit as a model to study host-pathogen interaction  
In the last 60 years, the Iberian rabbit populations suffered a sharp decline 
due to hunting, habitat destruction and the emergence of two viral diseases, 
myxomatosis in the 1950s and rabbit hemorrhagic disease (RHD) in the 1980s 
(Delibes-Mateos et al., 2009). These diseases led to a contraction of the wild 
rabbit populations with serious ecological and economic consequences for the 
ecosystem. In Australia, where the European rabbit is considered a pest, the 
dynamics observed between the genetic resistance of the European rabbit natural 
populations against myxomatosis and the virulence grades of its causative agent, 
the myxoma virus, is one of the best text-book examples of co-evolution (Kerr, 
2012). Regarding the RHD, caused by the rabbit hemorrhagic disease virus, the 
natural populations suffered a sharp decline in the end of 1980s and then 
recovered until reaching pre-RHDV effective sizes by 2008 (Elsworth and Cooke, 
2008), but in 2011 the emergence of a new variant, genetically and antigenically 
highly distinct from the previous described strains, led to a new contraction of the 
natural populations’ effective size (Abrantes et al., 2013b; Abrantes et al., 2014; 
Dalton et al., 2012; Le Gall-Recule et al., 2011; Lopes et al., 2014). This new 
variant shows frequent recombination and is still highly lethal (Lopes et al., 2015) 
which makes this situation an opportunity to understand how the host and the virus 
will co-evolve. 
 
Myxomatosis 
Myxomatosis is a viral disease caused by the myxoma virus (MYXV) of the 
family Poxviridae. The MYXV is naturally found in Sylvilagus spp., where it causes 
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a benign cutaneous fibroma, however in the European rabbit it proved to be a 
highly fatal pathogen (Fenner and Ratcliffe, 1965; Kerr and Donnelly, 2013; Kerr et 
al., 2015; Marshall and Regnery, 1960). The main symptoms of infection are 
swelling of the body, conjunctival inflammation and mucopurulent release from the 
nose and eyes which may occur 4 to 8 days after infection. Usually these 
symptoms become more severe leading to secondary infections and, ultimately, to 
death (Best and Kerr, 2000). First identified in 1896 in rabbits from a laboratory in 
South America (Sanarelli, 1898), MYXV was later deliberately introduced in 
Australia (1950) and in France (1952) in order to control wild rabbit populations 
(Ratcliffe et al., 1952). In Australia this killed approximately 99.8% of the infected 
rabbits while in France, MYXV killed over 90% of the wild population, affecting also 
30-40% of the domestic rabbits (Kerr, 2012). After its introduction in France, the 
MYXV rapidly spread to other European countries arriving in 1953 to Britain 
(mortality over 99%) and to the Iberian Peninsula (mortality over 90%) (Barcena et 
al., 2000; Fenner and Ratcliffe, 1965; Fenner and Ross, 1994; Muñoz Goyanes, 
1960). Currently, some rabbit populations still experience high mortality rates while 
in others, the disease has almost no impact (Marchandeau et al., 2014). 
In Australia, after the first epizootics that decimated the European rabbit 
populations, rabbit numbers recovered to some extent (Fenner, 1953; Fenner et 
al., 1953). Over the next 30 years mildly attenuated MYXV strains that naturally 
emerged in the field out-competed the most virulent strain that had been initially 
introduced. These mildly attenuated strains allowed the infected rabbits to survive 
longer and, as such, were more readily transmitted by the mosquito vectors. At the 
same time rabbit populations were increasingly resistant to the disease as the 
breeding population became dominated by survivors to myxomatosis (reviewed in 
Kerr et al, 2015). 
 
Rabbit hemorrhagic disease 
Rabbit hemorrhagic disease is a viral disease caused by a calicivirus, the 
rabbit hemorrhagic disease virus (RHDV), that causes a severe, lethal and 
contagious disease that affects both domestic and wild populations (Abrantes et 
al., 2012). Clinical signs of RHD are inconspicuous, but a blood mucous discharge 
from the nose might be observed, and death occurs within 24-48 hours post 
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infection. The main histopathological alterations are observed upon necropsy with 
hemorrhages in several organs, mainly lungs and kidneys, discolored liver and 
splenomegaly (Cooke, 2002; Kerr and Donnelly, 2013). First described in China in 
1984 following the importation of Angora rabbits from Germany, RHD had a 
tremendous impact in rabbitries killing approximately 140 million rabbits (Liu et al., 
1984; Xu, 1991). The virus quickly spread to other countries in Asia (Park N Y et 
al., 1987), Europe (Cancellotti and Renzi, 1991), America (Gregg and House, 
1989) and Africa (Morisse et al., 1991) in the following years. The first cases of 
RHD in the Iberian Peninsula occurred in 1988 (Spain) (Argüello et al., 1988) and 
1989 (Portugal) (Anonymous, 1989), further reducing the small extant populations 
that were still recovering from myxomatosis. Such as with MYXV, RHDV was also 
deliberately introduced in Australia in 1995 as a biocontrol agent. The first trials 
began on the Wardang Island (5 kilometers of the South Australian coast), 
however it quickly spread to the mainland decreasing the rabbit population in 
~60% (Cooke, 2002; Cooke, 2007, 2012). 
Interestingly, young rabbits less than 2 months are not affected by RHD, 
probably due to their immunity acquired by vertical transmission (Cooke, 2014; 
Marques et al., 2012; Marques et al., 2014; Prieto et al., 2000), which allow them 
to develop an immune response that blocks the virus replication, while adult 
rabbits die before developing such an effective immune response. More recently, a 
new variant of RHDV (RHDV2 or RHDVb) that is able to kill young rabbits was 
identified in France (Le Gall-Recule et al., 2011). This new variant, which differs 
more than 15% of nucleotide diversity from the old RHDV strains, rapidly 
disseminated across Europe and caused mortalities similar to those observed in 
the first RHDV outbreaks (Abrantes et al., 2013b; Abrantes et al., 2014; Baily et 
al., 2014; Dalton et al., 2014; Le Gall-Recule et al., 2011). In Portugal, this new 
variant replaced the older strains and its evolution is associated with several 
recombination events (Lopes et al., 2015). The emergence of RHDV2 and even 
the origin of RHDV remain poorly understood. Two major hypotheses are debated 
and propose that the pathogenic virus either evolved from non-pathogenic virus 
strains circulating in European leporids or through a species jump from non-native 
leporids, possibly the American eastern cottontail, introduced into Europe in the 
1960s-1970s (Esteves et al 2015). 
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Rabbit as a model  
Laboratory animals have long been used as models to improve our 
understanding of several human conditions. The main goal is to artificially replicate 
in the laboratory animal the condition under study. The European rabbit was the 
first animal model used in several immunological studies, being crucial, for 
example, for the development of the rabies vaccine by Louis Pasteur in 1881 
(Pasteur, 1885). Furthermore, it was the study of rabbit immunoglobulins that 
established much of what is known about immunoglobulins structure, function and 
regulated expression (Pinheiro et al., 2011; Pinheiro et al., 2016). 
Despite being the only animal model for the study of molecular immunology 
in the late 1980s, in the following years rabbits were replaced by rodents 
(Burkholder et al., 2012). The main reasons for the use of rodents instead of 
rabbits are the low maintenance costs, smaller size, ease of breeding, short 
reproductive cycle, high number of progeny, lower inter-individual variability and a 
wide availability of commercial reagents (Mullane and Williams, 2014; Webb, 
2014). However, rabbits have the advantage to be in-between the smaller animals 
as rodents and the larger ones as primates that are too costly (Fontanesi et al., 
2016). In addition, in genes of the immune system, rabbits are more similar to 
primates than rodents (Graur et al., 1996; Neves et al., 2015; Perkins et al., 2000), 
they present a longer lifetime and similar organs’ size to humans, and they are 
also carriers or reservoirs of several pathogens that can cause zoonotic diseases 
(e.g. tularemia, Lyme borreliosis, paratuberculosis, hemorrhagic and diarrheal 
diseases) (Fontanesi et al., 2016; Hill and Brown, 2011). Furthermore, some 
studies highlight the lower success rate of the mouse as a model in studying 
human diseases (James et al., 2005; Seok et al., 2013; Takao and Miyakawa, 
2015). Indeed, the European rabbit is highly used as a laboratory model for 
immunological studies in different areas: atherosclerosis (Fan et al., 2015; Tian et 
al., 2012), intestinal immunity (Jimenez-Garcia et al., 2004), reproduction (Fischer 
et al., 2012), arthritis (Desando et al., 2013), cancer (Kang and Grossniklaus, 
2011), Alzheimer’s disease (Woodruff-Pak et al., 2007), viral infections (Cheng et 
al., 2012; Ma et al., 2010) and infectious diseases (Burkholder et al., 2012; Peng 
et al., 2015). One of the most important features is its ability to produce specific 
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and with high affinity antibodies that are largely used against several target 
antigens (Fontanesi et al., 2016; Jacquier et al., 2015). 
Studies of Human immune-deficiency virus type 1 (HIV-1) pathogenesis and 
new possible treatments are a good example of the advantageous use of rabbit as 
a model as opposed to rodent and simian models. Though having allowed major 
breakthroughs in the understanding of HIV pathogenesis and treatment, both 
simian and rodent models have serious limitations that are overcome with the 
rabbit model. Tervo and Keppler (2010) demonstrated that rabbits show a natural 
HIV-1 permissivity and propose that it is possible to render this species fully 
permissive to infection by HIV-1 (Tervo and Keppler, 2010). It has been shown 
that the European rabbit can be used as an animal model in AIDS vaccine 
development (Chen et al., 2013; Pan et al., 2013). Indeed, the European rabbit 
antibodies can recognize immunogenic regions of gp120 and mimic the binding 
modes of human antibodies (Pan et al., 2013). The study of APOBEC1, an 
important anti-viral molecule, showed that the European rabbit is the species with 
the strongest activity to inhibit the infectivity of HIV-1 in 293T cell-based assays 
(Ikeda et al., 2008). Anchored in this observation, the creation of chimeric 
human/rabbit APOBEC1 with HIV-1 restrictions and DNA mutation activities 
showed that the C-terminal region of rabbit apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide 1 (APOBEC1) is involved in both its packaging into 
the HIV-1 virion and its deamination activity against both viral cDNA and genomic 
RNA (Ikeda et al., 2016).  
Chemokines and their receptors play crucial roles in immune and 
inflammatory responses. C–C motif chemokine receptor 5 (CCR5) is one of the 
most well studied by the relevant role it has in the HIV infection process being 
involved in the HIV uptake into host cells (Barmania and Pepper, 2013). The 
CCR5 of European rabbit and two other related leporids, Bunolagus and 
Pentalagus, is unique among mammals. Indeed, the three genera suffered a 
change at the second extracellular loop resulting from a gene conversion event 
with the paralogous CCR2 (Abrantes et al., 2011; Carmo et al., 2006). This unique 
feature makes the European rabbit a suitable model to study the co-evolution 
between this receptor and its ligands. The study of its putative ligands showed 
different evolutionary patterns with a strong purifying selection in CCL3, CCL4 and 
CCL5 (de Matos et al., 2014) while CCL8 contrastingly showed a 
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pseudogenization specific to these three genera (van der Loo et al., 2012). The 
correlation observed between CCR5 and CCL8 evolution remains to be 
functionally evaluated. 
The discovery of endogenous lentiviruses in rabbits (RELIK) showed that 
lentiviruses had the ability for germline integration (Katzourakis et al., 2007; Yap 
and Stoye, 2013). Furthermore, the comparison of their genomic structures 
showed high similarity with the modern-day lentiviruses (de Sousa-Pereira et al., 
2016; Goldstone et al., 2010). Thus, the RELIK could provide important insights 
into lentivirus biology and host interactions. 
Fragments homologous to Hepatitis C Virus were found to be present in the 
European rabbit (Oryctolagus cuniculus) and hare (Lepus europaeus) genomes 
and were successfully replicated in bovine cell cultures (Silva et al., 2012). 
Additionally, it was suggested that these genomic fragments can be internalized in 
the MDBK cells and together with the cell machinery initiate the replication and the 
generation of novel HCV-like virus (Silva et al., 2015). These results give important 
insights on the HCV evolution and diversity and open new avenues for therapeutic 
approaches.  
The similarities of hepatic damage caused by RHDV infection and human 
fulminant hepatic failure (FHF) of viral origin (Mikami et al., 1999) suggested that 
RHDV infection would be a good model to study FHF. Tuñon and co-workers 
(2003) successfully characterized this new animal model for acute liver failure and 
have since been studying RHDV infection as to aid in finding new therapeutics to 
protect livers from acute liver failure. Their studies have focused on the effects of 
melatonin (Crespo et al., 2016; Laliena et al., 2012; San-Miguel et al., 2014; 
Tunon et al., 2013; Tunon et al., 2011a), but also on other signaling pathways 
involved in the autophagic response induced by RHDV (Garcia-Lastra et al., 2010; 
San-Miguel et al., 2006; Vallejo et al., 2014). 
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Knowledge on interleukins and chemokine ligands in lagomorphs has been 
mostly restricted to the European rabbit, an animal model for the study of 
speciation, domestication, medical immunology research, virology and diseases. 
To fill in this gap in the Lagomorpha order, we performed a genomic 
characterization and studied the genetic diversity and evolution of interleukins and 
chemokine ligands with biological relevance. Thus, in order to unveil the scenarios 
driving the evolutionary patterns of these genes, the sequences obtained in this 
work were compared with other mammalian orthologous sequences.   
This thesis is organized into five chapters and includes seven scientific 
papers, six already published in journals indexed in the Science Citation Index 
(SCI) and one in preparation. 
 
In the first chapter, entitled Chapter 1. General Introduction, an overview of 
the lagomorph’s phylogeny is given and the basic principles of innate immune 
system are described, with a main focus in the interleukins and chemokine 
ligands. Furthermore, the state of the art on these proteins in lagomorphs is 
revisited. Finally, the host-pathogen co-evolution theory is discussed. In addition 
this chapter describes the natural history of the European rabbit populations and 
highlights the importance of the European rabbit as an animal model. Indeed, this 
species has been used to study speciation events and to decipher the genes 
responsible for the genetic traits associated with the domestication process. The 
European rabbit is present in more than 800 islands with contrasting climatic 
conditions, making it a perfect model to study adaptations to new environments. 
Until the 1980s, the European rabbit was widely used as an animal model for 
human research, but it has been replaced by mouse (Mus musculus). However, 
the uniqueness of the immune system of the European rabbit makes it a valuable 
model for several fields, particularly for the study of human diseases, basic 
immunology and virology. 
 
This Chapter 2. Objectives presents a brief description of all the chapters 
that compose this thesis as well as the pappers published. 
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Interleukins (ILs) are crucial in the regulation and determination of immune 
responses. Population genetic analyses and sequence analyses have been shown 
that ILs are evolving under positive selection. However, the amino acids 
presenting such signatures are almost unknown. In order to identify codons under 
positive selection in mammalian interleukins we used different codon-based 
maximum-likelihood (ML) approaches (paper II). Our results showed that the 
European rabbit IL6 gene differs from the other mammal species by having a 27 
base pair extension. To infer the evolution of this gene in lagomorphs, we 
extended the genetic characterization to eight more lagomorph species. 
Additionally, it has been suggested that IL1, IL2, IL4, IL6, IL8, IL10, IL12, IL15 and 
IL18 are associated with rabbit susceptibility to rabbit hemorrhagic disease (RHD) 
and myxomatosis, and that IL17A might be related with Tularaemia. However, the 
genetic characterization of these genes in lagomorphs was limited. In order to 
improve the current knowledge, we sequenced these genes for seven lagomorph 
species. The resulting scientific manuscripts are compiled in Chapter 3. Innate 
Immunity – Evolution of Interleukins in lagomorphs in four scientific manuscripts: 
 
Paper I. Neves F, Abrantes J, Steinke JW, Esteves PJ. (2014) Maximum-
likelihood approaches reveal signatures of positive selection in IL genes in 
mammals. Innate Immunity, 20(2): 184–191. 
 
Paper II. Neves F, Abrantes J, Pinheiro A, Almeida T, Costa PP, Esteves PJ. 
(2014) Convergent evolution of IL-6 in two leporids (Oryctolagus and Pentalagus) 
originated an extended protein. Immunogenetics, 66(9):589–595. 
 
Paper III. Neves F, Abrantes J, Almeida T, Costa PP, Esteves PJ. (2015) 
Evolutionary Insights into IL17A in Lagomorphs. Mediators of Inflammation, vol. 
2015, Article ID 367670, 7 pages, 2015. 
 
Paper IV. Neves F, Abrantes J, Almeida T, de Matos AL, Costa PP, Esteves PJ. 
(2015) Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, 
IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs. 
Innate Immunity 21(8):787-801. 
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Previous studies have focused on the genetic variability of the C-C 
chemokine receptor 5 (CCR5) in lagomorphs showing significantly differences 
between them. Indeed, the European rabbit, riverine rabbit and Amami rabbit 
present a gene conversion of a CCR5 motif in the second extracellular loop with a 
motif that is characteristic of CCR2. Interestingly, this was not observed in the 
other lagomorphs. This observation impelled us to genetically characterize the 
CCR5 ligands CCL11, CCL14 and CCL16. The results obtained showed different 
evolution patterns, described in Chapter 4. Innate immunity – Genetic aspects of 
CC motif chemokines in lagomorphs. The results are presented in three scientific 
papers: 
 
Paper V. Neves F, Abrantes J, Lissovsky AA, Esteves PJ. (2015) 
Pseudogenization of CCL14 in the Ochotonidae (pika) family. Innate Immunity 
21(6):647-654. 
 
Paper VI. Neves F, Abrantes J, Esteves PJ. (2016) Evolution of CCL11: genetic 
characterization in lagomorphs and evidence of positive and purifying selection in 
mammals. Innate immunity 22(5):336-343. 
 
Paper VII. Neves F, Abrantes J, Lopes AM, Magalhães MJ, Esteves PJ. Evolution 
of CCL16 in Glires (Rodentia and Lagomorphs) shows an unusual random 
pseudogenization pattern. (In preparation) 
 
In Chapter 5. Final considerations, the major findings and conclusion of this 
thesis are discussed and the implications for future research are presented. 
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Innate Immunity – Evolution of Interleukins in 
lagomorphs 
 
 
Paper I. Neves F, Abrantes J, Steinke JW, Esteves PJ. (2014) Maximum-
likelihood approaches reveal signatures of positive selection in IL genes in 
mammals. Innate Immunity, 20(2): 184–191. 
Paper II. Neves F, Abrantes J, Pinheiro A, Almeida T, Costa PP, Esteves PJ. 
(2014) Convergent evolution of IL-6 in two leporids (Oryctolagus and Pentalagus) 
originated an extended protein. Immunogenetics, 66(9):589–595. 
Paper III. Neves F, Abrantes J, Almeida T, Costa PP, Esteves PJ. (2015) 
Evolutionary Insights into IL17A in Lagomorphs. Mediators of Inflammation, vol. 
2015, Article ID 367670, 7 pages, 2015. 
Paper IV. Neves F, Abrantes J, Almeida T, de Matos AL, Costa PP, Esteves PJ. 
(2015) Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, 
IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs. 
Innate Immunity 21(8):787-801. 
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MAXIMUM-LIKELIHOOD APPROACHES REVEALED SIGNATURES OF POSITIVE 
SELECTION IN INTERLEUKIN ( IL) GENES IN MAMMALS 
 
Fabiana Neves, Joana Abrantes, John W Steinke, Pedro J Esteves 
 
 
1. ABSTRACT  
Interleukins (ILs) are part of the immune system being involved in multiple 
biological activities. ILs have been shown to be evolving under positive selection, 
however little information exists regarding which codons are specifically selected. 
By using different codon-based maximum-likelihood (ML) approaches, signatures 
of positive selection in mammalian ILs were searched for.  
Sequences of 46 ILs were retrieved from publicly available databases of 
mammalian genomes to detect signatures of positive selection in individual 
codons. Evolutionary analyses were conducted under two ML frameworks, the 
HyPhy package implemented in the Data Monkey Web Server and CODEML 
implemented in PAML. 
Signatures of positive selection were found in 28 ILs: IL1A and B, IL2, IL4-
IL10, IL12A and B, IL14-IL17A and C, IL18, IL20-IL22, IL25, IL26, IL27B, IL31, 
IL34, IL36A and G. Codons under positive selection varied between 1 and 15. No 
evidence of positive selection was detected in IL13, 17B and F, IL19, IL23, IL24, 
IL27A and IL29. 
Most mammalian ILs have sites evolving under positive selection, which 
may be explained by the multitude of biological processes in which ILs are 
enrolled. The results obtained raise hypotheses concerning the ILs functions’ that 
should be pursued by using mutagenesis and crystallographic approaches. 
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selection 
 
2. INTRODUCTION 
Different cells of the immune system are able to secrete regulatory proteins, 
namely cytokines (cks) in response to a variety of stimuli. In mammals, cytokines 
produced as a part of the innate immune response have the ability to influence the 
extent and nature of the adaptive immunity response and are thus crucial for many 
aspects of the immune response (Brocker et al., 2010; Kaiser et al., 2004; 
O'Connell and McInerney, 2005; Poon et al., 2009; Zelus et al., 2000; Zhang and 
Nei, 2000). When cks are secreted by leukocytes and act on other cells they are 
called interleukins (ILs) (Akdis et al., 2011; Beadling and Slifka, 2006; Kaiser et al., 
2004; Ozaki and Leonard, 2002; Schrader, 2003). Ils are polypeptides of low 
molecular weight involved in several biological activities, including immunity, 
inflammation, inflammatory diseases, hematopoiesis, oncogenesis, neurogenesis, 
fertility, among many others. Each interleukin is normally involved in a multiple 
biological processes (Afzal et al., 2012; Akdis et al., 2011; Heinrich et al., 2003; 
Ishihara and Hirano, 2002). Currently, 37 interleukins have been identified in 
mammals, some with a variable number of variants. Classification of ILs has been 
based on sequence homology, receptor chain similarities, activity, structural or 
functional features, leading to complex and intricate classifications (Akdis et al., 
2011; Beadling and Slifka, 2006; Borish and Steinke, 2003; Commins et al., 2010; 
Krause and Pestka, 2005; Leonard and Lin, 2000; Sabat, 2010; Secombes et al., 
2011; Steinke and Borish, 2006). The activities of ILs are possible through the 
binding of these polypeptides to specific cell-surface receptors, components of 
which can be shared by several interleukins, that are able to transmit intracellular 
signals through different signaling pathways (Afzal et al., 2012; Fumagalli et al., 
2009; Ishihara and Hirano, 2002; O'Connell and McInerney, 2005). Sometimes, for 
optimal function, interaction between complementary interleukins is necessary 
(Commins et al., 2008). These interactions can be synergistic, additive or 
antagonistic and exhibit both negative and positive regulatory effects (Afzal et al., 
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2012; Akdis et al., 2011; Commins et al., 2008; Feghali and Wright, 1997; Haddad, 
2002). 
Owing to the host-pathogen co-evolution, the immune system and its genes 
are constantly evolving, being under constant pressure and selection for 
adaptation and where advantageous mutations are highly favored and deleterious 
mutations are quickly eliminated (Barreiro and Quintana-Murci, 2010; Brocker et 
al., 2010). ILs such as IL2, IL3, IL4, IL5, IL13, IL23A, IL28A, IL28B and IL29 
(Barreiro and Quintana-Murci, 2010; Brocker et al., 2010; Koyanagi et al., 2010; 
Makalowski and Boguski, 1998; Manry et al., 2011; O'Connell and McInerney, 
2005; Pillai and Bix, 2011; Tindall and Hayes, 2010; Zelus et al., 2000; Zhang and 
Nei, 2000; Zhou et al., 2004) have been identified as some of the immune system 
genes under positive selection in different mammals. Despite all of these studies, 
most do not specify the codons positively selected (Makalowski and Boguski, 
1998; Manry et al., 2011; Tindall and Hayes, 2010; Zelus et al., 2000; Zhang and 
Nei, 2000; Zhou et al., 2004), with the exception of IL4 (Koyanagi et al., 2010) in 
which 15 residues were detected as being under positive selection and located on 
sites responsible for binding to receptors. Regarding these results, we have 
extended the search for signatures of positive selection to include mammalian ILs 
1-37 by using different maximum-likelihood approaches (ML). 
 
3. MATERIALS AND METHODS 
Sequences 
The sequences of the mammalian ILs used in the analyses were retrieved 
from GenBank (http://www.ncbi.nlm.nih.gov/), Ensembl 
(http://useast.ensembl.org/index.html) and UniProt (http://www.uniprot.org/). For 
each IL, amino acid residues were numbered from the first human methionine 
residue, with signal peptides and propeptide amino acids included in the 
numbering. The number of sequences retrieved for each IL ranged from 14-47 
(some of the IL genes were not found in all mammalian genomes) and included 
representatives of most mammalians groups (e.g. Artiodactyla, Carnivores, 
Lagomorphs, Primates, Rodents, etc). The identification of the species used for 
each IL and the accession numbers are listed in Table 3.3 of Supplementary 
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material. Each of the 37 interleukins was aligned using ClustalW, as implemented 
in the software program BioEdit version 7.1.3 (Hall, 1999), and adjusted manually. 
 
Codon based analyses of positive selection 
According to Poon and collaborators (Poon et al., 2009), and in order to 
reliably identify codons under positive selection, only interleukins that were 
represented in at least 10 species were analyzed. Hence, IL17D, IL28 A and B 
IL32, IL36B and IL37 were not considered. IL3 and IL33 were also excluded since 
the alignments produced were not reliable and prone to affect the detection of 
positive selection by leading to false predictions (Majewski and Ott, 2003). 
Signatures of positive selection are inferred if the ratio of nonsynonymous 
substitutions per nonsynonymous substitutions site (dN) over synonymous 
substitutions per synonymous sites (dS) is statistically higher than the value 
observed under neutrality, 1. Here, to detect such signatures in individual codons 
of mammalian IL sequences, the different dN/dS ratios (ω) were compared using 
two Maximum-Likelihood (ML) frameworks, the HyPhy package implemented in 
the Data Monkey Web Server (http://www.datamonkey.org/) (Poon et al., 2009) 
and CODEML implemented in PAML version 4 (Majewski and Ott, 2003; Yang, 
1997, 2007), being considered in the analysis the results where dN/dS ratios were 
significantly higher than 1. 
In the Data Monkey Web Server, the best fitting nucleotide substitution 
model was first determined using the automated tool available on the server. 
Sequences of the IL genes were analyzed under three available models, Single 
Likelihood Ancestor Counting (SLAC), Fixed-Effect Likelihood (FEL) and Random 
Effect Likelihood (REL). The SLAC model is based on the reconstruction of 
ancestral sequences and counts the number of dS and dN changes at each codon 
position of the phylogeny. FEL estimates ratios of dN to dS changes for each site in 
an alignment. REL uses a flexible distribution and allows dS and dN to vary across 
sites independently (Kosakovsky Pond and Frost, 2005; Pond and Frost, 2005; 
Poon et al., 2009). 
In CODEML two opposing models, M7 and M8, were compared using 
Likelihood Ratio Tests (LRT). While M7 assumes that ω ratios are distributed 
among sites according to a beta distribution allowing codons to evolve neutrally or 
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under purifying selection, M8 is an extension of the M7 model with an extra class 
of sites with an independent ω ratio freely estimated from the data allowing 
positive selection. M7 vs. M8 were compared by computing twice the difference in 
the natural logs of the likelihoods (2∆lnL). The value obtained was used in a 
likelihood ratio test along with the degrees of freedom (2) and allowed the rejection 
of the null model (p<0.05). Amino acids detected as under positive selection in M8 
were identified using the Bayes Empirical Bayes approach (BEB), with posterior 
probability > 95%. BEB is the preferred approach because it accounts sampling 
errors in the ML (Bielawski and Yang, 2003; Yang, 1997, 2002, 2007; Yang et al., 
2000). For each gene, a neighbor-joining tree was constructed in MEGA5 (Tamura 
et al., 2011) as working topology with selected options p-distance as the 
substitution model and complete deletion to gaps/missing data treatment. 
For a more conservative approach and as used previously (Areal et al., 
2011; Wlasiuk and Nachman, 2010), only sites detected to be under positive 
selection in more than one ML method were considered.  
 
4. RESULTS 
Positive selection was found in 24 of the 46 ILs: IL1 (A and B), IL2, IL4, IL5, 
IL6, IL7, IL8, IL9, IL10, IL12 (A and B), IL14, IL15, IL16, IL17 (A and C), IL18, IL20, 
IL21, IL22, IL25, IL26, IL27B, IL31, IL34, IL36 (A and G), as shown in Table 3.1. 
Codons under positive selection detected by, at least, two ML approaches ranged 
between 1 and 15, with IL6 being the interleukin with the highest percentage of 
positively selected codons (2.28% with 15 codons under positive selection) 
followed by IL7 (2.04% and 11 codons under positive selection). The smallest 
percentages of positively selected codons were 0.06% in IL14 and 0.10% in 
IL12B, each with 1 codon. No positively selected codons were detected in IL13, 
17B and F, IL19, IL23, IL24, IL27A and IL29.  
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Alterations in coding regions of genes that lead to amino acids substitutions 
can induce changes in protein conformation. These changes may be conservative 
or radical and may alter physiochemical properties of the proteins such as charge 
and polarity (Majewski and Ott, 2003). From our physiochemical study of the 
amino acids under postive selection (see Table 3.4 in Supplementary material) we 
observed that for the majority of codons under positive selections changes in 
charge and polarity occur. For example, in IL36G, amino acid positions 2 and 5 
correspond to 13 and 12 amino acid possibilities respectively, i.e., the different 
amino acids that can be found in all the species analyzed.  
 
5. DISCUSSION 
Mammalian genes involved in the immune response are among the most 
rapidly evolving genes (Barreiro and Quintana-Murci, 2010; Ferrer-Admetlla et al., 
2008; Kosiol et al., 2008) as they include proteins with biological activities 
designed to protect the host (antibacterial, antiviral, antifungal or antiparasitic). 
Since positive selection is likely correlated with sites of important activity, an effort 
was made to try and verify if the positions under positive selection have any 
particular function that led to their evolution. For most ILs with sites under positive 
selection, a correlation between those sites and interaction with other molecules, 
such as receptors, pathogens, and binding proteins (BP), was found. It is known 
that sites where interaction of the interleukins with their receptors occurs are 
essential for their function (Koyanagi et al., 2010; Smith, 2006). To verify a cause-
effect relationship between ILs and their receptors, we extended our positive 
selection analyses to interleukin receptors’ (ILR), in particular focusing on sites 
which interact with interleukins at sites detected as being under positive selection 
(Table 3.2). From all interleukins where positive selection was detected, only in IL4 
and IL18 was that correlation found. For IL4, and by focusing on the residues 
under positive selection known to interact with IL4 receptors, mainly IL4Rα and 
IL13Rα (see figure 3.1), our results are in agreement with previous studies (Hage 
et al., 1999; LaPorte et al., 2008; Zarlenga et al., 2004; Zhang et al., 2002).  
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Indeed of the IL4 residues detected under positive selection, Glu84 is 
located between sites of interaction with IL4Rα and IL13Rα while Arg105 and 
Phe106 are located in interaction sites of IL4 with IL4Rα. No codons under positive 
selection were detected at the sites of IL4:γc interaction as suggested by others 
(Koyanagi et al., 2010; O'Connell and McInerney, 2005). Of the two residues of 
IL4Rα under positive selection, only Ser95 has a direct interaction with IL4 
(Asn113). IL4 positively selected sites Arg105 and Phe106 are located near sites 
where IL4 interacts with IL4Rα (Koyanagi et al., 2010; LaPorte et al., 2008; Mueller 
et al., 2002). For IL13Rα, none of the 7 residues detected as under positive 
selection interacted with Glu84 of IL4, but the positively selected Ile254 from 
IL13Rα interacts with IL4. The sites detected are in accordance with those 
described by Koyanagi et al., 2010, but not with those detected by O’Connel et al., 
2005. One explanation for this discordance is the number of species used which 
differs between studies. For IL18, of the 7 residues detected as under positive 
selection, only Leu45 is located near the site of interaction with IL18Rα (Lys44) 
and IL18BP (Glu42). The signatures of positive selection in these sites might also 
be involved in modulating signaling intensity (Koyanagi et al., 2010). 
 
 
Figure 3. 1. Positively selected sites in the 3D structures of IL4-IL4Rα-IL13Rα (marked in yellow). IL4 appears 
in pink, IL4Rα in blue and IL13Rα in brown. 
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In their evolution, pathogens have evolved an arsenal of immune evading 
strategies which include antagonists for the host immune related proteins   that 
target critical sites for these proteins’ functions. Thus, to escape from antagonists, 
those targeting sites need to continuously evolve so that the IL-ILR interaction can 
still be functional. Supporting this concept, sites under positive selection for IL4 
have been suggested to be associated with escaping from pathogen-encoded 
antagonistic proteins (Koyanagi et al., 2010). 
Binding proteins (BP) are polypeptides that have the ability to interact with 
corresponding proteins and neutralize them. In the interleukins studied, there are 
many examples of such proteins. Indeed, IL18BP has the ability to bind to IL18 
with high affinity preventing IL18-IL18R interaction, and therefore, neutralizing their 
biological activities. Some authors have demonstrated that IL18BP prevents 
lipopolysaccharide (LPS) induced IFN-γ production (Dinarello, 2000; He et al., 
2008; Mallat et al., 2001). In some models, it has been described that blocking 
IL18 results in a reduction in disease severity in injuries related to IL18 increased 
production, namely injuries of heart, kidneys, liver, arthritis, etc (Dinarello, 2006). 
By studying IL18, Leu45 which was detected as under positive selection is located 
close to the site of interaction of IL18 (Glu42) with IL18BP. In addition, when we 
studied IL18BP, we detected that Cys131 is under positive selection, next the site 
of interaction of IL18BP (Lys130) with IL18.  
Nevertheless, for some ILs, the evidence of positive selection is not so 
intelligible. When pathogens or stress are encountered, the initial response is via 
the innate immune system with activation of the inflammasome. Interestingly, 
when examined (Table 3.1) two of the genes with largest number of positively 
selected residues are IL1A and IL6. IL1A is the initial cytokine produced upon 
inflammasome activation which directly leads to increased expression of IL6 
(Akdis et al., 2011). Given their critical importance in the early activation of the 
immune response, it is tempting to speculate that there has been selective 
pressure to maintain (rather than to change) structure and function of these 
molecules from their early precursors. However, the knowledge on the functional 
role of IL1A and IL6 derives mostly from studies in humans with almost nothing 
known for other mammals. It is possible that, in other species, these ILs might 
have evolved for other tasks, leading to the observed divergence in sequence 
across species. 
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Codons under positive selection were also detected within sites of N-
glycosylation or where disulfide bonds exist. Glycosylation is considered to be 
important for protein folding, oligomerization, intrinsic stability, solubility, capacity 
to diffuse troughout the organism, interaction with cell surface receptors and 
subsequent biological activity (Shental-Bechor and Levy, 2008; Szabo et al., 2009; 
Waetzig et al., 2010). This modification is an effective way to generate diversity 
and modulate protein properties due to inherent structural variations of the glycans 
(Chamorey et al., 2002; Shental-Bechor and Levy, 2008; Waetzig et al., 2010). For 
IL1A, IL9, IL22, IL25 and IL31, residues under positive selection were found in 
close proximity to sites where N-glycosylation occurs (Table 3.1). Disulfide bonds 
play an important role in folding, stability and function of the protein, being, 
according to some authors (Fass, 2012; Li et al., 2011), associated with functional 
differentiation of the proteins. These bonds are thought to be well conserved in 
proteins (Li et al., 2011). Positive selection was detected at sites where disulfide 
bonds exist for IL2 and IL17A (Table 3.1) and may compromise their structure, 
stability and function. The changes in charge and polarity observed at the 
positively selected codons are likely to impose changes in the protein 
conformation with consequences at the protein function. 
 
6. CONCLUSIONS 
Positive selection may function to maintain a host response to pathogens, 
diseases, and environmental conditions. Here, we have detected positive selection 
in 28 interleukins with some of the identified codons associated with critical 
functions of these proteins. Several reasons might underlie our results, including 
the specific biological functions in which ILs are involved and the maintenance of 
critical structural features of the ILs. However, the limited knowledge of the role of 
specific codons in IL functions’ for most mammalian species hampers the 
complete understanding of our observations. Further functional and structural 
studies by using mutagenesis and crystallographic approaches should be 
performed for a full comprehension of the role of the observed variation in 
mammalian ILs.  
 
92 
 
7. REFERENCES 
Afzal, N., Tahir, R., Jahan, S., 2012. Cytokines: an ever expanding area Biological and 
Biomedical Reports 2, 37-43. 
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., 
O'Mahony, L., Palomares, O., Rhyner, C., Ouaked, N., Schaffartzik, A., Van De Veen, W., Zeller, 
S., Zimmermann, M., Akdis, C.A., 2011. Interleukins, from 1 to 37, and interferon-gamma: 
receptors, functions, and roles in diseases. J Allergy Clin Immunol 127, 701-721 e701-770. 
Areal, H., Abrantes, J., Esteves, P.J., 2011. Signatures of positive selection in Toll-like 
receptor (TLR) genes in mammals. BMC Evol Biol 11, 368. 
Barreiro, L.B., Quintana-Murci, L., 2010. From evolutionary genetics to human immunology: 
how selection shapes host defence genes. Nature reviews. Genetics 11, 17-30. 
Beadling, C., Slifka, M.K., 2006. Regulation of innate and adaptive immune responses by the 
related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp (Warsz) 54, 15-24. 
Bielawski, J.P., Yang, Z., 2003. Maximum likelihood methods for detecting adaptive evolution 
after gene duplication. J Struct Funct Genomics 3, 201-212. 
Borish, L.C., Steinke, J.W., 2003. 2. Cytokines and chemokines. J Allergy Clin Immunol 111, 
S460-475. 
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D.W., Vasiliou, V., 2010. Evolutionary 
divergence and functions of the human interleukin (IL) gene family. Hum Genomics 5, 30-55. 
Chamorey, A.L., Magne, N., Pivot, X., Milano, G., 2002. Impact of glycosylation on the effect of 
cytokines. A special focus on oncology. Eur Cytokine Netw 13, 154-160. 
Commins, S., Steinke, J.W., Borish, L., 2008. The extended IL-10 superfamily: IL-10, IL-19, IL-
20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121, 1108-1111. 
Commins, S.P., Borish, L., Steinke, J.W., 2010. Immunologic messenger molecules: cytokines, 
interferons, and chemokines. J Allergy Clin Immunol 125, S53-72. 
Dinarello, C.A., 2000. Targeting interleukin 18 with interleukin 18 binding protein. Ann Rheum 
Dis 59 Suppl 1, i17-20. 
Dinarello, C.A., 2006. Interleukin 1 and interleukin 18 as mediators of inflammation and the 
aging process. Am J Clin Nutr 83, 447S-455S. 
Fass, D., 2012. Disulfide bonding in protein biophysics. Annu Rev Biophys 41, 63-79. 
Feghali, C.A., Wright, T.M., 1997. Cytokines in acute and chronic inflammation. Front Biosci 2, 
d12-26. 
Ferrer-Admetlla, A., Bosch, E., Sikora, M., Marques-Bonet, T., Ramirez-Soriano, A., Muntasell, A., 
Navarro, A., Lazarus, R., Calafell, F., Bertranpetit, J., Casals, F., 2008. Balancing selection is the 
main force shaping the evolution of innate immunity genes. J Immunol 181, 1315-1322. 
Fumagalli, M., Pozzoli, U., Cagliani, R., Comi, G.P., Riva, S., Clerici, M., Bresolin, N., Sironi, M., 
2009. Parasites represent a major selective force for interleukin genes and shape the 
genetic predisposition to autoimmune conditions. J Exp Med 206, 1395-1408. 
Haddad, J.J., 2002. Cytokines and related receptor-mediated signaling pathways. Biochem 
Biophys Res Commun 297, 700-713. 
Hage, T., Sebald, W., Reinemer, P., 1999. Crystal structure of the interleukin-4/receptor alpha 
chain complex reveals a mosaic binding interface. Cell 97, 271-281. 
Hall, T.A., 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis 
program for Windows 95/98/NT. Nucl. Acids. Symp. Ser.  41, 95-98. 
He, Z., Lu, L., Altmann, C., Hoke, T.S., Ljubanovic, D., Jani, A., Dinarello, C.A., Faubel, S., 
Edelstein, C.L., 2008. Interleukin-18 binding protein transgenic mice are protected against 
ischemic acute kidney injury. American journal of physiology. Renal physiology 295, F1414-
1421. 
Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Muller-Newen, G., Schaper, F., 2003. 
Principles of interleukin (IL)-6-type cytokine signalling and its regulation. The Biochemical 
journal 374, 1-20. 
Ishihara, K., Hirano, T., 2002. Molecular basis of the cell specificity of cytokine action. Biochim 
Biophys Acta 1592, 281-296. 
93 
 
Kaiser, P., Rothwell, L., Avery, S., Balu, S., 2004. Evolution of the interleukins. Developmental 
and comparative immunology 28, 375-394. 
Kosakovsky Pond, S.L., Frost, S.D., 2005. Not so different after all: a comparison of methods 
for detecting amino acid sites under selection. Mol Biol Evol 22, 1208-1222. 
Kosiol, C., Vinar, T., da Fonseca, R.R., Hubisz, M.J., Bustamante, C.D., Nielsen, R., Siepel, A., 
2008. Patterns of positive selection in six Mammalian genomes. PLoS genetics 4, e1000144. 
Koyanagi, M., Kerns, J.A., Chung, L., Zhang, Y., Brown, S., Moldoveanu, T., Malik, H.S., Bix, M., 
2010. Diversifying selection and functional analysis of interleukin-4 suggests antagonism-
driven evolution at receptor-binding interfaces. BMC evolutionary biology 10, 223. 
Krause, C.D., Pestka, S., 2005. Evolution of the Class 2 cytokines and receptors, and 
discovery of new friends and relatives. Pharmacol Ther 106, 299-346. 
LaPorte, S.L., Juo, Z.S., Vaclavikova, J., Colf, L.A., Qi, X., Heller, N.M., Keegan, A.D., Garcia, 
K.C., 2008. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-
4/13 system. Cell 132, 259-272. 
Leonard, W.J., Lin, J.X., 2000. Cytokine receptor signaling pathways. The Journal of allergy and 
clinical immunology 105, 877-888. 
Li, X.Q., Zhang, T., Donnelly, D., 2011. Selective loss of cysteine residues and disulphide 
bonds in a potato proteinase inhibitor II family. PLoS One 6, e18615. 
Majewski, J., Ott, J., 2003. Amino acid substitutions in the human genome: evolutionary 
implications of single nucleotide polymorphisms. Gene 305, 167-173. 
Makalowski, W., Boguski, M.S., 1998. Synonymous and nonsynonymous substitution 
distances are correlated in mouse and rat genes. Journal of molecular evolution 47, 119-121. 
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, 
Y., Tedgui, A., 2001. Interleukin-18/interleukin-18 binding protein signaling modulates 
atherosclerotic lesion development and stability. Circulation research 89, E41-45. 
Manry, J., Laval, G., Patin, E., Fornarino, S., Itan, Y., Fumagalli, M., Sironi, M., Tichit, M., Bouchier, 
C., Casanova, J.L., Barreiro, L.B., Quintana-Murci, L., 2011. Evolutionary genetic dissection of 
human interferons. J Exp Med 208, 2747-2759. 
Mueller, T.D., Zhang, J.L., Sebald, W., Duschl, A., 2002. Structure, binding, and antagonists in 
the IL-4/IL-13 receptor system. Biochim Biophys Acta 1592, 237-250. 
O'Connell, M.J., McInerney, J.O., 2005. Gamma chain receptor interleukins: evidence for 
positive selection driving the evolution of cell-to-cell communicators in the mammalian 
immune system. Journal of molecular evolution 61, 608-619. 
Ozaki, K., Leonard, W.J., 2002. Cytokine and cytokine receptor pleiotropy and redundancy. 
The Journal of biological chemistry 277, 29355-29358. 
Pillai, M.R., Bix, M., 2011. Evolution of IL4 and pathogen antagonism. Growth Factors 29, 153-
160. 
Pond, S.L., Frost, S.D., 2005. Datamonkey: rapid detection of selective pressure on individual 
sites of codon alignments. Bioinformatics 21, 2531-2533. 
Poon, A.F., Frost, S.D., Pond, S.L., 2009. Detecting signatures of selection from DNA 
sequences using Datamonkey. Methods Mol Biol 537, 163-183. 
Sabat, R., 2010. IL-10 family of cytokines. Cytokine & growth factor reviews 21, 315-324. 
Schrader, J.W., 2003. Interleukin is as interleukin does. J Immunol Methods 276, 1-3. 
Secombes, C.J., Wang, T., Bird, S., 2011. The interleukins of fish. Developmental and 
comparative immunology 35, 1336-1345. 
Shental-Bechor, D., Levy, Y., 2008. Effect of glycosylation on protein folding: a close look at 
thermodynamic stabilization. Proc Natl Acad Sci U S A 105, 8256-8261. 
Smith, K.A., 2006. The structure of IL2 bound to the three chains of the IL2 receptor and how 
signaling occurs. Med Immunol 5, 3. 
Steinke, J.W., Borish, L., 2006. 3. Cytokines and chemokines. The Journal of allergy and clinical 
immunology 117, S441-445. 
Szabo, T.G., Palotai, R., Antal, P., Tokatly, I., Tothfalusi, L., Lund, O., Nagy, G., Falus, A., Buzas, 
E.I., 2009. Critical role of glycosylation in determining the length and structure of T cell 
epitopes. Immunome research 5, 4. 
94 
 
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., Kumar, S., 2011. MEGA5: molecular 
evolutionary genetics analysis using maximum likelihood, evolutionary distance, and 
maximum parsimony methods. Mol Biol Evol 28, 2731-2739. 
Tindall, E.A., Hayes, V.M., 2010. Comprehensive sequence analysis of the human IL23A gene 
defines new variation content and high rate of evolutionary conservation. DNA research : an 
international journal for rapid publication of reports on genes and genomes 17, 117-122. 
Waetzig, G.H., Chalaris, A., Rosenstiel, P., Suthaus, J., Holland, C., Karl, N., Valles Uriarte, L., Till, 
A., Scheller, J., Grotzinger, J., Schreiber, S., Rose-John, S., Seegert, D., 2010. N-linked 
glycosylation is essential for the stability but not the signaling function of the interleukin-6 
signal transducer glycoprotein 130. J Biol Chem 285, 1781-1789. 
Wlasiuk, G., Nachman, M.W., 2010. Adaptation and constraint at Toll-like receptors in 
primates. Mol Biol Evol 27, 2172-2186. 
Yang, Z., 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. 
Computer applications in the biosciences : CABIOS 13, 555-556. 
Yang, Z., 2002. Inference of selection from multiple species alignments. Current opinion in 
genetics & development 12, 688-694. 
Yang, Z., 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24, 
1586-1591. 
Yang, Z., Nielsen, R., Goldman, N., Pedersen, A.M., 2000. Codon-substitution models for 
heterogeneous selection pressure at amino acid sites. Genetics 155, 431-449. 
Zarlenga, D.S., Dawson, H., Kringel, H., Solano-Aguilar, G., Urban, J.F., Jr., 2004. Molecular 
cloning of the swine IL-4 receptor alpha and IL-13 receptor 1-chains: effects of experimental 
Toxoplasma gondii, Ascaris suum and Trichuris suis infections on tissue mRNA levels. 
Veterinary immunology and immunopathology 101, 223-234. 
Zelus, D., Robinson-Rechavi, M., Delacre, M., Auriault, C., Laudet, V., 2000. Fast evolution of 
interleukin-2 in mammals and positive selection in ruminants. Journal of molecular evolution 
51, 234-244. 
Zhang, J., Nei, M., 2000. Positive selection in the evolution of mammalian interleukin-2 
genes. Molecular biology and evolution 17, 1413-1416. 
Zhang, J.L., Simeonowa, I., Wang, Y., Sebald, W., 2002. The high-affinity interaction of human 
IL-4 and the receptor alpha chain is constituted by two independent binding clusters. J Mol 
Biol 315, 399-407. 
Zhou, G., Zhai, Y., Dong, X., Zhang, X., He, F., Zhou, K., Zhu, Y., Wei, H., Yao, Z., Zhong, S., 
Shen, Y., Qiang, B., 2004. Haplotype structure and evidence for positive selection at the 
human IL13 locus. Mol Biol Evol 21, 29-35. 
  
95 
 
8. SUPPLEMENTARY MATERIAL 
Table 3. 3. List of the accession numbers of the sequences used for each IL alignment. 
Species Accession number 
IL1A 
Ailuropoda melanoleuca ENSAMEG0000001075 
Bos taurus NM174092.1 
Bubalus bubalis AB246786.1 
Bubalus carabanensis DQ188096.1 
Callithrix jacchus ENSCJAT00000031857 
Canis lupus familiaris NM001003157.2 
Capra hircus D63350.1 
Cavia porcellus ENSCPOT00000027229 
Cercocebus torquatus U19836.1 
Echinops telfairi ENSETET00000017640 
Equus caballus NM001082500.1 
Felis catus NM001009351.1 
Homo sapiens NM000575.3 
Lama glama AB107645.1 
Loxodonta africana ENSLAFT00000001246 
Macaca fascicularis AB000553.1 
Macaca mulatta NM001042757.1 
Mus musculus NM010554.4 
Myotis lucifugus ENSMLUT00000000165 
Ochotona princeps ENSOPRT00000012798 
Oryctolagus cuniculus NM001101684.1 
Otolemur garnettii ENSOGAT00000005383 
Ovis aries NM001009808.1 
Pan troglodytes XM525866.2 
Procavia capensis ENSPCAT00000005993 
Pteropus vampyrus ENSPVAT00000014232 
Rattus norvegicus NM017019.1 
Sorex araneus ENSSART00000013019 
Spermophilus tridecemlineatus ENSSTOT00000002284 
Sus scrofa NM214029.1 
Tarsius syrichta ENSTSYT00000012201 
Tursiops truncatus ENSTTRT00000011057 
Vicugna pacos ENSVPAT00000011121 
IL1B 
Bos taurus NM174093.1 
Bubalus bubalis AB246787.1 
Bubalus carabanensis AB246783.1 
Callithrix jacchus ENSCJAT00000031803 
Canis lupus familiaris NM001037971.1 
Capra hircus D63351.1 
Cavia porcellus NM001172968.1 
Cercocebus torquatus U19837.1 
Cervus elaphus U20500.1 
Delphinapterus leucas AF320322.1 
Dipodomys ordii ENSDORG00000009905 
Echinops telfairi ENSETEG00000008505 
Equus caballus NM001082526.1 
Eumetopias jubatus AY517546.1 
Felis catus NM001077414.1 
Gorilla gorilla ENSGGOG00000006387 
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Homo sapiens NM000576.2 
Lama glama AB107644.1 
Loxodonta africana ENSLAFG00000004059 
Macaca fascicularis D63353.1 
Macaca mulatta NM001042756.1 
Macaca nemestrina U19853.1 
Microcebus murinus ENSMICG00000013334 
Mus musculus NM008361.3 
Myotis lucifugus ENSMLUG00000009941 
Nomascus leucogenys ENSNLEG00000001886 
Ochotona princeps ENSOPRG00000012817 
Oryctolagus cuniculus NM001082201.1 
Ovis aries NM001009465.2 
Pan troglodytes ENSPTRT00000022971 
Phoca hispida DQ358051.1 
Phoca vitulina richardsi AY578791.1 
Pteropus vampyrus ENSPVAG00000006483 
Rattus norvegicus ENSRNOG00000004649 
Sus scrofa NM214055.1 
Tursiops truncatus ENSTTRG00000011069 
Vicugna pacos ENSVPAG00000011126 
IL2 
Ailuropoda melanoleuca XM002923818.1 
Aotus lemurinus U88364.1 
Aotus nancymaae U88361.1 
Aotus nigriceps U88363.1 
Aotus vociferans U88362.1 
Bos taurus NM180997.2 
Boselaphus tragocamelus DQ017831.1 
Bubalus bubalis AF363786.1 
Bubalus carabanensis AB246271.1 
Camelus bactrianus AB246671.1 
Camelus dromedarius HM051105.1 
Canis lupus familiaris NM001003305.1 
Capra aegagrus EF056470.1 
Capra falconeri EF056471.1 
Capra hircus X76063.1 
Cavia porcellus NM001172837.1 
Cercocebus torquatus U19846.1 
Dasypus novemcinctus ENSDNOT00000009053 
Delphinapterus leucas AF072870.1 
Equus caballus NM001085433.1 
Felis catus NM001043337.1 
Gorilla gorila ENSGGOT00000028949 
Homo sapiens NM000586.3 
Loxodonta africana ENSLAFT00000004431 
Macaca fascicularis D63352.1 
Macaca mulatta NM001047130.1 
Macaca nemestrina U19852.1 
Meriones unguiculatus X68779.1 
Mesocricetus auratus EU729351.1 
Mirounga angustirostris U79187.1 
Moschus berezovskii AY840980.1 
Mus musculus NM008366.3 
Myotis lucifugus ENSMLUT00000011794 
Nomascusleucogenys K03174.1 
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Ochotonaprinceps ENSOPRG00000002193:ENSOPRT00000002175 
Oryctolagus cuniculus NM001163180.1 
Ovis aries NM001009806.1 
Pan troglodytes XM003310465.1 
Papio anubis AY234220.1 
Papio hamadryas U88365.1 
Rattus norvegicus NM053836.1 
Rousettus leschenaultii AB472358.1 
Saimiri sciureus AF294755.1 
Sorexaraneus ENSSARG00000000201:ENSSART00000000204 
Sus scrofa NM213861.1 
Syncerus caffer AB571123.1 
Vulpes vulpes AJ621188.1 
IL4 
Ailuropoda melanoleuca XM002912899.1 
Bison bonasus EU000422.1 
Bos taurus NM173921.2 
Boselaphus tragocamelus AY939910.1 
Bubalus bubalis AY293620.1 
Bubalus carabanensis AB246275.1 
Callithrix jacchus XM002744606.1 
Camelus bactrianus AB246673.1 
Camelus dromedarius HM051106.1 
Canis lupus familiaris NM001003159.1 
Capra hircus U34273.1 
Cercocebus torquatus U19838.1 
Elephas maximus EU000424.1 
Equus caballus NM001082519.1 
Equus zebra hartmannae EU000427.1 
Erinaceus europaeus ENSEEUT00000010882 
Felis catus NM001043339.1 
Giraffa camelopardalis EU000423.1 
Gorilla gorilla ENSGGOT00000005697 
Homo sapiens NM000589.2 
Lama glama AB107648.1 
Macaca fascicularis AB000515.1 
Macaca mulatta NM001032904.1 
Meriones unguiculatus L37779.1 
Microcebus murinus ENSMICT00000012463 
Mus musculus NM021283.2 
Mus musculus molossinus AB174765.1 
Mustela putorius furo EF368210.1 
Myotis lucifugus ENSMLUT00000016579 
Ochotona princeps ENSOPRG00000011775:ENSOPRT00000011766 
Oryctolagus cuniculus NM001163177.1 
Otolemur garnettii ENSOGAT00000015510 
Ovis aries NM001009313.2 
Pan troglodytes NM001011714.1 
Papio anubis NM001112653.1 
Peromyscus maniculatus DQ446203.1 
Pteropus vampyrus ENSPVAT00000015176 
Rattus norvegicus NM201270.1 
Rousettus leschenaultii AB472359.1 
Sigmodon hispidus AF421390.1 
Spermophilus tridecemlineatus ENSSTOT00000007974 
Sus scrofa NM214123.1 
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Syncerus caffer EU000421.1 
Tursiops truncatus AB020732.1 
IL5 
Bison bison EU915013.1 
Bos gaurus EU915001.1 
Bos tauros ENSBTAG00000031235:ENSBTAT00000044228 
Bubalus bubalis EF407851.1 
Callithrix jacchus DQ658152.1 
Canis familiaris ENSCAFT00000001335 
Capra hircus EU914965.1 
Cavia porcellus NM001172970.1 
Cercocebus torquatus L26033.1 
Choloepus hoffmanni ENSCHOT00000005746 
Dasypus novemcinctus ENSDNOT00000002731 
Echinops telfairi ENSETET00000007039 
Equus caballus ENSECAT00000017688 
Felis catus NM001009845.2 
Gorilla gorila ENSGGOT00000011623 
Homosapiens ENST00000231454 
Loxodontaafricana ENSLAFT00000009760 
Macacamulatta ENSMMUT00000004434 
Macropus eugenii AF064209.1 
Meriones unguiculatus L37780.1 
Monodelphis domestica ENSMODT00000017776 
Mus musculus ENSMUST00000048605 
Myotis lucifugus ENSMLUT00000016553 
Nomascus leucogenys ENSNLET00000016239 
Ochotona princeps ENSOPRT00000011721 
Oryctolagus cuniculus ENSOCUT00000004166 
Ovis aries NM001009783.1 
Pantroglodytes ENSPTRT00000031882 
Pteropus vampyrus ENSPVAT00000015170 
Rattus norvegicus ENSRNOT00000010729 
Saimiri sciureus AF294756.1 
Sigmodon hispidus AF148211.1 
Sorex araneus ENSSART00000011773 
Sus scrofa ENSSSCT00000015601 
Tarsius syrichta ENSTSYT00000010506 
Vicugna pacos ENSVPAT00000003840 
IL6 
Ailuropoda melanoleuca JN624856.1 
Bos taurus NM173923.2 
Bubalus bubalis AY347710.1 
Bubalus carabanensis AB246784.1 
Callithrix jacchus DQ658153.1 
Camelus bactrianus AB107656.1 
Camelus dromedarius HM051107.1 
Canis lupus familiaris NM001003301.1 
Capra hircus D86569.1 
Cercocebus torquatus L26032.1 
Chlorocebus sabaeus FJ194486.1 
Delphinapterus leucas AF076643.1 
Dipodomys ordii ENSDORT00000009373 
Echinops telfairi ENSETET00000001220 
Equus caballus NM001082496.1 
Erinaceus europaeus ENSEEUT00000005028 
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Felis catus NM001009211.1 
Gorilla gorila ENSGGOT00000005362 
Homo sapiens NM000600.3 
Lama glama AB107647.1 
Loxodonta africana ENSLAFT00000015572 
Macaca fascicularis AB000554.1 
Macaca mulatta NM001042733.1 
Macaca thibetana AY849928.1 
Microcebus murinus ENSMICT00000006697 
Myotis lucifugus ENSMLUT00000015856 
Mus musculus NM031168.1 
Mustela putorius furo EF368209.1 
Nomascus leucogenys ENSNLET00000021390 
Ochotona princeps ENSOPRT00000003065 
Oryctolagus cuniculus NM001082064.1 
Otolemur garnettii ENSOGAT00000004179 
Ovis aries NM001009392.1 
Papio anubis NM001173536.1 
Rattus norvegicus NM012589.1 
Rousettus leschenaultii AB472360.1 
Saimiri sciureus AF294757.1 
Sorex araneus ENSSART00000012781 
Sus scrofa NM214399.1 
Syncerus caffer AB571652.1 
Tursiops truncatus ENSTTRT00000009040 
Vulpes vulpes AJ621189.1 
IL7 
Bos taurus NM173924.2 
Canis lupus familiaris NM001048138.1 
Cavia porcellus ENSCPOT00000010043 
Chlorocebus sabaeus FJ194487.1 
Dasypus novemcinctus ENSDNOT00000016289 
Erinaceus europaeus ENSEEUT00000014134 
Gorilla gorila ENSGGOT00000000478 
Homo sapiens NM000880.3 
Macaca mulatta NM001032846.1 
Mus musculus NM008371.4 
Myotis lucifugus ENSMLUT00000024474 
Nomascus leucogenys ENSNLET00000002660 
Ovis aries NM001009777.1 
Pteropus vampyrus ENSPVAT00000015872 
Rattus norvegicus NM013110.2 
Sorex araneus ENSSART00000003720 
Sus scrofa NM214135.1 
Tarsius syrichta ENSTSYT00000008272 
Tupaia belangeri ENSTBET00000007176 
Tursiops truncatus ENSTTRT00000000917 
Vicugna pacos ENSVPAT00000008415 
IL8 
Ailuropoda melanoleuca ENSAMET00000005297 
Bos indicus EU490318.1 
Bos taurus ENSBTAT00000026275 
Canis familiaris ENSCAFT00000004871 
Cavia porcellus NM001173399 
Cercocebus torquatus U19839.1 
Chlorocebus sabaeus FJ194488.1 
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Choloepus hoffmanni ENSCHOT00000003064 
Dasypus novemcinctus ENSDNOT00000003797 
Echinops telfairi ENSETET00000016665 
Equus caballus ENSECAT00000016212 
Felis catus NM001009281 
Gorilla gorila ENSGGOT00000028757 
Homo sapiens ENST00000307407 
Loxodonta africana ENSLAFT00000000483 
Macaca mulatta ENSMMUT00000005432 
Macaca nemestrina U19851.1 
Marmota monax EU332349.1 
Monodelphis domestica ENSMODT00000024364 
Myotis lucifugus ENSMLUT00000004869 
Nomascus leucogenys ENSNLET00000010117 
Ochotona prínceps ENSOPRT00000002239 
Oryctolagus cuniculus NM001082293 
Ovis aries NM001009401 
Pan troglodytes ENSPTRT00000030085 
Papio anubis NM001173537 
Pteropus vampyrus ENSPVAT00000015367 
Sorex araneus ENSSART00000007042 
Sus scrofa ENSSSCT00000009807 
Tarsius syrichta ENSTSYT00000004113 
Tupaia belangeri ENSTBET00000010783 
Tursiops truncatus AB096002.1 
Vicugna pacos ENSVPAT00000003176 
IL9 
Bos taurus ENSBTAT00000024340 
Cavia porcellus ENSCPOT00000028361 
Chlorocebus sabaeus FJ194489.1 
Choloepus hoffmanni ENSCHOT00000010002 
Dasypus novemcinctus ENSDNOT00000005394 
Felis catus ENSFCAT00000013935 
Gorilla gorilla ENSGGOT00000014167 
Homo sapiens ENST00000274520 
Loxodonta africana ENSLAFT00000018403 
Microcebus murinus ENSMICT00000007280 
Mus musculus ENSMUST00000022019 
Nomascus leucogenys ENSNLET00000010589 
Ochotona princeps ENSOPRT00000010013 
Otolemur garnettii ENSOGAT00000009580 
Pan troglodytes ENSPTRT00000031950 
Pteropus vampyrus ENSPVAT00000010067 
Rattus norvegicus ENSRNOT00000016187 
Sus scrofa ENSSSCT00000015636 
Tarsius syrichta ENSTSYT00000014523 
Tursiops truncatus ENSTTRT00000014180 
IL10 
Bos taurus NM174088.1 
Bubalus bubalis AB246351.1 
Bubalus carabanensis AB246276.1 
Callithrix jacchus DQ658154.1 
Camelus bactrianus AB246674.1 
Canis familiaris ENSCAFT00000018154 
Cavia porcellus ENSCPOT00000009023 
Cercocebus torquatus L26030.1 
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Cervus elaphus U11767.1 
Dipodomys ordii ENSDORT00000011288 
Echinops telfairi ENSETET00000011736 
Equus caballus NM001082490.1 
Felis catus NM001009209.1 
Gorilla gorilla ENSGGOT00000014347 
Homo sapiens NM000572.2 
Lama glama AB107649.1 
Loxodonta africana ENSLAFT00000021835 
Macaca fascicularis AB000514.1 
Macaca mulatta NM001044727.1 
Macaca nemestrina L26031.1 
Macropus eugenii ENSMEUT00000006795 
Marmota himalayana EF414445.1 
Marmota monax AY253723.1 
Meriones unguiculatus L37781.1 
Microcebus murinus ENSMICT00000008350 
Monodelphis domestica ENSMODT00000002607 
Mus musculus NM010548.2 
Myotis lucifugus ENSMLUT00000017719 
Nomascus leucogenys ENSNLET00000000987 
Oryctolagus cuniculus AF068058.1 
Otolemur garnettii ENSOGAT00000004080 
Ovis aries NM001009327.1 
Pan troglodytes NM001135620.2 
Papio hamadryas AY796417.1 
Peromyscus maniculatus AY251293.1 
Procavia capensis ENSPCAT00000008764 
Rattus norvegicus NM012854. 2 
Rousettus leschenaultii AB472361.1 
Saimiri sciureus AF294758.1 
Sorex araneus ENSSART00000004540 
Sus Scrofa MN214041.1 
Syncerus caffer AB571124.1 
Trichosurus vulpecula AF026277.1 
Vulpes vulpes AJ621190.1 
IL12A 
Bos taurus ENSBTAT00000020153 
Bubalus carabanensis AB246272.1 
Canis familiaris ENSCAFT00000022543 
Capra hircus AF003542.1 
Cavia porcellus NM 001172840.1 
Cercocebus torquatus U19835.1 
Cervus elaphus U57751.1 
Equus caballus ENSECAT00000026617 
Erinaceus europaeus ENSEEUT00000004467 
Felis catus NM 001009833.1 
Gorilla gorilla ENSGGOT00000006855 
Homo sapiens ENST00000305579 
Lama glama AB107653.1 
Loxodonta africana ENSLAFT00000001088 
Macaca mulatta ENSMMUT00000032477 
Microcebus murinus ENSMICT00000006469 
Mus musculus ENSMUST00000029345 
Oryctolagus cuniculus ENSOCUT00000010149 
Otolemur garnettii/ ENSOGAG00000013000:ENSOGAT00000013001 
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Ovis aries NM 001009736.1 
Pan troglodytes ENSPTRT00000029052 
Papio anubis NM 001112637.1 
Pteropus vampyrus ENSPVAT00000006081 
Rattus norvegicus ENSRNOT00000012831 
Sigmodon hispidus AF421396.1 
Sus scrofa ENSSSCT00000012840 
Tursiops truncatus ENSTTRG00000009289:ENSTTRT00000009287 
IL12B 
Bos taurus ENSBTAT00000006222 
Bubalus bubalis AY198121.1 
Bubalus carabanensis AB246273.1 
Canis familiaris ENSCAFT00000027382 
Capra hircus AF007576.1 
Cavia porcellus NM 001172967.1 
Cercocebus torquatus U19834.1 
Cervus elaphus U57752.1 
Choloepus hoffmanni ENSCHOT00000000421 
Equus caballus ENSECAT00000013594 
Felis catus NM 001077413.1 
Gorilla gorilla ENSGGOT00000004439 
Homo sapiens ENST00000231228 
Lama glama AB107654.1 
Loxodonta africana ENSLAFT00000015755 
Macaca mulatta ENSMMUT00000030533 
Marmota monax X97019.1 
Mesocricetus auratus AB085792.1 
Mus musculus ENSMUST00000170513 
Myotis lucifugus ENSMLUT00000006353 
Nomascus leucogenys ENSNLET00000005482 
Ochotona princeps ENSOPRT00000013152 
Oryctolagus cuniculus ENSOCUT00000016318 
Otolemur garnettii ENSOGAT00000014013 
Ovis aries NM 001009438.1 
Pan troglodytes ENSPTRT00000032327 
Papio anubis AY234218.1 
Pongo abelii ENSPPYT00000018623 
Pteropus vampyrus ENSPVAT00000006918 
Rattus norvegicus ENSRNOT00000067620 
Sigmodon hispidus AF421395.1 
Sus scrofa ENSSSCT00000018557 
Tupaia belangeri ENSTBET00000009324 
IL14 
Ailuropoda melanoleuca XM 002921887.1 
Bos taurus XM 002685068.1 
Callithrix jacchus XM 002750558.1 
Canis lupus familiaris XM 544439.2 
Cricetulus griseus XM 003500640.1 
Equus caballus XM 001503841.2 
Gorilla gorilla ENSGGOG00000001571:ENSGGOT00000001581 
Homo Sapiens NM 175852.3 
Loxodonta africana XM 003415281.1 
Mus musculus NM 001005506.3 
Myotis lucifugus ENSMLUG00000017480:ENSMLUT00000017484 
Nomascus leucogenys XM 003276358.1 
Oryctolagus cuniculus ENSOCUT00000007529 
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Otolemur garnettii ENSOGAG00000009458:ENSOGAT00000009463 
Rattus norvegicus NM 001127633.1 
Sus scrofa XM 003127774.3 
Tarsius syrichta ENSTSYG00000000340:ENSTSYT00000000340 
Tursiops truncatus ENSTTRG00000009711:ENSTTRT00000009712 
IL15 
Ailuropoda melanoleuca EU375450.1 
Bos taurus NM 174090.1 
Bubalus bubalis AJ891036.1 
Cavia porcellus NM 001172829.1 
Cercopithecus aethiops U03099.1 
Chlorocebus sabaeus FJ194485.1 
Dipodomys ordii ENSDORT00000014153 
Equus caballus NM 001163986.1 
Felis catus NM 001009207.1 
Gorilla gorilla ENSGGOT00000011327 
Homo sapiens NM 000585.4 
Loxodonta africana ENSLAFT00000008638 
Macaca mulatta NM 001044731.1 
Macaca thibetana DQ021912.1 
Marmota himalayana EF414446.1 
Marmota monax AY426605.1 
Microcebus murinus ENSMICT00000003152 
Mus musculus NM 008357.1 
Myotis lucifugus ENSMLUT00000007614 
Nomascus leucogenys ENSNLEG00000005257:ENSNLET00000006706 
Oryctolagus cuniculus NM 001082216.1 
Otolemur garnettii ENSOGAG00000011090:ENSOGAT00000011094 
Ovis aries NM 001009734.1 
Pan troglodytes ENSPTRT00000030607 
Procavia capensis ENSPCAT00000013218 
Pteropus vampyrus ENSPVAT00000006435 
Rattus norvegicus NM 013129.2 
Sus scrofa NM 214390.1 
Tursiops truncatus ENSTTRG00000000131:ENSTTRT00000000131 
IL16 
Bos taurus ENSBTAT00000014556 
Callithrix jacchus ENSCJAT00000015521 
Canis familiaris ENSCAFT00000021964 
Cavia porcellus ENSCPOT00000015641 
Equus caballus ENSECAT00000024507 
Homo sapiens ENST00000394660 
Loxodonta africana ENSLAFT00000002339 
Macaca mulatta ENSMMUT00000016182 
Mus musculus ENSMUST00000001792 
Nomascus leucogenys ENSNLET00000001717 
Ochotona princeps ENSOPRT00000002093 
Oryctolagus cuniculus ENSOCUT00000010388 
Pan troglodytes ENSPTRG00000007369:ENSPTRT00000013586 
Pongo abelii ENSPPYT00000007936 
Pteropus vampyrus ENSPVAT00000016174 
Rattus norvegicus ENSRNOT00000016289 
Sus scrofa ENSSSCT00000002002 
IL17A 
Bos taurus NM 001008412.1 
Canis lupus familiaris NM 001165878.1 
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Capra hircus GU269912.1 
Cavia porcellus ENSCPOG00000010505:ENSCPOT00000010600 
Dipodomys ordii ENSDORG00000008932:ENSDORT00000008930 
Echinops telfairi ETEG00000002530:ENSETET00000002529 
Equus caballus NM 001143792.1 
Erinaceus europaeus ENSEEUG00000006605:ENSEEUT00000006571 
Felis catus ENSFCAG00000010067:ENSFCAT00000010070 
Gorilla gorilla ENSGGOG00000009736:ENSGGOT00000009771 
Homo sapiens ENST00000340057 
Loxodonta africana ENSLAFG00000001544:ENSLAFT00000001544 
Macaca mulatta XM 001106391.2 
Macropus eugenii ENSMEUG00000005305:ENSMEUT00000005320 
Microcebus murinus ENSMICG00000008438:ENSMICT00000008434 
Mus musculus ENSMUST00000027061 
Myotis lucifugus ENSMLUG00000001736:ENSMLUT00000001737 
Nomascus leucogenys ENSNLEG00000003884:ENSNLET00000004937 
Oryctolagus cuniculus ENSOCUG00000004270:ENSOCUT00000004268 
Pan troglodytes XM 527408.2 
Procavia capensis ENSPCAG00000011830:ENSPCAT00000011752 
Pteropus vampyrus ENSPVAG00000010174:ENSPVAT00000010174 
Rattus norvegicus ENSRNOT00000016664 
Sorex araneus ENSSARG00000007196:ENSSART00000007184 
Sus scrofa NM 001005729.1 
Tursiops truncatus ENSTTRG00000004836:ENSTTRT00000004832 
Vicugna pacos ENSVPAG00000000545:ENSVPAT00000000545 
IL17C 
Bos taurus ENSBTAG00000047128:ENSBTAT00000065977 
Canis familiaris ENSCAFG00000019883:ENSCAFT00000031634 
Cavia porcellus ENSCPOG00000001017:ENSCPOT00000001025 
Equus caballus ENSECAG00000009737:ENSECAT00000009944 
Gorilla gorilla ENSGGOG00000012533:ENSGGOT00000012570 
Homo sapiens NM 013278.3 
Microcebus murinus ENSMICG00000006713:ENSMICT00000006706 
Mus musculus NM 145834.3 
Myotis lucifugus ENSMLUG00000008861:ENSMLUT00000008843 
Nomascus leucogenys ENSNLEG00000000566:ENSNLET00000000696 
Ochotona princeps ENSOPRG00000006630:ENSOPRT00000006620 
Otolemur garnettii ENSOGAG00000000416:ENSOGAT00000000417 
Pan troglodytes ENSPTRG00000008457:ENSPTRT00000015582 
Procavia capensis ENSPCAG00000010041:ENSPCAT00000009979 
Pteropus vampyrus ENSPVAG00000017351:ENSPVAT00000017350 
Rattus norvegicus ENSRNOG00000013007:ENSRNOT00000017358 
Sorex araneus ENSSARG00000001623:ENSSART00000001615 
Tursiops truncatus ENSTTRG00000006251:ENSTTRT00000006245 
IL18 
Bos taurus NM174091.2 
Boselaphus tragocamelus AY842499.1 
Bubalus bubalis AY394479.1 
Canis lupus familiaris NM001003169.1 
Capra hircus AY605263.1 
Cavia porcellus AB025722.1 
Choloepus hoffmanni ENSCHOT00000003599 
Equus caballus NM001082512.1 
Felis catus NM001009213.2 
Gorilla gorilla ENSGGOT00000015920 
Homo sapiens NM001243211.1 
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Loxodonta africana ENSLAFT00000026165 
Macaca mulatta NM001032834.1 
Meriones unguiculatus AY095932.1 
Mus musculus NM008360.1 
Nomascus leucogenys ENSNLET00000009316 
Nyctereutes procyonoides EU200969.1 
Oryctolagus cuniculus NM001122940.1 
Ovis aries NM001009263.1 
Pan troglodytes ENSPTRT00000007973 
Rattus norvegicus NM019165.1 
Sus scrofa NM213997.1 
Vicugna pacos ENSVPAT00000000057 
Vulpes vulpes EF581889.1 
IL20 
Bos taurus ENSBTAT00000003574 
Canis familiaris ENSCAFT00000018180 
Cavia porcellus ENSCPOT00000005092 
Choloepus hoffmanni ENSCHOT00000010825 
Dasypus novemcinctus ENSDNOT00000014500 
Dipodomys ordii ENSDORT00000008856 
Equus caballus ENSECAT00000009853 
Felis catus ENSFCAG00000013827:ENSFCAT00000013831 
Gorilla gorilla ENSGGOT00000013318 
Homo sapiens ENST00000367096 
Loxodonta africana ENSLAFT00000018715 
Macaca mulatta ENSMMUT00000033157 
Microcebus murinus ENSMICT00000008363 
Monodelphis domestica ENSMODG00000002115:ENSMODT00000002626 
Mus musculus ENSMUST00000027673 
Nomascus leucogenys ENSNLET00000001030 
Ochotona princeps ENSOPRT00000011337 
Oryctolagus cuniculus ENSOCUT00000014282 
Otolemur garnettii ENSOGAT00000004083 
Pan troglodytes ENSPTRT00000003492 
Rattus norvegicus DQ229286.1 
Sus scrofa ENSSSCG00000015654:ENSSSCT00000017051 
Tarsius syrichta ENSTSYT00000008788 
Tupaia belangeri ENSTBET00000012959 
Tursiops truncatus ENSTTRT00000012109 
IL21 
Bos taurus ENSBTAT00000016413 
Canis familiaris ENSCAFT00000006415 
Cavia porcellus ENSCPOT00000012550 
Echinops telfairi ENSETET00000013163 
Homo sapiens ENST00000264497 
Loxodonta africana ENSLAFT00000006023 
Macaca mulatta ENSMMUT00000004728 
Mus musculus ENSMUST00000029273 
Myotis lucifugus ENSMLUT00000010925 
Nomascus leucogenys ENSNLET00000012063 
Oryctolagus cuniculus ENSOCUT00000015297 
Pan troglodytes ENSPTRT00000030528 
Pteropus vampyrus ENSPVAT00000016467 
Rattus norvegicus ENSRNOT00000023348 
Sus scrofa ENSSSCT00000009953 
Tarsius syrichta ENSTSYT00000002221 
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Tupaia belangeri ENSTBET00000015850 
Tursiops truncatus ENSTTRT00000014492 
Vicugna pacos ENSVPAT00000010534 
IL22 
Bos taurus ENSBTAT00000020476 
Canis familiaris ENSCAFT00000000647 
Capra hircus HM542482.1 
Cavia porcellus ENSCPOT00000010011 
Dasypus novemcinctus ENSDNOT00000005432 
Equus caballus XM 001491754.2 
Erinaceus europaeus ENSEEUT00000004607 
Gorilla gorilla ENSGGOT00000008988 
Homo sapiens ENST00000538666 
Macaca mulatta ENSMMUT00000026319 
Microcebus murinus ENSMICT00000003649 
Mus musculus ENSMUST00000096691 
Myotis lucifugus ENSMLUT00000002706 
Nomascus leucogenys ENSNLET00000004491 
Ochotona princeps ENSOPRT00000017262 
Oryctolagus cuniculus ENSOCUT00000001663 
Otolemur garnettii ENSOGAT0000000431 
Ovis aries HE617662.1 
Pan troglodytes ENSPTRG00000005195:ENSPTRT0000000952 
Procavia capensis ENSPCAT00000004576 
Pteropus vampyrus ENSPVAT00000015053 
Rattus norvegicus ENSRNOT00000009776 
Spermophilus tridecemlineatus ENSSTOT00000012769 
Sus scrofa ENSSSCT00000000520 
Tursiops truncatus ENSTTRT00000006507 
IL25 
Bos taurus ENSBTAT00000008806 
Canis familiaris ENSCAFT00000018418 
Cavia porcellus ENSCPOT00000007094 
Erinaceus europaeus ENSEEUT00000013993 
Gorilla gorilla ENSGGOT00000017179 
Homo sapiens ENST00000329715 
Loxodonta africana ENSLAFT00000016968 
Macropus eugenii ENSMEUT00000008676 
Mus musculus ENSMUST00000037863 
Myotis lucifugus ENSMLUT00000017213 
Ochotona princeps ENSOPRT00000016503 
Oryctolagus cuniculus ENSOCUT00000011024 
Otolemur garnettii ENSOGAT00000008716 
Ovis aries NM 001195219.1 
Pan troglodytes ENSPTRT00000011316 
Pteropus vampyrus ENSPVAT00000005164 
Rattus norvegicus ENSRNOT00000022563 
Spermophilus tridecemlineatus ENSSTOT00000002552 
Sus scrofa ENSSSCT00000002267 
Tupaia belangeri ENSTBET00000000948 
IL26 
Canis familiaris ENSCAFT00000000644 
Choloepus hoffmanni ENSCHOT00000007234 
Echinops telfairi ENSETET00000005718 
Felis catus ENSFCAT00000010577 
Gorilla gorilla ENSGGOT00000011227 
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Homo sapiens ENST00000229134 
Macaca mulatta ENSMMUT00000006205 
Microcebus murinus ENSMICT00000003642 
Myotis lucifugus ENSMLUT00000002700 
Nomascus leucogenys ENSNLET00000004457 
Oryctolagus cuniculus ENSOCUT00000000495 
Otolemur garnettii ENSOGAT00000028397 
Pan troglodytes ENSPTRT00000009541 
Procavia capensis ENSPCAT00000005542 
Pteropus vampyrus ENSPVAT00000015051 
Sorex araneus ENSSART00000002471 
Sus scrofa ENSSSCT00000000518 
Tupaia belangeri ENSTBET00000000479 
Tursiops truncatus ENSTTRT00000006497 
Vicugna pacos ENSVPAT00000000924 
IL27B 
Bos taurus ENSBTAG00000012829:ENSBTAT00000017046 
Canis familiaris ENSCAFG00000019114:ENSCAFT00000030356 
Cavia porcellus ENSCPOG00000000706:ENSCPOT00000000711 
Equus caballus ENSECAG00000018667:ENSECAT00000019767 
Gorilla gorilla ENSGGOG00000011932:ENSGGOT00000011974 
Homo sapiens ENSG00000105246:ENST00000221847 
Loxodonta africana ENSLAFG00000022621:ENSLAFT00000022044 
Macaca mulatta ENSMMUG00000010099:ENSMMUT00000014097 
Mus musculus ENSMUSG00000003206:ENSMUST00000003274 
Myotis lucifugus ENSMLUG00000008782:ENSMLUT00000008775 
Nomascus leucogenys ENSNLET00000003939 
Otolemur garnettii ENSOGAG00000001661:ENSOGAT00000001662 
Pan troglodytes ENSPTRG00000010298:ENSPTRT00000018919 
Pteropus vampyrus ENSPVAG00000016926:ENSPVAT00000016926 
Rattus norvegicus NM 001109421.1 
Sus scrofa ENSSSCG00000013498:ENSSSCT00000014744 
IL31 
Canis lupus familiaris NM 001165914.1 
Echinops telfairi ENSETEG00000012673:ENSETET00000012673 
Gorilla gorilla ENSGGOG00000005159:ENSGGOT00000005183 
Homo sapiens ENST00000377035 
Loxodonta africana ENSLAFG00000016441:ENSLAFT00000016441 
Macaca mulatta XM 001096743.2 
Microcebus murinus ENSMICG00000001165:ENSMICT00000001164 
Nomascus leucogenys ENSNLEG00000001440:ENSNLET00000001788 
Otolemur garnettii ENSOGAG00000032826:ENSOGAT00000029496 
Pan troglodytes XM 001166732.2 
Pteropus vampyrus ENSPVAG00000001268:ENSPVAT00000001268 
Tarsius syrichta ENSTSYG00000009008:ENSTSYT00000009006 
Tupaia belangeri ENSTBEG00000003295:ENSTBET00000003277 
Tursiops truncatus ENSTTRG00000015785:ENSTTRT00000015781 
IL34 
Bos taurus ENSBTAT00000049652 
Canis familiaris ENSCAFT00000032088 
Dipodomys ordii ENSDORT00000009844 
Equus caballus XM 001500794.1 
Erinaceus europaeus ENSEEUT00000005513 
Gorilla gorilla ENSGGOT00000032414 
Homo sapiens ENST00000288098 
Loxodonta africana ENSLAFT00000009189 
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Macaca mulatta ENSMMUT00000028714 
Mus musculus ENSMUST00000076846 
Nomascus leucogenys ENSNLET00000020565 
Ochotona princeps ENSOPRT00000009881 
Otolemur garnettii ENSOGAT00000000060 
Pan troglodytes ENSPTRT00000015330 
Rattus norvegicus ENSRNOT00000023823 
Spermophilus tridecemlineatus ENSSTOT00000015368 
Sus scrofa EU872447.1 
IL36A 
Bos taurus ENSBTAG00000002087:ENSBTAT00000002694 
Cavia porcellus ENSCPOG00000015601:ENSCPOT00000015754 
Echinops telfairi ENSETEG00000011917:ENSETET00000011916 
Erinaceus europaeus ENSEEUG00000006257:ENSEEUT00000006228 
Gorilla gorilla ENSGGOG00000015991:ENSGGOT00000016039 
Homo sapiens ENSG00000136694:ENST00000259211 
Loxodonta africana ENSLAFG00000032446:ENSLAFT00000027734 
Macaca mulatta ENSMMUG00000000988:ENSMMUT00000001409 
Mus musculus ENSMUSG00000026984:ENSMUST00000028361 
Ochotona princeps ENSOPRG00000012842:ENSOPRT00000012832 
Oryctolagus cuniculus ENSOCUG00000014998:ENSOCUT00000014993 
Otolemur garnettii ENSOGAG00000016767:ENSOGAT00000016770 
Pan troglodytes ENSPTRG00000012375:ENSPTRT00000022974 
Procavia capensis ENSPCAG00000007974:ENSPCAT00000007935 
Rattus norvegicus ENSRNOG00000005722:ENSRNOT00000007540 
Sorex araneus ENSSARG00000003704:ENSSART00000003683 
Spermophilus tridecemlineatus ENSSTOG00000001732:ENSSTOT00000001728 
Tarsius syrichta ENSTSYG00000013789:ENSTSYT00000013787 
IL36G 
Bos taurus ENSBTAG00000002085:ENSBTAT00000045402 
Callithrix jacchus ENSCJAG00000013959:ENSCJAT00000027116 
Canis familiaris ENSCAFG00000007267:ENSCAFT00000011633 
Dipodomys ordii ENSDORG00000013003:ENSDORT00000013003 
Echinops telfairi ENSETEG00000011919:ENSETET00000011919 
Erinaceus europaeus ENSEEUG00000006174:ENSEEUT00000006151 
Gorilla gorilla ENSGGOG00000015985:ENSGGOT00000016036 
Homo sapiens NM 019618.2 
Loxodonta africana ENSLAFG00000022694:ENSLAFT00000022158 
Macaca mulatta ENSMMUG00000000989:ENSMMUT00000043106 
Microcebus murinus ENSMICG00000016744:ENSMICT00000016740 
Mus musculus AY071843.1 
Nomascus leucogenys ENSNLEG00000001973:ENSNLET00000002475 
Ochotona princeps ENSOPRG00000016759:ENSOPRT00000016757 
Oryctolagus cuniculus ENSOCUG00000006660:ENSOCUT00000006659 
Otolemur garnettii ENSOGAG00000016763:ENSOGAT00000016767 
Pan troglodytes ENSPTRG00000012374:ENSPTRT00000022973 
Pteropus vampyrus ENSPVAG00000010752:ENSPVAT00000010752 
Rattus norvegicus ENSRNOG00000005701:ENSRNOT00000007512 
Spermophilus tridecemlineatus ENSSTOG00000001727:ENSSTOT00000001723 
Tursiops truncatus ENSTTRG00000011809:ENSTTRT00000011811 
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Table 3. 4. Characterization of the amino acids possibilities for each residue identified under positive selection 
for each IL. 
Position Amino acid 
IL1A 
104 T*,  P#, I#, A#, V#, L#, S*, K*+ 
122 V#, M#, A#, E*-, R*+, T*, G#, L# 
132 H*+, Q*, G#, S*, R*+, K*+ 
173 S*, V#,  L#, T*, P#, K*+,  I# 
174 S*, A#, E*-, K*+, P#, R*+, G# 
175 K*+, E*-, D*-, G#, S*, A#, L#, N*, T* 
180 I#, V#, L#, D*-, F#, R*+, Y* 
215 T*, K*+, R*+, P#, I#, M# 
227 T*, K*+, N*, R*+, S*, I# 
230 T*, S*+, N*, I#, D*- 
248 Q*, H*+, G#, E*-, D*-, N*, S*, P#, V#, M# 
IL1B 
8 A#, T*, I#,  S*, N*, P#, F# 
84 T*, P#, I#, V#, A#, S*, Y*, G#, D*- 
IL2 
100 L#, P#, T*, S*, K*+, G# 
101 R*+, S*, N*, A#, K*+, T*, I#, E*-, Q*, G# 
124 T*, R*+, G#, S*, A#, K*+ 
IL4 
84 E*-, Q*, K*+, R*+, D*-, C*, N*, A#, T*, M#, G# 
105 R*+, K*+, E*-, Q*, S*, D*-, M#, G# 
106 F#, S*, L#, Y*, I#, C*, H*+, P#, E*-, D*-, A# 
120 L#, S*, A#, M#, K*+, G#, R*+, D*-, T*, Q* 
IL5 
100 G#, R*+, L#, Q*, S*, A# 
IL6 
8 A#, I#, T*, D*- 
46 P#, L#, T*, V#, Q*, S* 
55 K*+, D*-, G#, E*-, A#, Q*, N*, I# 
62 D*-, G#, R*+, W#, S*, L#, A#, K*+, M#, E*- 
75 S*, Y*, H*+, N*, F#, D*-, G#, E*- 
120 L#, S*, V#, M#, Q*, A# 
141 R*+, N*, G#, M#, I#, E*-, K*+ 
145 M#, F#, D*-, T*, I#, S*, K*+, R*+, N*, Q*, L# 
149 V#, G#, A#, N*, T*, I#, H*+, Y*, S* 
158 A#, V#, N*, E*-, G#, M#, Q*, I#, P#, L# 
161 L#, Q*, K*+, P#, A#, E*-, S*, R*+, T* 
162 D*-, S*, G#, Y*, H*+, N*, V#, E*-, T* 
168 D*-, E*-, N*, T*, V#, S*, K*+ 
174 S*, G#, N*, T*, D*-, L#, K*+, E*-, 
177 T*, S*, K*+, D*-, N*, A#, E*-, P# 
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IL7 
38 E*-, Q*, K*+, G#, S* 
47 Q*, D*-, Y*, E*-, I# 
51 S*, R*+, N*, I#, D*-,K*+ 
53 K*+, I#, L#, R*+, T*, N* 
54 E*-, D*-, N*, K*+, H*+, G# 
55 I#, F#, T*, N*, V# 
92 L#, F#, V#, S*, N* 
105 L#, S*, T*, E*- 
106 K*+, T*, R*+, I#, V# 
113 I#, T*, Q*, S*, K*+ 
IL8 
22 G#, D*-, A# 
30 K*+, S*, G#, A#, T* 
71 S*, Q*, V#, I#, F#, A#, K*+, T*, E*- 
IL9 
5 M#, V#, T*, A#, R*+, Y* 
24 L#, F#, H*+, S*, R*+, T* 
25 A#, M#, T*, L#, A#, Q*, S*, W#, V#, F# 
79 T*, S*, V#, K*+, A# 
84 R*+, E*-, T*, S*, K*+, G# 
86 P#, I#, H*+, S*, T*, L# 
106 Y*, F#, S*, V#, T*, L#, D*-, N* 
IL10 
18 A#, V#, T*, I#, F#, L#, S*, P# 
26 S*, L#, P#, E*-, G#, A#, Y*, N* 
63 N*, S*, D*-, T* 
71 L#, M#, Q* 
121 L#, V#, S*, M#, I#, R*+ 
IL12A 
39 H*+, N*, S*, Q*, D*-, A# 
161 A#, S*, G#, T*, V#, M# 
IL12B 
83 G#, T*, E*-, A#, S*, L# 
IL14 
501 P#, S*, T* 
IL15 
51 V#, H*+, I#, Q*, C*, E*- 
59 K*+, I#, R*+, T* 
105 A#, T*, E*-, M#, S*, V#, G#, H*+ 
106 S*, D*-, T*, P#, A#, N*, V# 
108 H*+, N*, K*+, Y*, S*, Q*, V#, R*+, D*-, E*- 
116 I#, F#, Y*, M#, L# 
IL16 
118 L#, A#, S*, P# 
188 A#, V#, M#, S*, L#, T* 
335 A#, G#, L#, T*, V#, I#, S* 
708 T*, I#, S*, A# 
745 N*, S*, G#, V#, H*+, R*+ 
111 
 
801 N*, T*, G#, H*+, S* 
930 N*, S*, T*, D*-, G#, A#, R*+ 
1075 L#, H*+, P#, S*, G# 
IL17A 
18 E*-, V#, M#, A#, G#, L# 
98 G#, R*+, S*, N*, F# 
IL17C 
11 T*, P#, I#, L#, F#, A#, G# 
17 L#, V#, T*, I#, M# 
IL18 
4 E*-, N*, I#, S*, G#, A#, Q* 
6 V#, A#, I#, S*, P# 
45 L#, V#, F#, A#, T* 
75 P#, A#, R*+, S*, T*, I#, N*, E*- 
105 E*-, K*+, N*, S*, T*, G#, R*+ 
180 L#, D*-, N*, C*, K*+, Y*, I#, F# 
192 E*-, P#, Q*, K*+, N*, L# 
IL20 
56 K*+, S*, R*+, E*-, Q*, N* 
62 I#, V#, F#, M#, L#, K*+ 
IL21 
86 S*, P#, A#, L# 
98 V#, L#, I#, M#, S*, D*- 
112 A#, T*, G#, E*-, S* 
119 R*+, E*-, S*, K*+, M#, I#, G# 
IL22 
8 V#, L#, A#, M#, G# 
53 T*, I#, F#, A#, N*, V# 
86 S*, N*, R*+, T*, G#, K*+, M# 
IL25 
137 K*+, G#, E*-, S*, H*+, D*-, R*+, Q* 
IL26 
2 L#, Q*, W#, R*+ 
IL27B 
114 S*, A#, V#, T*, I# 
IL31 
31 L#, F#, Q*, P#, S*, R*+, W#, G#, V# 
33 R*+, Q*, G#, P#, D*-, S* 
38 V#, I#, R*+, L#, E*-, Q*, W# 
56 V#, Q*, R*+, K*+, 
67 N*, S*, R*+, E*-, K*+, P#, Q* 
133 C*, N*, Q*, K*+, R*+, W#, H*+, L# 
IL34 
31 T*, G#, R*+, L#, M#, K*+, A#, P# 
IL36A 
2 E*-, S*, N*, A#, F#, Q*, D*- 
5 L#, S*, V#, F#, K*+, H*+ 
8 D*-, E*-, T*, K*+ G# I#, A#, P#, Y* 
9 T*, M#, Y*, E*-, K*+, H*+, S*, A#, Q*, V# 
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Polarity: *hydrophilic; #hydrophobic  
Charge: +positive; -negative  
 
12 Q*, W#, P#, R*+, K*+, L#, H*+, F# 
133 E*-, K*+, Q*, C*, T*, S*, A# 
IL36G 
2 C*, Y*, R*+, G#, N*, D*-, A#, S*, P#, E*-, H*+, Q*, L# 
5 I#, G#, Q*, H*+, R*+, W#, V#, Y*, D*-, I#, E*-, K*+ 
6 T*, N*, V#, Y*, L#, S*, F#, P# 
104 A#, V#, L#, D*-, S*, Q*, G#, M#, T* 
113 
 
CONVERGENT EVOLUTION OF IL6 IN TWO LEPORIDS (ORYCTOLAGUS  AND 
PENTALAGUS)  ORIGINATED AN EXTENDED PROTEIN 
 
Fabiana Neves, Joana Abrantes, Ana Pinheiro, Tereza Almeida, Paulo P Costa, Pedro 
J Esteves  
 
1. ABSTRACT 
Interleukin 6 (IL6) is a class-I helical cytokine with a broad spectrum of 
biological activities and a gene structure conserved throughout vertebrates, with 
5 coding exons. IL6 from European rabbits belonging to the subspecies 
Oryctolagus cuniculus cuniculus, was previously shown to differ from the other 
mammals by extending an additional 27 amino acids. However, in other leporids 
(Sylvilagus spp. and Lepus spp.) that diverged from the European rabbit ~12 
million years ago this mutation was not present. In this study we extended the 
study of IL6 for the O. c. algirus subspecies and five additional lagomorphs’ 
genera (Brachylagus, Bunolagus, Pentalagus, Romerolagus and Ochotona). 
We confirmed the presence of the mutated stop codon in both O. c. cuniculus 
and O. c. algirus.  We found that the typical stop codon is present in S. 
bachmani and L. europaeus, in agreement with previous reports, but also in 
Bunolagus, Brachylagus and Ochotona. Remarkably, in Pentalagus we 
detected a deletion of the stop codon causing an extension of IL6 for 17 extra 
residues. Our results indicate that the IL6 extension in those species occurred 
by two independent events: one occurred between 2 and 8 million years ago in 
the ancestral of the Oryctolagus subspecies, and the other occurred in a 
Pentalagus ancestral at a maximum of 9 million years ago. The absence of this 
IL6 extension in Bunolagus, sister genus of Oryctolagus, shows that this 
evolutionary event happened by convergence suggesting some functional 
relevance. 
 
Keywords: Interleukin 6 (IL6), Lagomorphs, Convergent evolution, 
Oryctolagus, Pentalagus 
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2. INTRODUCTION 
Interleukins are secreted proteins involved in multiple biological functions 
in the immune system that exert their function by binding to specific receptors. 
Interleukin 6 (IL6), also known as interferon beta 2, is a class-I helical cytokine 
with a broad spectrum of biological activities in immune regulation, 
hematopoiesis, inflammation and oncogenesis, among others (Akdis et al., 
2011; Huising et al., 2006; Kishimoto, 2010). This protein is produced after 
stimulation of several differents cells (T, B, smooth muscle cells, eosinophils, 
granolocytes, etc) with mononuclear phagocytes as the main source (Akdis et 
al., 2011; Huising et al., 2006; Tanabe et al., 1988). Essential for Th17 
differentiation, IL6 has a gene structure conserved throughout vertebrates, with 
5 coding exons (Huising et al., 2006; Tanabe et al., 1988). Characterized by 4 
long α helices (A, B, C and D), this immunoregulatory cytokine is able to 
activate a cell surface signaling assembly composed by IL6, IL6Rα (which 
interacts with low affinity with the D helix of IL6) and the shared signaling 
receptor gp130 that interacts with high affinity with IL6 in sites located in the A 
and C helices. IL6 first interacts with the extracelular region of IL6Rα, and then, 
this complex is able to associate with gp130 and initiate signaling (Akdis et al., 
2011; Kalai et al., 1997; Savino et al., 1994). Furthermore, it has been shown 
that in mammals IL6 has been evolving under strong positive selection (Neves 
et al., 2014). 
In the European rabbit, IL6 is involved in the immune response against a 
highly fatal and contagious viral disease, the rabbit hemorrhagic disease (RHD) 
(Abrantes et al., 2012; Marques et al., 2012; Teixeira et al., 2012). Previously, 
IL6 from European rabbits belonging to the subspecies Oryctolagus cuniculus 
cuniculus, was shown to differ from other mammals IL6 by extending an 
additional 27 amino acids (Perkins et al., 2000). A mutation in the typical stop 
codon, conserved in other mammals, into a glutamate encoding codon caused 
the elongation of IL6. However, in other leporids (Sylvilagus spp. and Lepus 
spp.) that diverged from the European rabbit ~12 million years ago (mya) 
(Esteves et al., 2005; Matthee et al., 2004), this mutation was not present. The 
family Leporidae, (Figure 3.2) includes 11 genera (Brachylagus, Bunolagus, 
Caprolagus, Lepus, Nesolagus, Oryctolagus, Pentalagus, Poelagus, 
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Pronolagus, Romerolagus and Sylvilagus) of which three are closely related to 
the Oryctolagus genus: Bunolagus is thought to have diverged from 
Oryctolagus at ~7mya, Caprolagus at ~8 mya and Pentalagus at ~9 mya 
(Matthee et al., 2004; Pinheiro et al., 2011). 
 
 
Figure 3. 2. Evolutionary topology showing the relationships within the order Lagomorpha based on a 
molecular super matrix. Adapted from Matthee et al., 2004. 
 
The aim of this study was to determine the evolution of IL6 in other 
lagomorphs, Oryctolagus cuniculus algirus, Brachylagus idahoensis, Sylvilagus 
bachmani, Lepus europaeus, Bunolagus monticularis, Pentalagus furnessi, 
Romerolagus diazi and Ochotona princeps.  
 
3. MATERIALS AND METHODS 
The IL6 gene was PCR-amplified with primers designed (Table 3.5) 
according to the European rabbit and O. princeps IL6 sequences available in 
public databases and sequenced for eight lagomorphs (conditions are available 
upon request): Oryctolagus cuniculus (subspecies O. c. cuniculus, and O. c. 
algirus), Brachylagus idahoensis, Bunolagus monticularis, Pentalagus furnessi, 
Sylvilagus bachmani, Lepus europaeus, Romerolagus diazi and Ochotona 
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princeps. All obtained sequences were submitted to GenBank and the following 
accession numbers provided: KJ939512-KJ939527. 
The obtained IL6 sequences were translated and compared with other 
mammalian IL6 sequences retrieved from public databases (GenBank, Ensembl 
and Uniprot). Sequences were aligned using ClustalW implemented in the 
software program BioEdit version 7.1.3 (Hall, 1999) and adjusted manually. 
For secondary structure prediction we used PsiPred 
(http://bioinf.cs.ucl.ac.uk/psipred/) (Buchan et al., 2013; Jones, 1999) and 
DiAminoacid Neural Network Application (DiANNA) 
(http://clavius.bc.edu/~clotelab/DiANNA/) (Ferre and Clote, 2006). These 
methods predict protein cysteines that create permanent structural disulfide 
bonds. Psipred uses Position Specific Iterated – BLAST (PSI-BLAST) searches 
of the non-redundant protein sequence database to obtain evolutionary 
information used to predict the secondary structure of the query protein. 
DiANNA is a neural network trained to recognize cysteines in an oxidized state 
(sulfur covalently bonded) from those in a reduced state.  
Putative N-glycosylation sites were predicted using NetNGlyc 1.0 server 
available at http://www.cbs.dtu.dk/services/NetNGlyc/ (Gupta et al., 2004). 
 
4. RESULTS/DISCUSSION 
In this study we amplified and sequenced the IL6 gene for eight different 
lagomorphs belonging to two families, Leporidae (rabbits and hares) and 
Ochotonidae (pikas), that separated ~35 mya (Matthee et al., 2004). We further 
compared our sequences to sequences of IL6 from representatives of most 
mammalian groups available in online databases (e.g.  Artiodactyla, Carnivores, 
Chiroptera, Primates, Rodents, etc). 
 
 
 
 
 
 
 
117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ta
bl
e 
3.
 5
. 
Li
st
 o
f 
pr
im
er
 p
ai
rs
 u
se
d 
by
 u
si
ng
 a
) 
th
e 
ge
no
m
ic
 D
N
A 
(g
D
N
A)
 a
s 
te
m
pl
at
e 
(p
os
iti
on
s 
ar
e 
ac
co
rd
in
g 
to
 O
ry
C
un
2.
0:
10
:7
77
12
92
:7
77
61
03
:1
 f
or
 L
ep
or
id
s 
an
d 
pi
ka
:s
ca
ffo
ld
_6
61
8:
68
35
9:
73
62
3:
1n
 fo
r O
. p
rin
ce
ps
), 
b)
 c
D
N
A 
as
 te
m
pl
at
e 
(p
os
iti
on
s 
ar
e 
ac
co
rd
in
g 
to
 N
M
_0
01
08
20
64
.2
 fo
r L
ep
or
id
s 
an
d 
XM
_0
04
58
25
61
.1
 fo
r O
. p
rin
ce
ps
. 
a)
  
Pr
im
er
s 
se
qu
en
ce
 (5
’- 
3’
) 
Pr
im
er
 n
am
e 
Po
si
tio
n 
in
 g
D
N
A 
(b
as
e 
pa
ir)
 
Ex
on
s 
am
pl
ifi
ed
 
Sp
ec
ie
s 
am
pl
ifi
ed
 
Leporids 
C
G
AC
G
TC
AC
AT
TG
C
AC
AA
TC
 
IL
6O
rc
uF
1 
13
4-
15
3 
E
xo
n1
 
+ 
ex
on
2 
O
.c
.c
un
ic
ul
us
, O
.c
.a
lg
iru
s,
 L
. e
ur
op
ae
us
, 
C
AG
G
G
TG
TT
C
C
TC
TC
TT
C
TG
 
IL
6O
rc
uR
1 
84
9-
86
8 
C
G
AC
TA
TG
AA
C
TC
C
TT
C
AC
 
IL
6O
rc
uF
1.
1 
35
2-
37
1 
S
. b
ac
hm
an
i, 
, B
.id
ah
oe
ns
is
, P
. f
ur
ne
ss
i, 
R
.d
ia
zi
 
G
AT
TC
TC
AC
G
TC
TC
G
C
TT
C
TC
 
IL
6O
rc
uR
1.
1 
94
1-
96
1 
C
TT
C
AG
C
AT
G
AG
C
G
G
TT
C
TG
 
IL
6O
rc
uF
2 
16
75
-1
69
4 
E
xo
n 
3 
+ 
ex
on
 4
 
O
.c
.c
un
ic
ul
us
, O
.c
.a
lg
iru
s,
 B
.id
ah
oe
ns
is
, S
. b
ac
hm
an
i, 
G
C
TG
AG
G
AG
AG
TT
C
AG
TT
G
 
IL
6O
rc
uR
2 
30
24
-3
04
2 
G
C
C
C
TC
TA
G
TG
G
TG
TT
TC
 
IL
6O
rc
uF
2a
 
16
46
-1
66
3 
L.
 e
ur
op
ae
us
, P
. f
ur
ne
ss
i, 
B
. m
on
tic
ul
ar
is
, R
.d
ia
zi
 
C
AA
AG
G
TG
G
G
TG
C
TC
C
TT
S 
IL
6O
rc
uR
2a
 
29
25
-2
94
3 
C
TT
C
C
AC
TG
AG
AG
G
AT
G
TG
TG
 
IL
6O
rc
uF
3 
44
79
-4
49
9 
E
xo
n 
5 
O
.c
.c
un
ic
ul
us
, O
.c
.a
lg
iru
s,
 B
.id
ah
oe
ns
is
, S
. b
ac
hm
an
i, 
L.
 
eu
ro
pa
eu
s,
 P
. f
ur
ne
ss
i, 
B
. m
on
tic
ul
ar
is
, R
.d
ia
zi
 
C
TA
G
G
AA
G
AT
G
AG
C
G
TT
AG
G
AC
 
IL
6O
rc
uR
3 
48
07
-4
82
8 
O.princeps 
G
C
TA
AG
G
C
TC
AT
TC
TG
C
C
TC
T 
IL
6O
cp
rF
1 
6-
25
 
E
xo
n1
 +
 
ex
on
 2
 
  
O
.p
rin
ce
ps
 
C
TT
C
TG
C
AG
TT
C
TC
TG
C
AG
C
 
IL
6O
cp
rR
1 
65
8-
67
7 
C
TT
C
TA
G
C
TG
AG
C
AT
G
AA
C
TG
G
 
IL
6O
cp
rF
2 
14
74
-1
49
5 
E
xo
n 
3 
+ 
ex
on
 4
 
C
TA
G
AG
G
AG
C
TC
AA
TC
G
TC
AG
 
IL
6O
cp
rR
2 
28
12
-2
83
2 
C
AC
TG
C
AG
AA
C
TC
AC
C
C
TA
AC
 
IL
6O
cp
rF
3 
36
70
-3
69
0 
E
xo
n 
5 
G
AA
TA
C
G
C
C
AT
C
C
TG
TC
C
AC
 
IL
6O
cp
rR
3 
40
29
-4
04
8 
 b)
 
Pr
im
er
s 
se
qu
en
ce
 (5
’- 
3’
) 
Pr
im
er
 n
am
e 
Po
si
tio
n 
in
 c
D
N
A
 
(b
as
e 
pa
ir)
 
Sp
ec
ie
s 
am
pl
ifi
ed
 
AT
G
AA
C
TC
C
TT
C
AC
AA
G
C
G
 
IL
6O
rc
uF
cD
N
A
 
1-
19
 
Le
po
rid
s 
C
TG
TC
C
AT
TG
G
AC
AC
AT
AA
 
IL
6O
rc
uR
cD
N
A
 
72
0-
73
8 
G
C
C
G
TG
G
G
C
C
TG
AT
G
TA
G
 
IL
6R
cD
N
A
 
64
0-
65
7 
AT
G
AA
C
TC
C
G
TC
TT
C
G
C
AA
G
 
IL
6O
cp
rF
cD
N
A
 
1-
20
 
O
.p
rin
ce
ps
 
G
C
G
G
TG
C
G
C
C
TG
AT
G
TA
G
 
IL
6O
cp
rR
cD
N
A
 
63
4-
65
1 
 
 
118 
 
 
Figure 3. 3. a) Alignment of IL-6 for the different mammalian species (GenBank, Ensembl and Uniprot 
reference numbers are given for the retrieved sequences). The extra cysteines in the extended IL-6 are 
boxed in black. (*) represent stop codons b) Alignment of the 3’UTR of IL-6 for the different lagomorphs 
studied. The stop codons are in lower-case letters and boxed in dark grey. *1 and *2 represent alleles; (.) 
represent identity with the reference sequence (O. c. cuniculus *1); (-) represent deletions; P. furnessi 
deletion is boxed in grey. 
 
Our results confirmed the presence of the mutated stop codon in both O. 
cuniculus subspecies (O. c. cuniculus and O. c. algirus) causing an extension of 
27 amino acids in the IL6 protein (Figure 3.3). In agreement with what has been 
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reported by Perkins et al., 2000, we observed that the typical stop codon is 
present in Sylvilagus and Lepus. We further observed the presence of the 
expected stop codon for Brachylagus idahoensis, Bunolagus monticularis, 
Romerolagus diazi and Ochotona princeps. Interestingly, for Pentalagus 
furnessi we found a 10 amino acid deletion starting at the typical stop codon. 
This deletion extends the IL6 coding sequence for 17 extra amino acids. 
Therefore, P. furnessi as in Oryctolagus spp. sequences translation of IL6 
continues into the sequence corresponding to the 3’ UTR in other leporids and 
stops in the next in-frame stop codon (81 and 51 nucleotides downstream for 
Oryctolagus spp. and P. furnessi, respectively). The extension of IL6 in 
Oryctolagus and Pentalagus, but not in Bunolagus, shows that two independent 
events led to a longer IL6 protein: i) in Oryctolagus spp. this extension is due to 
a mutation of the stop codon into a glutamate residue (E), and ii) in Pentalagus 
is due to the deletion of the stop codon. The mutation of the stop codon into a 
glutamate residue (E) occurred at least 2 mya in the ancestral of the two 
Oryctolagus subspecies (Carneiro et al., 2009) and at most at 7 mya after 
Oryctolagus diverged from all other leporids (Matthee et al., 2004). The deletion 
of the stop codon occurred at a maximum of ~9 million years ago when P. 
furnessi diverged from the other leporids (Matthee et al., 2004). Interestingly, in 
lagomorphs the IL6 3’UTR is well conserved, as had already been described for 
other species (Dassi et al., 2013; Duret et al., 1993; Paschoud et al., 2006). 
3’UTR is known to be important for translation, stabilization and localization of 
mRNA, and, alterations in this region, namely mutations in the stop codon, can 
cause translation de-regulation and may be associated with several diseases 
and their progressions (Chatterjee and Pal, 2009; Lau et al., 2010; Soifer et al., 
2007; Szostak and Gebauer, 2013). This region is also described to be 
important for the interaction between mRNA and related-proteins, and therefore, 
alteration in this region may alter these interactions leading to changes in 
structure and function of the gene (Chatterjee and Pal, 2009; Lau et al., 2010; 
Soifer et al., 2007; Szostak and Gebauer, 2013). Thus, while mutation of the 
stop codon and extension of IL6 might interfere with its functions, these are not 
expected to be negatively affected as they appeared independently in two 
leporid species. 
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In addition to these alterations, some specific differences were also 
observed: for O. princeps, 3 amino acid insertions (Val4, Ala31 and Pro32) and 
1 deletion at position 53 were detected, and for  L. europaeus and B. idahoensis 
there were 3 shared amino acid insertions (Tyr65, Ile66, Leu67). 
IL6 has 4 conserved cysteines (Cys) that form two disulfide bonds, 
Cys72-Cys78 and Cys101-Cys111 (amino acid residues were numbered from 
the ﬁrst human methionine residue, with signal peptide included in the 
numbering). The first bond is known to contribute minimally to IL6 activity, while 
the second is considered to be essential for human IL6 activity (Boulanger et 
al., 2003; Breton et al., 1995; Huising et al., 2006; Savino et al., 1993; Simpson 
et al., 1997; Somers et al., 1997; Xu et al., 1997). Additional cysteine residues 
are found in other mammalian species: Rousettus leschenaultia Cys5, 
Dipodomys ordii Cys10, Rattus norvegicus Cys116, Canis lupus familiaris 
Cys185 and Saimiri sciureus Cys204. For O. princeps we observed two extra 
cysteines: Cys81 and Cys196. Moreover, all studied leporids share a cysteine, 
Cys14, located in the signal peptide. Additionally, in the 27 amino acid 
extension O. cuniculus has four extra cysteines, Cys214, 216, 218 and 235, and 
in P. furnessi there are two extra cysteine residues, Cys48 and Cys235 (located 
in the 17 amino acid extension). The results of the analysis of protein secondary 
structure, using the PsiPred (Buchan et al., 2013; Jones, 1999) and DiANNA 
(Ferre and Clote, 2006) and the comparison with the human IL6 sequence, 
revealed a predicted extra helix in the extension of O. cuniculus (from Cys218 
to Phr222 included) and that the nine cysteine residues that exist in the coding 
sequence would form four predicted bonds, three of which do not match the 
disulfide bonds present in the human IL6 (Cys14-Cys78, Cys72-Cys216, 
Cys101-Cys111 and Cys214-Cys235). As for Pentalagus, the 17 amino acid 
extension increases the length of the 3’ terminal coil and the seven cysteine 
residues are predicted to form the following bonds: Cys14-Cys48, Cys72-Cys78 
and Cys101-Cys235. For the regular IL6 in O. princeps three cysteine bonds 
are predicted, the two links present in the human sequence and another 
between Cys81-Cys196. Disulﬁde bonds are considered to be the strongest link 
in proteins, being important for protein folding and stability (Petersen et al., 
1999; Simpson et al., 1997). According to some authors these bonds are also 
associated with functional differentiation of the proteins (Fass, 2012; Li et al., 
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2011). Although the biological implications of the predicted secondary structure 
remain to be assessed, the four additional cysteines present in the 3’ sequence 
of O. cuniculus may have some functional relevance, with implications in the IL6 
protein conformation and its interaction with receptors. 
Glycosylation is also important for protein structure and function. Indeed, 
glycosylation is involved in diverse biological processes ranging from protein 
folding to immune response (Helenius and Aebi, 2004; Rudd et al., 2001). Our 
search for putative N-glycosylation (Asn-X-Ser/Thr motifs where X can be any 
amino acid except proline) sites in Lagomorphs IL6 showed that, unlike human 
IL6 that has 2 potential N-glycosylation sites at Asn73 and Asn172 (Breton et 
al., 1995; Simpson et al., 1997; Xu et al., 1997), some Lagomorphs have only 1 
potential N-glycosylation site (O. princeps – Asn89, P. furnessi - Asn108, O. 
cuniculus and P. furnessi - Asn108; L. europaeus – Asn197), while others 
(Sylvilagus bachmani and Brachylagus idahoensis) have none. 
 
5. CONCLUSIONS 
Our results show the extension of IL6 in two different lagomorph genera: 
in Oryctolagus in which the extension of 27 amino acids is due to a mutation of 
the stop codon, and in Pentalagus in which the extension of 17 amino acids is 
due to a deletion of the typical stop codon. These events occurred 
independently in these two lineages and are the outcome of a process of 
convergent evolution to have a longer IL6. Biological implications of this 
extension remain to be assessed but its occurrence in two independent genera 
might suggest some functional relevance. Further  functional  and  structural  
studies  should  be  performed  to  fully understand the impact of these 
alterations in the IL6 of Oryctolagus and Pentalagus. 
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EVOLUTIONARY INSIGHTS FROM IL17A IN LAGOMORPHS  
 
Fabiana Neves, Joana Abrantes, Tereza Almeida, Paulo P Costa, Pedro J Esteves 
 
 
1. ABSTRACT 
In leporids, IL17A have been implicated in the host defense against 
extracellular pathogens, such as Francisella tularensis that infects hares and 
rabbits and causes the zoonotic disease tularemia. Here, we studied IL17A from 
five lagomorphs, European rabbit, pygmy rabbit, brush rabbit, European brown 
hare and American pika. We observed that this protein is highly conserved 
between these species, with a similarity of 97-99% in leporids and ~88% 
between leporids and American pika. The exon/intron structure, N-glycosylation 
sites and cysteine residues are conserved between lagomorphs. However, at 
codon 88, one of the interaction sites between IL17A and it receptor IL17RA 
there is an Arg>Pro mutation that only occurs in European rabbit and European 
brown hare. This could induce critical alterations in the IL17A structure, 
conformation and consequently modify its function. The differences observed 
between leporids and humans or rodents might also represent important 
alterations in protein structure and function. In addition, as for other interleukins, 
IL17A sequences of human and European rabbit are more closely related than 
the sequences of human and mouse or European rabbit and mouse. This study 
gives further support to the hypothesis that European rabbit might be a more 
suitable animal model for studies on human IL17. 
 
Keywords: Immune system, IL17, lagomorphs 
 
2. INTRODUCTION 
Interleukin 17, first known as cytotoxic T lymphocyte associated antigen 
(CTLA)-8, is originated from a T-cell derived factor with cytokine-like activity 
(Rouvier et al., 1993; Yao et al., 1995). With a ubiquitous expression in different 
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tissues, this protein, nowadays known as IL17A, has a sequence composition 
different from all the other cytokine families (Gaffen, 2008; Yao et al., 1995). 
IL17A, along with five functional homodimers (IL17B-F), one heterodimer 
(IL17A/F) and 5 receptors (IL17RA-RE), compose the IL17 family, which is 
important to adaptive immunity responses, namely as mediator of chronic 
inflammation and autoimmune diseases (Ely et al., 2009; Gaffen, 2008; 
Gerhardt et al., 2009; Ouyang et al., 2008). There is a wide range of genes that 
are targeted by IL17, such as pro-inflammatory and hematopoietic cytokines, 
genes associated with acute phase response and anti-microbial substances 
(Gaffen, 2008; Shen and Gaffen, 2008). This protein is also part of a subset of 
CD4 T helper (Th) cells known as Th17 which are able to establish a connection 
between innate and adaptive immune responses, being a complement to Th1 
and Th2 defense mechanisms (Hemdan et al., 2010). Furthermore, the 
production of IL17A is important for host defense against extracellular 
pathogens (fungi, viruses, bacteria and parasites) assisting in neutrophils 
recruitment and activation and also promoting antimicrobial peptides (Bettelli et 
al., 2007; Hemdan et al., 2010; Ishigame et al., 2009; Iwakura et al., 2011; van 
de Veerdonk et al., 2009). Studies in mice (Huang et al., 2004; Ishigame et al., 
2009; Khader and Gopal, 2010; Skyberg et al., 2013) and humans 
(Paranavitana et al., 2010; Tesmer et al., 2008; Zhu and Qian, 2012) 
highlighted the importance of IL17 expressing cells for immunity against several 
diseases, and low expression levels of IL17 and IL17RA make organisms more 
susceptible to disease, including those caused by extracellular pathogens such 
as Francisella tularensis.  
F. tularensis is a highly pathogenic Gram negative intracellular bacteria 
included by the Center of Disease Control and Prevention (CDC) into the 
category A of bioterrorism (http://emergency.cdc.gov/agent/agentlist.asp). Able 
to cause the zoonotic disease tularemia, this microorganism has several known 
hosts, from mammals to protozoans; however transmission to humans is 
normally associated with direct contact with lagomorphs, rodents and some 
arthropods (Carvalho et al., 2014; Kubelkova and A., 2015; Skyberg et al., 
2013; Valentino et al., 2010). In lagomorphs and rodents, F. tularensis has the 
ability to cause septicemia while in humans the outcome of infection is a multi-
system organ failure (Kim et al., 2010). There are several reports of F. 
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tularensis infections in leporids, mainly in rabbits (European rabbit and 
cottontails) (Lepitzki et al., 1990; Mailles and Vaillant, 2014; Wobeser et al., 
2009) and hares (Mailles and Vaillant, 2014; Rijks et al., 2013; Wobeser et al., 
2009) and despite an apparent period of stasis (2006-2010), there were some 
recently documented outbreaks of tularemia in Europe (Carvalho et al., 2014; 
Hestvik et al., 2015). 
The order Lagomorpha includes two families, Leporidae (rabbits and 
hares) with eleven genera and Ochotonidae (pikas) with only one genus, 
Ochotona (Matthee et al., 2004). Together with rodents, lagomorphs form the 
clade Glires, a sister group of Euarchonta that includes primates (Horner et al., 
2007; Murphy et al., 2001). Along with mouse, the European rabbit had been 
used as a research model for several human diseases, development of 
therapeutics and vaccines (Schnupf and Sansonetti, 2012). Several studies 
have suggested that the European rabbit may be a better research model than 
mouse (Fischer et al., 2012; Neves et al., 2015; Pinheiro et al., 2016; Vaure and 
Liu, 2014; Vuillaumier et al., 1997). With the exception of humans and mouse, 
there is a big gap of information on IL17A in other mammalian groups, including 
leporids. Thus, considering the important biological role of the European rabbit 
immune response against several diseases, including tularemia, we performed 
a genetic characterization of IL17A in four leporid genera (Oryctolagus, 
Brachylagus, Sylvilagus, Lepus).  
 
3. MATERIALS AND METHODS 
Samples of European rabbit (Oryctolagus cuniculus cuniculus and 
Oryctolagus cuniculus algirus), pygmy rabbit (Brachylagus idahoensis), brush 
rabbit (Sylvilagus bachmani) and European brown hare (Lepus europaeus) 
were provided by the CIBIO Lagomorpha tissue collection. Genomic DNA 
(gDNA) was extracted using the EasySpin Genomic DNA Minipreps Tissue Kit 
(Citomed, Torun, Poland) according to the manufacturer’s instructions. Total 
RNA was extracted by using the RNeasy Mini Kit also according to the 
manufacturer’s instructions (Qiagen, Hilden, Germany) from one specimen of 
European rabbit and one of European brown hare. Complementary DNA 
(cDNA) was synthesized using oligo(dT) as primers and SuperScript III reverse 
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transcriptase (Invitrogen, Carlsbad, CA, USA). The European rabbit and 
American pika IL17A sequences were retrieved from public databases 
(accession numbers are given in bold in Figure 1). PCR amplification was 
performed with the Multiplex PCR Kit (Qiagen) by using two pairs of primers 
designed according to the retrieved sequences (for genomic DNA F1- 
CGTCCAACCTCAGTTGATC + R1- CACTGTACCATCTATCCTGC and F2- 
CCTTCATTTACTCCCATTCG + R2- CATCCATCACATGGCCTAA; for cDNA 
the combination of primers F1+R2 was used). Sequencing was performed on 
an ABI PRISM 310 Genetic Analyzer (PE Applied Biosystems, Foster City, CA, 
USA) and PCR products were sequenced in both directions.  The sequences 
obtained were submitted to GenBank with the following accession numbers: 
KU163611-KU163619. 
Haplotype phases of the sequences obtained were reconstructed with 
the program PHASE, built into the software DnaSP (Librado and Rozas, 2009). 
Multiple Sequence Comparison by Log-Expectation (MUSCLE; 
http://www.ebi.ac.uk/) (Edgar, 2004) was used for sequence alignment. The 
putative N-glycosylation sites were predicted using NetNGlyc 1.0 
(http://www.cbs.dtu.dk/services/NetNGlyc/) (Gupta et al., 2004). 
The number of nucleotide differences per site between sequences was 
estimated in MEGA6 (Tamura et al., 2013) with the following options: bootstrap 
method (1000 replicates), p-distance as model and pairwise deletion for 
gaps/missing data treatment. A Maximum Likelihood approach was used to 
estimate the phylogenetic relationships between the IL17A nucleotide 
sequences by using MEGA6; the best-fit nucleotide substitution model was 
predicted by the same software and 1000 bootstrap replicates were used. 
 The secondary structure of IL17A was predicted using PsiPred 
(http://bioinf.cs.ucl.ac.uk/psipred/) (Buchan et al., 2013; Jones, 1999) and 
DiAminoacid Neural Network Application (DiANNA) 
(http://clavius.bc.edu/~clotelab/DiANNA/) (Ferre and Clote, 2006). Both 
methods predict protein cysteines that create disulfide bonds, but while PsiPred 
uses Position Specific Iterated – BLAST (PSI-BLAST) to obtain evolutionary 
information used to predict the secondary structure of the query protein, 
DiANNA is a neural network that recognize cysteines in an oxidized state (sulfur 
covalently bonded) distinguishing them from those in a reduced state. 
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4. RESULTS AND DISCUSSION 
In this study we amplified and sequenced the IL17A gene for four 
leporids species (European rabbit, European brown hare, brush rabbit and 
pygmy rabbit). For European rabbit (O. c. cuniculus) and European brown hare, 
both genomic and cDNA sequences were identical and only one of the 
sequences is presented; however both sequences have been assigned different 
accession numbers. These sequences were further compared to sequences of 
IL17A from another lagomorph, American pika (Ochotona princeps), and from 
representatives of the most relevant mammalian groups (e.g. Artiodactyla, 
Carnivores, Chiroptera, Primates, Rodents, etc.) available in online databases. 
In the European rabbit, IL17A is located in the forward strand of chromosome 
12 and has a similar structure to other mammals with three coding exons. The 
IL17A cDNA sequence obtained in this work for Lepus europaeus showed a 
similar structure. 
In humans, IL17A codes for a protein with 155 amino acids (aa) and has 
the ability to bind with high affinity to IL17RA and IL17RC (Ely et al., 2009; Liu 
et al., 2013; Sabat et al., 2013). The interaction between interleukins and their 
receptors is crucial for their function and signalling and any changes in the 
amino acid composition may induce alterations in the protein conformation. In 
humans and rodents these interactions sites are described (Ely et al., 2009; 
Sabat et al., 2013) and include Leu52, Ile54, Ser61, Ser70-Tyr72, Arg75, Arg84, 
Arg88-Val94, Trp96, Leu103, His114, His115, Asn117, Ser118, Gln122-Glu124, 
Leu128, Arg130, Phe139, Pro155-Met160 (Figure 3.4).  
In leporids, the IL17A codes for a protein with 153 aa and we observed 
that the sites that likely interact with the receptors are quite conserved. Indeed, 
from the thirty three amino acids involved in the linkage between IL17A and 
IL17RA, eighteen are conserved: twelve are maintained between mammals and 
the other six, despite being different, do not alter the charge neither the polarity. 
For the remaining fifteen amino acids, only three are differently charged, seven 
have distinct polarity and five have both different charge and polarity (Table 
3.6).  
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Between leporids these sites are highly conserved, but a mutation was 
observed that is located in the external coil of the IL17A in a site where this 
protein interacts with IL17RA (Figure 3.5).  
 
 
Figure 3. 5. 3D structures of the IL17A-IL17RA complex. IL17A appears in blue while IL17RA appears in 
grey. Marked in yellow is the 88Arg>Pro mutation described for leporids. 
 
This mutation, 88Arg>Pro, occurs in the European rabbit and in the 
European brown hare, while in brush rabbit and the American pika the amino 
acid present is a Proline as in most mammals. Some studies showed that 
Arg>Pro mutations have crucial effects in the protein function (Fang et al., 2007; 
Ferrer-Costa et al., 2002; Yap et al., 2005). Indeed, the 332Arg>Pro mutation in 
human Trim5α restricts infection by HIV-1 (Human Immunodeficiency Virus-1) 
(Yap et al., 2005) while the 132Arg>Pro mutation in the helicase protein of 
coronavirus infectious bronchitis virus was lethal to infectivity in vitro (Fang et 
al., 2007). Additionally, this mutation alters the physiochemical properties of the 
amino acid by changing from a basic polar and positively charged Arginine to a 
nonpolar and neutral Proline.  
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Table 3. 6. Characterization of the IL17A amino acids differences in the sites important for binding to 
IL17RA. 
Amino acid 
position 
Amino acids 
Leporids  
European rabbit 
European 
brown 
hare 
Brush 
rabbit 
Pygmy 
rabbit Other mammals 
52 L# M#, S* 
54 I# V#, S*, T* 
61 S* N*, K*+ 
70 S* T*, L# 
71 D*- 
72 Y* 
75 R*+ 
84 R*+ P#, V# 
88 R*+ P# P#, S* 
89 E*- D*- 
90 R*+ 
91 Y* F# 
92 P# S* 
93 S*, F# F# S* F#, P#, R*+ 
94 V# 
96 W# L# 
103 L# Q*, S*, M# 
114 H*+ P#, Y*, F#, L# 
115 H*+ 
117 N* 
118 S* 
122 Q* K*+ 
123 Q* 
124 E*- 
128 L# 
130 R*+ K*+ 
139 F# 
155 P# S* 
156 I# M# 
157 I# V# 
158 H*+ S*, R*+, Q*, K*+ 
159 H*+ Q*, Y*, T* 
160 M# I#, V#, A, L# 
The amino acid polarity (*hydrophilic; #hydrophobic) and charge (+positive; -negative) are properly 
annotated. The amino acid present in the human IL17A sequence is underlined. Numbering is according to 
the European rabbit IL17A sequence. 
 
 
Disulfide bounds and N-glycosylation sites (Asn-X-Ser/Thr/Cys motifs 
where X can be any amino acid except proline) are important for the protein 
structure, stability and function (Helenius and Aebi, 2004; Lee et al., 2015; Rudd 
et al., 2001). Disulphide bounds occur between cysteines side chains and these 
linkages are also important for protein protection (Fass, 2012). In human and 
rodents, IL17A has a cysteine knot fold characterized by two sets of paired β-
strands (1/2 and 3/4) interconnected by two disulfide bounds between strand 2 
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and 4 linked between four conserved cysteines (Cys100-Cys150 and Cys105-
Cys152) (Hymowitz et al., 2001; Liu et al., 2013; Wright et al., 2008). In addition 
to these cysteines two other cysteines are common to all mammals, Cys36 and 
Cys135. For the European rabbit, the Psi-Pred predicted secondary structure 
and the DIANNA predicted disulfide bonds results are in agreement to those 
obtained and described for human and rodents (Hymowitz et al., 2001; Liu et 
al., 2013). An extra linkage is also predicted between Cys31 and Cys135. When 
compared to other mammals, there is an extra cysteine (Cys19) in leporids 
located in the signal peptide. The rat and the European hedgehog also have an 
extra cysteine located in different sites of the signal peptide (Cys11 and Cys3, 
respectively). Given that the signal peptide is cleaved in order to the protein to 
become active, this extra cysteine should not have an impact in the IL17A 
structure. 
N-glycosylation is a crucial factor for the modulation of protein activity; 
therefore, alteration on these sites may interfere with recognition of targets, 
including receptors, and consequently affects the biological activity of the 
proteins and also their ability to diffuse through the organism (Chamorey et al., 
2002; Shental-Bechor and Levy, 2008). Human IL17A is N-glycosylated at 
Asn68. Detection of putative N-glycosylation sites indicated that this N-
glycosylation site is present in the majority of mammals, including rodents and 
lagomorphs. Other putative N-glycosylation sites were detected and include 
Asn56 in lagomorphs, pig and cattle, Asn51 in American pika and armadillo and 
Asn49 in the lesser hedgehog tenrec. The killer whale and the African bush 
elephant have no putative N-glycosylation sites. The implications of the 
absence/presence of N-glycosylation sites in IL17A are unknown, however 
some studies indicate that presence/removal of glycans in some proteins do not 
alter their folding or function, although a decrease in the protein dynamics is 
observed (Helenius and Aebi, 2004; Lee et al., 2015; Shental-Bechor and Levy, 
2008). 
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Table 3. 7. IL17A nucleotide distances (the lowest values are in bold and the highest values are 
underlined). 
 1 2 3 4 5 6 7 8 9 
1 European_rabbit (O.c.cuniculus) -         
2 European_rabbit (O.c.algirus) 0.002 -        
3 European brown hare 0.011 0.013 -       
4 Brush rabbit 0.011 0.013 0.013 -      
5 Pygmy rabbit 0.024 0.026 0.026 0.022 -     
6 American pika XM_004590436.2 0.112 0.115 0.120 0.112 0.112 -    
7 Human NM_002190.2 0.169 0.171 0.175 0.171 0.173 0.159 -   
8 Mouse NM_010552.3 0.251 0.251 0.249 0.249 0.245 0.240 0.236 -  
9 Rat NM_001106897.1 0.260 0.260 0.258 0.258 0.253 0.232 0.236 0.111 - 
 
Comparison of the nucleotide sequences (Table 3.7) indicated that in 
leporids, the European rabbit and the European brown hare IL17A sequences 
are the least divergent (0.011) while the European rabbit and the pygmy rabbit 
IL17 sequences are the most divergent (0.026). Between the European rabbit 
and American pika, the genetic diversity obtained was 0.112-0.115. For the 
remaining mammals the highest divergence occurs for the lesser hedgehog 
tenrec (0.312) and the lowest for the flying lemur (0.145). The comparison of the 
nucleotide diversity of several interleukins in the European rabbit suggested that 
it could represent a better animal model for research (Neves et al., 2015). For 
IL17A, similar results were obtained, with the human sequence being more 
closely related to the European rabbit (0.169) than to mouse or rat IL17A 
sequences (0.236). This is further supported by a Maximum Likelihood tree 
inferred for IL17A mammalian sequences (Figure 3.6). 
 
 
Figure 3. 6. Maximum Likelihood (ML) tree of the IL17A nucleotide sequences. Only bootstrap values ≥ 
94% are shown. In order to facilitate visualization, only one sequence/allele of each species was used. 
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5. CONCLUSIONS 
In the present study we sequenced and characterized IL17A for four 
leporids. Overall, the genomic organization, the location of the cysteine residues 
and the presence of N-glycosylation sites are highly conserved in leporids. 
Nevertheless, a single mutation was detected within the interaction site with 
IL17RA which may induce crucial changes in IL17A structure, function, stability, 
signaling and conformation. Further  functional  and  structural  studies  should  
be  performed  to  fully understand the impact of this specific mutation. The 
lowest divergence between the European rabbit and human IL17A sequences 
reinforces the hypothesis that the European rabbit might be a more suitable 
animal model for studies in the human innate immunity. 
(Neves et al., 2014) 
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GENETIC CHARACTERIZATION OF INTERLEUKINS (IL1Α,  IL1Β,  IL2, IL4, 
IL8, IL10, IL12A, IL12B, IL15 AND IL18) WITH RELEVANT BIOLOGICAL 
ROLES IN LAGOMORPHS 
 
Fabiana Neves, Joana Abrantes, Tereza Almeida, Ana Lemos de Matos, Paulo P 
Costa, Pedro J Esteves 
 
 
1. ABSTRACT 
Interleukins (ILs), as essential innate immune modulators, are involved in 
an array of biological processes. In the European rabbit (Oryctolagus cuniculus) 
IL1α, IL1β, IL2, IL4, IL8, IL10, IL12A, IL12B, IL15 and IL18 have been 
implicated in inflammatory processes and in the immune response against 
rabbit hemorrhagic disease virus and myxoma virus infections. In this study we 
characterized these ILs in six Lagomorpha species (European rabbit, pygmy 
rabbit, two cottontail rabbit species, European brown hare and American pika). 
Overall, these interleukins are conserved between lagomorphs, including in 
their exon/intron structure. Most differences were observed between leporids 
and American pika. Indeed, when comparing both, some relevant differences 
were observed in American pika such as the location of the stop codon in IL1α 
and IL2, the existence of a different transcript in IL8 and the number of cysteine 
residues in IL1β. Changes at N-glycosylation motifs were also detected in IL1, 
IL10, IL12B and IL15. IL1α is the protein that presents the highest evolutionary 
distances, in contrast to IL12A where the distances between lagomorphs are 
the lowest. For all these ILs, sequences of human and European rabbit are 
more closely related than between human and mouse or European rabbit and 
mouse.  
 
Keywords: Immune system, Interleukins, lagomorphs 
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2. INTRODUCTION 
Interleukins (ILs) are polypeptides of low molecular weight involved in 
several biological activities, including immunity, inflammation, inflammatory 
diseases, hematopoiesis, oncogenesis, and fertility, among others (Afzal et al., 
2012; Heinrich et al., 2003; Ishihara and Hirano, 2002). In vertebrates, many of 
these proteins participate in host defense with complementary and conflicting 
roles in induction, regulation and functioning of the immune system by 
regulating growth, differentiation, effector functions and survival of cells 
(Brocker et al., 2010; Kaiser et al., 2004). ILs are crucial for the immune 
response. They are produced as an integral part of the innate immune 
response, and have the ability to influence the result and nature of adaptive 
immune response (Brocker et al., 2010; Kaiser et al., 2004; O'Connell and 
McInerney, 2005; Zelus et al., 2000; Zhang and Nei, 2000). Despite these 
functions, ILs are also considered important therapeutic targets (Bessis and 
Boissier, 2001; He et al., 2014; Rossi et al., 2015), thereby any changes in their 
sequence or structure may lead to alteration in their normal functioning. In 
mammals, ILs encoding genes are among the ones with faster evolution 
(Brocker et al., 2010; O'Connell and McInerney, 2005), and 28 of the 46 known 
ILs present signatures of positive selection (Neves et al., 2014b). 
Although being well characterized in most mammalian groups, little is 
known about ILs in lagomorphs, with the exception of the European rabbit 
(Oryctolagus cuniculus). The order Lagomorpha comprises two families, 
Ochotonidae and Leporidae that diverged ~35 million years ago (mya) (Matthee 
et al., 2004). While family Ochotonidae comprise only one  genus (Ochotona or 
pikas), the family Leporidae comprises eleven genera of hares and rabbits 
widely distributed: pygmy rabbit (genus Brachylagus), riverine rabbit (genus 
Bunolagus), striped rabbit (genus Nesolagus), European rabbit (genus 
Oryctolagus), Amami rabbit (genus Pentalagus), Bunyoro rabbit (genus 
Poelagus), Red rock rabbit (genus Pronolagus), volcano rabbit (genus 
Romerolagus), cottontail rabbits (Sylvilagus spp.), hispid hare (genus 
Caprolagus) and true hares and jackrabbits (Lepus spp.) (Chapman and Flux, 
2008; Ge et al., 2013; Matthee et al., 2004). The ones that are more closely 
related to the Oryctolagus genus are Bunolagus, Caprolagus and Pentalagus 
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with divergence times of ~7, ~8 and ~9 mya, respectively. In contrast, 
Nesolagus, Poelagus and Pronolagus are the less related to Oryctolagus with 
divergence times of ~15 mya (Matthee et al., 2004). The other two leporidae 
genera with some information for ILs, Sylvilagus and Lepus, diverged from 
Oryctolagus at ~12 mya (Esteves et al., 2005; Matthee et al., 2004; Pinheiro et 
al., 2013; van der Loo et al., 2009). 
The European rabbit is one of the most used laboratory animal models 
for immunological research, including the study of atherosclerosis (Tian et al., 
2012), intestinal immunity (Jimenez-Garcia et al., 2004), arthritis (Desando et 
al., 2013), cancer (Kang and Grossniklaus, 2011), Alzheimer’s disease 
(Woodruff-Pak et al., 2007)  and several viral infections (Marchandeau et al., 
2014; Marques et al., 2012; Teixeira et al., 2012). In addition, the European 
rabbit is a key species in the Mediterranean ecosystem, where it is strongly 
affected by two viral diseases, the rabbit hemorrhagic disease (RHD) and 
myxomatosis (Abrantes et al., 2013; Dalton et al., 2014; Delibes-Mateos et al., 
2008; Garcia-Bocanegra et al., 2010; Lopes et al., 2014; Muller et al., 2009). 
RHD is caused by a single-stranded RNA virus, the rabbit hemorrhagic disease 
virus (RHDV), while myxomatosis is caused by the myxoma virus (MYXV), a 
double-stranded DNA virus. 
Rabbit resistance to both viral diseases is highly dependent on the 
immune response of the host in order to develop an effective adaptive immune 
response to control these viruses (Kerr and McFadden, 2002; Marques et al., 
2012). ILs are important in the European rabbit immune response against 
RHDV and MYXV infections (Marchandeau et al., 2014; Marques et al., 2012), 
but also in inflammatory processes (Perkins et al., 2000). For RHDV, IL1, IL2, 
IL6, IL8 and IL10 are among the most important ILs. Indeed, young European 
rabbits infected with RHDV showed an increase of IL1 during an early stage of 
infection until 18 hours post-infection, with a decrease to normal values at 24 
hours of infection while IL8 is particularly increased at 24 hours after infection, 
probably due to an increase of leucocyte migration to the site of infection 
(Marques et al., 2012). In contrast, in infected adult rabbits, IL10 is significantly 
increased in the course of the disease (Marques et al., 2012; Teixeira et al., 
2012). 
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For MYXV, IL12, IL15 and IL18 have an important anti-viral activity. 
Indeed, recombinants of myxoma virus expressing human IL12, despite being 
similar to the wild type, do not induce myxomatosis in rabbits (Stanford et al., 
2007). IL15 prevents lethal myxomatosis in the New Zealand rabbit breed 
through the stimulation of an immune response that leads to the elimination of 
the viral infection (Liu et al., 2009). Poxviruses developed the ability to block 
IL18 by interfering with proteins crucial for IL18 activation or function 
highlighting the importance of its anti-viral activity (Johnston and McFadden, 
2003, 2004; Vande Walle and Lamkanfi, 2011). In contrast, expression of 
European rabbit IL4 by recombinant myxoma virus strains increases virus 
virulence and overcomes genetic resistance in wild rabbits (Kerr et al., 2004). 
Considering the important biological role in the European rabbit immune 
response, we performed a genetic characterization of IL1, which includes two 
biologically similar antagonist proteins IL1α and IL1β , IL2, IL4, IL8, IL10, IL12A, 
IL12B, IL15 and IL18 in five Lagomorpha genera (Oryctolagus, Brachylagus, 
Sylvilagus, Lepus and Ochotona).  
 
3. MATERIALS AND METHODS 
Samples of European rabbit (O. c. cuniculus and O. c. algirus), pygmy 
rabbit (Brachylagus idahoensis), cottontail rabbits (brush rabbit - Sylvilagus 
bachmani and eastern cottontail - Sylvilagus floridanus), European brown hare 
(Lepus europaeus) and American pika (Ochotona princeps) were provided by 
the CIBIO Lagomorpha tissue collection. Genomic DNA (gDNA) was extracted 
using the EasySpin Genomic DNA Minipreps Tissue Kit (Citomed) according to 
the manufacturer’s instructions. Total RNA was extracted by using the RNeasy 
Mini Kit according to the manufacturer’s instructions (Qiagen) from one 
specimen of: European rabbit, European brown hare, eastern cottontail and 
American pika. Complementary DNA (cDNA) was synthesized using oligo(dT) 
as primers and SuperScript III reverse transcriptase (Invitrogen). The European 
rabbit and American pika IL sequences were retrieved from public databases 
(accession numbers are given in bold in Figure 3.7). PCR amplification was 
performed with the Multiplex PCR Kit (Qiagen) by using several pairs of primers 
designed according to the retrieved sequences (supplementary material Table 
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3.10). Sequencing was performed on an ABI PRISM 310 Genetic Analyzer (PE 
Applied Biosystems) and PCR products were sequenced in both directions.  
The sequences obtained were submitted to GenBank (accession numbers: 
KT216045-KT216070; KT273911-273919; KT279631-KT279692). 
The program PHASE, built into the software DnaSP (Librado and Rozas, 
2009), was used to reconstruct the haplotype phases of the obtained 
sequences that were aligned using MUltiple Sequence Comparison by Log-
Expectation (MUSCLE) available at http://www.ebi.ac.uk/ (Edgar, 2004). 
Putative N-glycosylation sites were predicted using the NetNGlyc 1.0 
server available at http://www.cbs.dtu.dk/services/NetNGlyc/ (Blom et al., 2004). 
Predicted splicing sites were determined by using the NetGene2 server 
available at http://www.cbs.dtu.dk/services/NetGene2/ (Brunak et al., 1991; 
Hebsgaard et al., 1996). 
The number of amino acid differences per site between sequences was 
estimated in MEGA6 (Tamura et al., 2013) with the options: bootstrap method 
(1000 replicates), p-distance as model and pairwise deletion for gaps/missing 
data treatment. A Maximum Likelihood (ML) approach was used to estimate, for 
each gene, the phylogenetic relationships between the amino acid sequences. 
The ML trees were estimated in MEGA6 by using the best-fit nucleotide 
substitution model predicted by the same software and bootstrap 1000 
replicates. In order to simplify the outputs and avoid duplicated sequences, only 
one sequence from each species was used.  
The secondary structure of each IL was predicted using PsiPred 
(http://bioinf.cs.ucl.ac.uk/psipred/) (Buchan et al., 2013; Jones, 1999) and 
DiAminoacid Neural Network Application (DiANNA) 
(http://clavius.bc.edu/~clotelab/DiANNA/) (Ferre and Clote, 2006). These 
methods predict protein cysteines that create permanent structural disulfide 
bonds. PsiPred uses Position Specific Iterated – BLAST (PSI-BLAST) searches 
of the non-redundant protein sequence database to obtain evolutionary 
information used to predict the secondary structure of the query protein. 
DiANNA is a neural network trained to recognize cysteines in an oxidized state 
(sulfur covalently bonded) telling them apart from those in a reduced state. 
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4. RESULTS  
The interleukins IL1α, IL1β, IL2, IL4, IL8, IL10, IL12A, IL12B, IL15 and 
IL18 were amplified from gDNA for the two European rabbit subspecies, 
European brown hare, pygmy rabbit, brush rabbit and American pika. These ILs 
were also successfully amplified from cDNA of European rabbit (O. c. 
cuniculus), European brown hare, eastern cottontail and American pika. The 
allelic forms identified in DnaSP are shown in Figure 3.7. The results obtained 
are summarized in Table 3.8. 
 
Table 3. 8. Summary of the alterations observed between lagomorph species for the ILs studied. 
 Insertion/Deletion Cysteine residues 
N-Glycosylation 
(N-X-T) 
IL1α American pika: deletion aa 52; insertion aa 179, aa 272-275 - 
Cottontails: N-X-T missing 
(Asn64) 
America pika: two different N-X-T 
(Asn55 and Asn92) 
IL1β 
American pika: deletion aa 39-43; 
deletion aa 102 and 108. 
Pygmy rabbit and cottontail rabbits: 
deletion aa254 
American pika: 
extra Cys aa 135. 
European rabbit and European 
brown hare: extra N-X-T (Asn254) 
IL2 
Pygmy rabbit: insertion aa 7 and 8. 
American pika: insertion aa 139-141 
and aa 174; deletion of aa 146. 
- - 
IL4 - - - 
IL8 American pika: insertion aa 50-53; - - 
IL10 - - European brown hare: extra N-X-T (Asn67) 
IL12A - Brush rabbit: extra cys aa 54 - 
IL12B 
European rabbit, Brush rabbit and 
European brown hare: insertion aa 
174-177; 
Brush rabbit, European brown hare 
and American pika: insertion aa 
189. 
- Brush rabbit: extra N-X-T (Asn147 and Asn 280); 
IL15 - American pika: extra Cys aa 140. 
Pygmy rabbit and European 
brown hare: N-X-T missing 
(Asn152). 
American pika: N-X-T missing 
(Asn168). 
IL18 European rabbit: deletion aa 14; - - 
 
IL1 
IL1 is composed by two proteins IL1α and IL1β. According to the public 
databases NCBI, Ensembl and Uniprot, in the European rabbit these proteins 
are located in tandem in the reverse strand of chromosome 2, while in the 
American pika they are located in the forward strand. 
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IL1α 
In lagomorphs, IL1α is organized into 7 exons, with 6 of them being 
coding exons. The coding sequence comprises 801 base pairs (bp) that 
translate into a protein with 267 amino acids (aa). However, for American pika, 
and like the human IL1α, the coding sequence has 813 bp translating into a 
protein with 271 aa (Figure 3.7.a). Some differences existed between 
lagomorphs: American pika presents an amino acid deletion at position 52 of 
the European rabbit and an insertion of five amino acids at positions 179 and 
from 272 to 275. All cysteine residues are conserved between lagomorphs 
(Cys14 and Cys47). Three potential N-glycosylation sites were detected for all 
leporids (Asn 64, Asn103 and Asn144), but Asn64 is absent in the cottontail 
rabbits studied. For American pika, there are two other potential N-glycosylation 
sites (Asn55 and Asn92).  
 
L1β 
In lagomorphs, IL1β comprises 6 coding exons, translating into proteins 
with different amino acid lengths: 268 aa in the European rabbit and 261 aa in 
American pika (Figure 3.7.b). In the American pika sequence we observed three 
deletions: five aa between positions 39 and 43 and which include the deletion of 
two cysteine residues that are conserved in all leporids; the two other deletions 
are located at amino acids 102 and 108. Between leporids there are nine 
conserved cysteines at sites 35, 42, 43, 54, 81, 105, 117, 126 and 189. In the 
American pika sequence, only four cysteines are conserved (Cys81, Cys117, 
Cys126 and Cys189), and an extra cysteine is found at position 135. All 
lagomorphs have a putative N-glycosylation site at Asn58; European rabbit and 
European brown hare have an additional putative N-glycosylation site at 
Asn254 that had been lost in both the brush rabbit and in the eastern cottontail 
rabbit due to a deletion of this amino acid. 
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Figure 3. 7. Alignment of the studied interleukins for the different lagomorphs a) IL1α; b) IL1β; c) IL2; d) 
IL4; e) IL8; f) detail of the splicing region of exon 2 of IL8, with the splicing regions underlined; g) IL10; h) 
IL12A; i) IL12B; j) IL15; k) IL18. GenBank and Ensembl accession numbers are indicated in bold for the 
retrieved sequences. Positively selected amino acids are boxed according to Neves et al., 2014. N-
glycosylation sites are shaded in light grey and cysteine residues are shaded in dark grey. (*) represent 
stop codons; (-) represent deletions; *1 and *2 represent alleles. The numbering is according to the 
European rabbit sequences. The signal peptide and indels, indicated as (-), were included in the 
numbering. 
 
IL2 
Regarding IL2 sequence, this protein is highly conserved between 
European rabbit, human, cat and horse. In the European rabbit, IL2 is located in 
the reverse strand of chromosome 15, with 4 coding exons that translate into a 
protein with 153 aa. In American pika IL2 has also 4 exons that translate into a 
156 aa protein (Figure 3.7.c). Differences between lagomorphs include the 
insertion of two aa in pygmy rabbit (Met7 and Phe8) and four aa in American 
pika (Thr139, Ser140, Arg141 and Asn174). In American pika we also observed 
a deletion of one aa that corresponds to position 146 of European rabbit. All 
cysteine residues are conserved between lagomorphs (Cys11, Cys94, Cys144 
and Cys164). The search of putative N-glycosylation sites identified one site 
(Asn127) common to all lagomorphs. 
 
IL4 
In the European rabbit, IL4 is located in chromosome 3 (forward strand). 
In the European rabbit and American pika, IL4 is organized into 4 coding exons 
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that translate into a protein of 147 aa (Figure 3.7.d). No alterations, including 
insertions/deletions, were observed between IL4 of lagomorphs. Also, cysteine 
residues were conserved (Cys13, Cys48, Cys70, Cys89, Cys115 and Cys123) 
and the same potential N-glycosylation site was detected (Asn62).  
 
IL8 
IL8 from European rabbit is located in the reverse strand of chromosome 
15 and it is encoded by 4 exons that translate into a 101 aa protein. For 
American pika, the coding sequence available in Ensembl.org 
(ENSOPRT00000002239) is only known by projection and it is incomplete by 
not starting with an initiation codon and by missing the stop codon. 
Nevertheless, we successfully amplified IL8 for American pika from both gDNA 
and cDNA (Figure 3.7.e and 3.7.f). Our results showed that American pika has 
an insertion of four aa (Gly50, Phe51, Pro52 and Thr53). The cysteine residues 
are conserved among lagomorph species (Cys48, Cys61, Cys63, Cys93 and 
Cys109) and there are no putative N-glycosylation sites.  
 
IL10 
IL10 from European rabbit is located in the forward strand of 
chromosome 2 and, in both the European rabbit and American pika, it is 
composed by 5 coding exons that translate into a protein with 178 aa (Figure 
3.7.g). The cysteine residues are conserved between species (Cys8, Cys9 
Cys30, Cys80, Cys126 and Cys132). The search for N-glycosylation sites 
revealed two potential sites in leporids (Asn100 and Asn134). Ans67 was also 
predicted for European brown hare and American pika has only one of the sites 
predicted for N-glycosylation (Asn134). 
 
IL12 
IL12 is a heterodimeric protein composed by two proteins, IL12A and 
IL12B. For European rabbit, and according to the public databases NCBI and 
Ensembl, the encoding genes are located in the forward strand of chromosome 
14 and in the reverse strand of chromosome 3, respectively.   
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IL12A 
IL12A from European rabbit is composed by 7 coding exons that 
translate into a protein with 219 aa. For American pika, there are 2 different 
coding sequences available in NCBI (XM_012930663.1) and Ensembl 
(ENSOPRT00000006274). When compared with the European rabbit 
sequence, the American pika sequence available in NCBI has a start codon 109 
amino acids upstream, while the sequence available in Ensembl is incomplete, 
since it lacks an initiation codon and amino acid information in the middle of the 
sequence.  We were not able to amplify IL12A from gDNA or cDNA of American 
pika (Figure 3.7.h). All cysteine residues are conserved between leporids (Cys2, 
Cys71, Cys98, Cys119, Cys130, Cys144, Cys157 and Cys230). In addition, 
brush rabbit presents an extra cysteine at position 54. Four potential N-
glycosylation sites were detected for all leporids (Asn73, Asn127, Asn141 and 
Asn214).  
 
IL12B 
IL12B from European rabbit and American pika is composed by 6 coding 
exons that translate into a protein with 324 and 329 aa, respectively. Despite all 
the attempts, we were unable to amplify IL12B from cDNA of any of the 
lagomorphs studied. Successful amplification from gDNA for all leporids showed 
that in the middle of exon 4 there is an insertion of four aa (Thr174 to Ala177) 
that is absent  in the predicted European rabbit sequence available in NCBI 
(XM_002710347.2). However, this insertion is present in human, mouse and rat 
cDNA (Figure 3.7.i). All cysteine residues (Cys2, Cys50, Cys90, Cys131, 
Cys142, Cys170, Cys194 and Cys200, Cys275, Cys291, Cys309 and Cys336) 
and the two potential N-glycosylation sites (Asn135, Asn223) are conserved 
between lagomorphs. In addition, brush rabbit evidenced two other potential N-
glycosylation sites (Asn147 and Asn280). 
 
IL15 
In the European rabbit, IL15 is located in chromosome 15 (reverse 
strand) and it is organized into 6 coding exons that translate into a protein with 
162 aa. There are two sequences described for the European rabbit in NCBI, 
with the accession numbers NM_001082216.2 and XM_008267272.1, being the 
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latter a variant with an insertion of one amino acid (Gln127) (Figure 3.7.j). For 
American pika the information available in NCBI and Ensembl is different for the 
5’ coding region. Amplification was only successful using the primers 
constructed according to the American pika IL15 sequence available in 
Ensembl (ENSOPRT00000008393). All cysteine residues are conserved in 
lagomorphs (Cys39, Cys42, Cys62, Cys107, Cys114, Cys158 and Cys161), 
although American pika has an extra cysteine (Cys40). Four potential N-
glycosylation sites were detected in lagomorphs, Asn132, Asn143, Asn152 and 
Asn168, but Asn152 is absent in pygmy rabbit and in European brown hare, 
and Asn168 is absent in American pika. 
 
IL18 
The European rabbit’s IL18 is located in the forward strand of 
chromosome 1 and is organized into 5 coding exons that translate into a protein 
with 192 aa. For American pika there are two different predicted sequences 
available, one from NCBI (XM_004585222.1) and the other from Ensembl 
(ENSOPRG00000012703). When compared with the other lagomorphs, the 
American pika sequence from NCBI had an insertion of six amino acids in the 
first exon, while exon 5 presented low amino acid identity and a smaller size. 
The sequence from Ensembl is incomplete since it lacks an initiation codon and 
exon 5 (Figure 3.7.k). For this reason, and despite all attempts, we were unable 
to amplify IL18 from gDNA or cDNA of American pika. The European rabbit has 
a deletion at amino acid 14 whereas all the other leporids have a glutamine 
residue. All cysteine residues are conserved between leporids (Cys16, Cys80, 
Cys110, Cys118 and Cys169). Our search revealed that Asn135 is the only 
putative N-glycosylation site.  
Regarding the number of amino acid differences, brush rabbit and pygmy 
rabbit are among the species more related for IL1, 2, 4 and 18, while cottontail 
rabbits and European rabbit evidenced a closer relationship for IL4, 8, 10, 12 
and 15. On the other hand, American pika was the most distantly related when 
compared to other lagomorphs (supplementary material Table 3.11). IL1α 
presented the higher amino acid distances between lagomorphs (0.038 – 0.308) 
while IL12A showed the lowest (0.018 – 0.096). When comparing the amino 
acids distances between human, mouse and European rabbit ILs sequences 
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(Table 3.9), we observed that for all the ILs studied the amino acid distances 
are significantly lower between human-European rabbit than between human-
mouse or European rabbit-mouse. These results were further confirmed with 
the phylogenetic analysis (Figure 3.8). Overall, we also observed that for the 
studied interleukins, lagomorphs cluster according to the accepted evolutionary 
topology. However, for IL1, IL10, IL12A, IL15 and IL18, these proteins present 
low bootstrap values to support these clusters.  
 
Table 3. 9. Amino acid distances between rabbit, mouse and human for the different interleukins studied 
(the lowest values for each interleukin are in bold). 
 
 
5. DISCUSSION 
Interleukins are important proteins for the innate and adaptive immune 
responses. In the European rabbit IL1α, IL1β, IL2, IL4, IL8, IL10, IL12A, IL12B, 
IL15 and IL18 have been implicated in the immune response against two highly 
fatal viral diseases, rabbit hemorrhagic disease and myxomatosis, and in 
inflammatory processes. Recently, we described a mutation in the European 
rabbit and Amami rabbit (Pentalagus furnessi) IL6 stop codon that leads to a 
larger protein with a considerable increase of the number of cysteines (Neves et 
al., 2014a). For the ILs included in this study, no significant alterations were 
  Rabbit Mouse 
IL1α Human 0.350 0.383 Rabbit - 0.383 
IL1β Human 0.254 0.315 Rabbit - 0.271 
IL2 Human 0.199 0.373 Rabbit - 0.399 
IL4 Human 0.463 0.564 Rabbit - 0.593 
IL8 Human 0.192 - Rabbit - - 
IL10 Human 0.202 0.270 Rabbit - 0.281 
IL12A Human 0.183 0.400 Rabbit - 0.391 
IL12B Human 0.177 0.310 Rabbit - 0.341 
IL15 Human 0.167 0.272 Rabbit - 0.259 
IL18 Human 0.266 0.358 Rabbit - 0.389 
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observed in any of the stop codons. Interestingly, American pika IL1α and IL2 
sequences presented an insertion of four and one aa, respectively, in the site 
where the others lagomorphs have a stop codon. 
 
 
Figure 3. 8. Maximum Likelihood (ML) trees of the interleukins studied a) IL1α; b) IL1β; c) IL2; d) IL4; e) 
IL8; f) IL10; g) IL12A; h) IL12B; i) IL15; j) IL18. Only bootstrap values ≥ 0.75 are shown. In order to 
facilitate visualization, only one sequence/allele of each species was used. GenBank e Ensembl accession 
numbers are indicated for human, rodents and, in some cases, American pika sequences. 
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Some differences were observed between the European rabbit and the 
American pika sequences reported here and those already available in public 
databases (Supplementary material table 3.12). The major differences are in 
American pika IL8 and in the European rabbit IL12B, where both sequences 
have an insertion of 4 aa. However, the sequences available in public 
databases are predicted which might explain the differences observed. The 
remaining punctual differences are due to single polymorphisms arising from 
species diversity. 
Alternative splicing is an important step for the production of mature 
mRNA that leads to protein diversity and may occur by: exon skipping (38%); 
alternative 5’ or 3’ spliced sites (26%); intron retention (3%); mutually exclusive 
exons, alternative promoters or multiple polyadenylation sites (33%) (Keren et 
al., 2010; Sahoo and Im, 2010). Exon skipping occurs by cleavage of specific 
exon-intron motifs located in the 5’ and 3’ termini regions of the intron. These 
motifs include, by decreasing order of relevance, GT-AG, CG-AG, AC-AT or AT-
AC in the 5’ and 3’ regions, respectively (Holste and Ohler, 2008; Shimada et 
al., 2010; Wu and Krainer, 1999). Studies in the European rabbit reported 
alternative splicing in several ILs that leads to novel and functional proteins. 
Indeed, in IL2 and IL7 alternative splicing occurs with exclusion of exon 2 
(Perkins et al., 2000; Siewe et al., 2010); for IL4 the presence of two variants 
(δ2, δ3) results from splicing out of exons 2 and 3, respectively (Perkins et al., 
2000); for IL10 a spliced variant was described with the spliced region occurring 
between exon 5 and the 3’ UTR region (Perkins et al., 2000). Beside these 
variants, abnormal transcripts were also characterized for European rabbit IL4 
and IL10 (IL4 int2A, IL4 int3A, IL4 int3B and IL10/C) (Perkins et al., 2000). 
Although, more recently Mage and Mage suggested  that there is no frameshit 
in exon 2 of IL4 (Mage and Mage, 2012). When comparing American pika IL8 
sequence with the corresponding European rabbit sequence, we observed an 
insertion of four aa in the 5’ region of exon 2 which is derived from the 3’ region 
of the preceding intron. This suggests that in American pika the splicing 
occurred in a CA motif located 12bp upstream of the motif found in the 
European rabbit (Figure 3.7.f). These results were further confirmed by 
analyzing the human and American pika sequences using NetGene2 (Brunak et 
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al., 1991; Hebsgaard et al., 1996). Indeed, for human IL8 the splicing is 
predicted to occur by NetGene2 at nucleotide position 18 (Figure 3.7.f) 
(CCCCCAACA|GGTGCAGTTTT; with a 0.77 confidence value), while for 
American pika the confidence value is of 0.17, with the most likely splicing motif 
(confidence value of 0.65) being located at nucleotide position 6 
(TAATTTTCA|GGTTTCCCCA). Thus, IL8 from American pika has a different 
transcript. 
Disulfide bonds and glycosylation are important for protein protection 
against denaturation and proteolytic degradation (Bulaj, 2005). Disulﬁde bonds 
are formed between the thiol groups of cysteine residues and ensure important 
roles in folding, stability, function and in the regulation of protein activity, being 
well conserved between species (Bulaj, 2005; Fass, 2012; Li et al., 2011; Wong 
et al., 2011). In the studied ILs, and with the exception of IL1β, the cysteine 
residues are well conserved in lagomorphs. For American pika IL1β, and when 
comparing with other lagomorphs, the number and location of five out of nine 
cysteines residues is different. The analysis of protein secondary structure 
using PsiPred (Buchan et al., 2013; Jones, 1999) and DiANNA (Ferre and 
Clote, 2006) indicated that the loss of cysteine residues reduces the predicted 
bonds from four in the European rabbit (Cys35-Cys115; Cys42-Cys186; Cys43-
Cys123 and Cys54-Cys81) to two in American pika (Cys108-Cys125 and 
Cys116-Cys179). These differences lead to the formation of an extra helix 
(Gly84 to Phe89) in American pika (Figure 3.9). 
The glycosylation process is also important for several functions that 
include protein folding and interaction with cell surface receptors (Chamorey et 
al., 2002; Schwarz and Aebi, 2011). Thus, glycosylation can lead to protein 
diversity and modulation of protein properties (Chamorey et al., 2002; Helenius 
and Aebi, 2004; Rudd et al., 2001; Shental-Bechor and Levy, 2008). Putative N-
glycosylation sites prediction showed some differences between lagomorphs, in 
particular for IL1α, IL1β, IL10, IL12B and IL15, however the consequences of 
these alterations should be considered in future studies.  
Animal models are important tools for the study of human diseases. 
Historically, the European rabbit was the first animal model for immunological 
studies. Indeed, some of the foundations of molecular immunology were laid 
with the use of the European rabbit reviewed in (Pinheiro et al., 2011). 
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Nevertheless, over the last decade the European rabbit as a research animal 
model has been replaced by the mouse model due to its smaller size, lower 
cost, ease of breeding, etc (Webb, 2014). However, the choice of mouse as the 
best model to study human diseases has been controversial due to the high 
variability of results observed between mouse and human especially when the 
focus are inflammatory diseases (Burkhardt and Zlotnik, 2013; Mullane and 
Williams, 2014; Seok et al., 2013; Shay et al., 2015; Takao and Miyakawa, 
2015; Webb, 2014). 
 
 
Figure 3. 9. IL1β PsiPred sequence analysis results for the a) European rabbit and b) American pika (the 
extra helix is marked with a black circle). 
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A previous study in ILs showed that European rabbit-human sequences 
are more related than mouse-human or European rabbit-mouse sequences 
(Perkins et al., 2000). Overall, the results of the phylogenetic analysis are in 
agreement with the evolutionary topology described for lagomorphs (Matthee et 
al., 2004), where, the American pika is the most divergent species. 
Nevertheless, the ML trees depicted in figure 3.8 correspond to gene trees that 
do not necessarily reflect the true species tree (Nakhleh et al., 2009; Nichols, 
2001). Overall, the human IL sequences appear more closely related with those 
from European rabbit than with mouse and rat. This pattern had been already 
observed for other molecular markers and might suggest that the European 
rabbit might be a more appropriate animal model for the study of immunity in 
humans (Fischer et al., 2012; Koch et al., 2013; Perkins et al., 2000; Vaure and 
Liu, 2014; Vuillaumier et al., 1997; Wang et al., 2014). 
  
6. CONCLUSIONS 
In this study we sequenced and characterized ten interleukins for six 
lagomorph species and in the two European rabbit subspecies. As expected, 
most differences were observed between leporids and American pika. While 
these differences may lead to alterations in the biological roles of these 
proteins, the overall genomic organization, the location of the cysteine residues 
and the presence of N-glycosylation sites is well conserved. In addition, and 
according to divergence between the European rabbit and human for the ILs 
studied, the European rabbit might be a more suitable animal model for studies 
in the human innate immunity. 
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8.  SUPPLEMENTARY MATERIAL 
 Table 3. 10. Primers used for amplification of each interleukin in lagomorphs 
   Reference sequence Primers sequence (5’- 3’) Primer name Exons amplified Species amplified 
IL
1A
 
Le
po
rid
s 
OryCun2.0:2:97559306:97569785:
1 
 
CAATCTAGTAGAGGAGGCAG IL1AOrcuF1.1 
Exon 2 
European rabbit, European brown 
hare, Brush rabbit, Pygmy rabbit 
GCACAGCAATGGCTTGAATC IL1AOrcuR1 
CAAACTCCTGCTGAAAGRGTC IL1AOrcuF2b 
Exon 3 + exon 4 
GAAGAAGGTAAGGGGTAAG IL1AOrcuR2b 
CTGTGCTTGTAGGAGAGTG IL1AOrcuF3 
Exon 5 + exon 6 
CATCTGAATTCTCACCCAGC IL1AOrcuR3a 
GGTCATTGGCAATCTTCCTG IL1AOrcuF4 
Exon 7 
European rabbit, Brush rabbit, 
European brown hare CTGCTTGAAGCTGAGCTTC IL1AOrcuR4  
CACAGTCATGGTCCTRAAG IL1AOrcuF4a 
Pygmy rabbit 
GAAGCCAAGTCTAATGGSAC IL1AOrcuR4a 
NM_001101684.1 
ATGGCCAAAGTCCCTGAYC IL1AOrcuFcDNA 
cDNA European rabbit, Eastern cottontail 
CTGAKTTTCAGATCTCATAA IL1AOrcuRcDNA 
Am
er
ic
an
 p
ik
a 
GeneScaffold_4797:475551:48401
2:-1 
CTTCACAGGCATCTGGTAC IL1AOcprF1a  
Exon1 + exon 2 
American pika 
GGCGAGCAGTAGCTTGAATC IL1AOcprR1 
GGAGATCTTCCTAAGTCTGC IL1AOcprF2 
Exon 3 
GGTGTCAAGATAACAAGAGGC IL1AOcprR2 
GTATCGTCTGTGACAGTACC IL1AOcprF3 
Exon 4 + exon 5 
CAGAGAAGCCAACTGGTATC IL1AOcprR3 
CTGAGCCATACATCTAACAG IL1AOcprF4a 
Exon 6 + exon 7 
GTGCTGAGCCTGTGTAATTC IL1AOcprR4b  
IL
1B
 
Le
po
rid
s  
ATGGCAACAGTACCTGAGCTC IL1BOrcuF1  
Exon1 + exon 2 
+ exon 3 
European rabbit, Brush rabbit, 
Pygmy rabbit, 
GTGCTTGGAGACTAGATGTG IL1BOrcuRex1 
CTGCAYTTCATGCTCAGCTG IL1BOrcuRex2 
CTCAGAATCCATGGCTCAACAG IL1BOrcuR1 
CTAACCTWACTGTGTGCTC IL1BOrcuF1e 
European brown hare 
CCTTAATCTTTGAAGAAGG IL1BOrcuR1e 
TGACCACCCGTGCTTAGATGT IL1BOrcuF2 
Exon 4 + exon 5 
+ exon 6 
European rabbit,  Brush rabbit, 
European brown hare GACATCCTGGTTTCCCTTC IL1BOrcuRint2 
CATCACTCACTTCCCACACAG IL1BOrcuR2 
CACCTGTGCTCTCTGTTTC IL1BorcuF2a Pygmy rabbit, 
GWCCACCTTTCACTGCTGC IL1BOrcuF2d Exon 6 European brown hare 
CTTCAACCTGCTGAACCACA IL1BOrcuF3 
Exon 7 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit, GGTGCTGAATGTGTTCACC IL1BOrcuR3c  
 
ATGGCAACAGTACCTGAGC IL1BOrcuFcDNA 
cDNA Eastern cottontail 
GGAATTCGTGTCTTCCTRA IL1BOrcuRcDNA 
Am
er
ic
an
 p
ik
a 
 
CTCATTATGCGACGATGCC IL1BOcprF1a  
Exon1 + exon 2 
+ exon 3 
American pika 
GTTCTGGACCACCTTCTTC IL1BOcprRint1 
CTGTGAGCAGATAGTACAGC IL1BOcprR1 
GACCATCCATGCTTAGGTGT IL1BOcprF2 
Exon 4 + exon 5 
TGGCCATCACAGCCATCTGTT IL1BOcprR2 
CAGGTACTCTACTAAGACACGC IL1BOcprF3 
Exon 6 
CACGTTGTGATGCCTCACTG IL1BOcprR3b  
IL
2 
Le
po
rid
s OryCun2.0:15:98312429:98317577
:1 
CACGCTCTGTAATCACTACTC IL2OrcuF1 
Exon1 + exon 2 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit, GAGTACTATATAGCACCTC IL2OrcuR1a 
CTGGTCATAGCTACTGGAG IL2OrcuF2 
Exon 3 
European rabbit,  Brush rabbit, 
CATGCATCCAGAGCCAAG IL2OrcuR2b 
CAGGTCACAGAATTGAAAC IL2OrcuF2c European brown hare, Pygmy 
rabbit GYTCTCTCAGAAGTAAAM IL2OrcuR2c 
GGATGCTCATCCTCATTG IL2OrcuF3 
Exon 4 
Brush rabbit, Pygmy rabbit, 
GGGCTCTAAAATGGCTTCAC IL2OrcuR3 
CTGGCTCTATCCTGGTTTG IL2OrcuF3b European rabbit,  European brown 
hare, GGATGTATTGTTTGCTACC IL2OrcuR3a 
ENSOCUT00000010098 
 
CACGCTCTGTAATCACTACTC IL2OrcuF1 
cDNA Eastern cottontail 
GGGCTCTAAAATGGCTTCAC IL2OrcuR3 
Am
er
ic
an
 p
ik
a 
scaffold_6999:1:91496:1 
GCTTCTCTTGCTTAAGAGC IL2OcprF1a 
Exon1 + exon 2 
American pika 
GAGCAGAACACCTGAAGTG IL2OcprR1 
GTATAAGGGAAATGGTGGCTG IL2OcprF2a 
Exon 3 
CCTCAGTTCCACAGTTCAAC IL2OcprR2 
GGAGAAGCTCAGCCTTAAC IL2OcprF3 
Exon 4 
CCGTTCAAGACAAATCAGAC IL2OcprR3a 
IL
4 
Le
po
rid
s 
oryCun2:3:15702738:15715033:1 
GGTAGCGTCTCCTGATAAAC IL4OrcuF1 
Exon1 + exon 2 
European rabbit,  GAGACTTCTCCCMAKAC IL4OrcuF1c 
GAGAATCTGCGTCTTCACG IL4OrcuR1 
CATTGGTAGCGTCTCCTG IL4OrcuF1d European brown hare, Brush rabbit, 
Pygmy rabbit, CCAGGCTATCTGTAAGGTG IL4OrcuR1b 
GTGGCCGTCTGGTATTTCTC IL4OrcuF2a 
Exon 3 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit, 
GTGCTCTTCCAGACACTAGG IL4OrcuR2 
GCTTCCCAATGCAGCTAAC IL4OrcuF3a 
Exon 4 
CTTCTCAACGCTGTTCCTC IL4OrcuR3a 
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NM_001163177.1 
ATGGGGCTCCCTGCCCAG IL4OrcuFcDNA 
cDNA European rabbit,  European brown hare CTCWAAGCGTCRGAG IL4OrcuRcDNA 
Am
er
ic
an
 p
ik
a 
GeneScaffold_3588:636330:64401
5:1 
CTTCATCAGAATGCATCGG IL4OrcuF1a 
Exon1 + exon 2 
American pika 
CTGTCCACAAGGGTTAGAAC IL4OcprR1 
GAGTACTTGGCTACAGCTC IL4OcprF2 
Exon 3 
CTCCTGTTCAGGAGATGTAG IL4OcprR2 
CAAGTCCATAGGCATGAAAG IL4OcprF3 
Exon 4 
CAAAGCCAAGGTATGCAAC IL4OcprR3a 
IL
8 
Le
po
rid
s oryCun2:15:76368959:76371691:-1 
GAAGAAACCACTTCGCCTG IL8OrcuF1a 
Exon 1 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit, 
CATCTGTGTGCCACTTGTG IL8OrcuRint1a European rabbit,  European brown hare, Pygmy rabbit, 
GTCATCTGTATGCAACTC IL8OrcuRint1b Brush rabbit, 
GACAGTTCTCGGTACTGCA IL8OrcuF2a Exon 2 + exon 3 
+ exon 4 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit, CTGCATGGATCTGTCGTAG IL8OrcuR2a 
NM_001082293.1 
GAAGAAACCACTTCGCCTG IL8OrcuF1a 
cDNA European rabbit,  European brown hare, Eastern cottontail CTGCATGGATCTGTCGTAG IL8OrcuR2a 
Am
er
ic
an
 p
ik
a 
scaffold_1225:1:361409:1 
GCAGCAAGGAGCCAGAAG IL8OcprF1 
Exon1 + exon 2 
American pika 
CAGTATACTGCAAAGTTGGG IL8OcprR1 
CTGTGCTTCAAGGCCCATG IL8OcprF2 
Exon 3 + exon 4 
GGATCTGTCATAGAGTTGC IL8OcprR3b 
ENSOPRT00000002239 
ATGACTCCCAAGGTGGCTATG IL8OcprFcDNA 
cDNA 
GCTGAAAATCAAGCTTCATGA IL8OcprRcDNA 
IL
10
 
Le
po
rid
s OryCun2:16:65583171:65589395:1 
GCAAAAGCAAACCACAAGGC IL10OrcuF1b 
Exon1 + exon 2 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit, 
GTCCAGTTCTRTGTTGACTG IL10OrcuRint1a 
GATCTTAACTCAGCACTCAGC IL10OrcuR1 
GGAGGGTTACAAAGGACTAG IL10OrcuF2a 
Exon 3 + exon 4 
CTGTGAAGTGTCTTTGGGG IL10OrcuR2a 
CTCGGAGTGAAGATGCTTAG IL10OrcuF3 
Exon 5 
European rabbit,  Brush rabbit,  
GGAAAGCTGTTGTACCTCTC IL10OrcuR3a European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit, 
CAAAGTGACTCTCACCTTCC IL10OrcuF3a European brown hare, Pygmy rabbit, 
AF068058.1 
GCAAAAGCAAACCACAAGGC IL10OrcuF1b 
cDNA European rabbit,  European brown hare, GGAAAGCTGTTGTACCTCTC IL10OrcuR3a 
Am
er
ic
an
 p
ik
a 
 
GTGGAGCCTACCCATCAAG IL10OcprF1b 
Exon1 + exon 2 
+ exon3 
American pika 
GAGCATCAGAACAGCATGC IL10OcprF2a 
CATTCTGCAAGAGCTCCAAG IL10OcprR1a 
GTTGTGAACCTGCATAAGGC IL10OcprF2 
Exon 4 + exon 5 
CTCTGAGGCAGCTGACCCAGC IL10OcprR2b 
XM_004578691.1 
ATGCTCGGCTCTGCTCTAC IL10OcprF1a 
cDNA 
CCACGAGGATGAAAAGCTAA IL10OcprR2a 
IL
12
A
 
Le
po
rid
s 
OryCun2.0:14:54457840:54464306
:1 
CACGAGTCCACCCGCCTG IL12AOrcuF1a 
Exon1 + exon 2 
European rabbit,  
CAGCAGCATCCGCCCTC IL12AOrcuF1b  European brown hare, Brush rabbit, Pygmy rabbit, 
GTCTACACAGAGGAAACGAG IL12AOrcuR1 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit, 
GTTAGCAAGCTGAAGTTCTCC IL12AOrcuF2 
Exon 3 + exon 4 
+ exon 5 + exon 
6 
European rabbit,  
CTGCCTCATTCTGAAGATGG IL12AOrcuR2 
CTCCAGTCTCATGGGAAG IL12AOrcuF2b European brown hare, Brush rabbit, 
Pygmy rabbit, GAAAGCCAGGCAGAACTTC IL12AOrcuR2b 
GTCATRCTCTGTGTTCATTC IL12AOrcuF3a 
Exon 7 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit GTTGACCTGGTCCTACTG IL12AOrcuR3a 
ENSOCUT00000010149 
ATGTGCTCCCTGCGCGG IL12AOrcuFcDNA  European rabbit, Eastern cottontail 
GCTATCTGAGTTCTTCCTGA IL12AOrcuRcDNA 
IL
12
B
 
Le
po
rid
s 
OryCun2.0:3:40708623:40721869:
1 
GCTGCATAATTGCTGACATG IL12BOrcuF1a 
Exon 1 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit 
CTCAGAGTAAGGAGCCAACA IL12BOrcuR1 
CAGAGTGCATGGAGCTTAC IL12BOrcuF2 
Exon 2 + exon 3 
CTGAGAATAGTCGCTGCCATG IL12BOrcuR2 
CAGGCCTTATCTGTCTCAC IL12BOrcuF3a 
Exon 4 + exon 5 
 European brown hare, 
CACACCAGGAAGATGATGAAG IL12BOrcuR3a 
GCTCCCGTTAGTGTATAAC IL12BOrcuF3b European rabbit,  Brush rabbit, 
Pygmy rabbit GTAAGGTACGGTCTGGGTTC IL12BOrcuR3b 
CTGTCTTGTCACTGCATTGC IL12BOrcuF4 
Exon 6 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit CCCAGAGTCACAAGCTAAC IL12BOrcuR4b 
Am
er
ic
an
 p
ik
a 
scaffold_4486:1:129844:1 
CAACATTATTGACATGCCC IL12BOcprF1a 
Exon 1 + exon 2 
American pika 
CTGACACCTGCAAAGAACTTCC IL12BOcprR1 
GTGCAATGTAGTACTCTGCG IL12BOcprF2 
Exon 3 + exon 4 
CTTAAGCAACTTGCTCCAGG IL12BOcprR2 
CCATGTGCTCAGAGAAGTG IL12BOcprF3 
Exon 5 + exon 6 
GGGAGCATAGGGCCATAG IL12BOcprR3a 
IL
15
 
Le
po
rid
s 
oryCun2:15:22774049:22789507:-1 
GTCATAGCCAGCTCTTCTTC IL15OrcuF1 
Exon 1 + exon 2 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit 
GAGCTGTATTGGAAGCAGAG IL15OrcuR1 
GCACTRGTGYGCTCATTCCA IL15OrcuF2b 
Exon 3 
CTCCTTGTGTTTTCTGTCAC IL15OrcuR2b 
CCTGTACAAGAAGAGCAGG IL15OrcuF3 
Exon 4 
CTTAGGCTGAGTTAGGCATG IL15OrcuR3 
CCTCTCTCTGTGTAACTCTG IL15OrcuF4 
Exon 5 
CCATCCAGAATTACTCATGCGC IL15OrcuR4 
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GAAGTGCATTAGGCATGCC IL15OrcuF5 
Exon 6 
GYGGATCCTGTGCAGTG IL15OrcuR5a 
NM_001082216.2 
ATGAGAATTTCGAAACCG IL15OrcuFcDNA 
cDNA European rabbit, European brown hare GTTCATCAATTCTCCTTGA IL15OrcuRcDNA 
Am
er
i
ca
n 
pi
ka
 
ENSOPRT00000008393 
ATGACAATTTCGAAACC IL15OcprFcDNA 
cDNA American pika 
GTTCATCAACTCTCCTTGA IL15OcprR4 
IL
18
 
Le
po
rid
s oryCun2:1:104225304:104234571:
1 
GAGGTGGCACAAGTTAGTAG IL18OrcuF1a 
Exon 1 + exon 2 
European rabbit,  European brown 
hare, Brush rabbit, Pygmy rabbit 
GACACATCCATATCACCACG IL18OrcuR1  
GTAGGCAACACAGCAGTAAG IL18OrcuF2 
Exon 3 
European rabbit,  Brush rabbit, 
Pygmy rabbit 
yCTGAAATACATGRTAGGTC IL18OrcuF2a European brown hare 
CTTAGATGAAGTCACAGGAG IL18OrcuR2 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit 
GCCTGATCTTCTGCTGATTG IL18OrcuF3 
Exon 4 
European rabbit,  Brush rabbit,  
CTAGAGCACGAACAGCAG IL18OrcuR3 
CTCAGAGTTCAAGGTTGGC IL18OrcuF3a European brown hare, Pygmy 
rabbit GCTGTCACAGGGAAGATAG IL18OrcuR3a 
CTGCACATGTTCAAATTGCC IL18OrcuF4a 
Exon 5 European rabbit,  European brown hare, Brush rabbit, Pygmy rabbit CAGTCTATGAGCCTTATCTAGTC IL18OrcuR4a 
NM_001122940.1 
ATGGCTGCTGAACCAGAAG Il18FcDNA 
cDNA European rabbit,  European brown hare, Eastern cottontail CAGTGTCCAAAACAAGAATTAG IL18OrcuR4 
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Table 3. 12. Summary of the amino acid alterations observed between the sequences reported in this work 
and those already available in public databases for the ILs studied. 
 European rabbit American pika 
IL1α 30(Leu-Val); 128(Thr-Ile); 132(Ile-Asn);  
138(Thr-Ile); 247(Phe-Leu) 
105(Ser-Asn); 155(Tyr-Phe); 274(His-Gln) 
IL1β 68(Val-Ile); 108(Trp-Arg); 171(Asn-Ser) 17(Ser-Gly) 
IL2 - 12(Leu-Thr); 88(Glu-Asp); 138(Thr-Met) 
IL4 69(Val-Ile); 105(Arg-Lys); 118(Arg-Val) 988(His-Asn); 122(Asn-Tyr) 
IL8 - Insertion 4 aa (50-53) 
No coherence  in the last part of sequences. 
IL10 - - 
IL12A - - 
IL12B Insertion 4aa (179-182); 
21(Val-Met); 234(Ile-Val) 
25(Gln-Glu); 139(Arg-His); 219(Leu-Arg); 
234(Ile-Val) 
IL15 - - 
IL18 33(Thr-Ser) - 
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PSEUDOGENIZATION OF CCL14 IN THE OCHOTONIDAE (P IKA) FAMILY  
 
Fabiana Neves, Joana Abrantes, Andrey A. Lissovsky, Pedro J Esteves 
 
1. ABSTRACT 
The interaction between chemokines and their receptors is crucial for 
inflammatory cells trafficking. CCL14 binds with high affinity to the CCR5. In 
leporids, CCR5 underwent gene conversion with CCR2. In some leporid 
species, CCL8 is pseudogenized while CCL3, CCL4 and CCL5 are all 
functional. Here, we study the evolution of CCL14 in mammals with emphasis in 
the order Lagomorpha. By employing Maximum Likelihood methods we 
detected 6 sites under positive selection. The Tajima´s Relative Rate Test 
showed that the Ochotona princeps sequence evolved faster than in leporids. 
Sequencing of 10 Ochotona species showed that O. princeps, O. pallasi, O. 
alpina and O. turuchanensis have a mutation at the start codon (Met>Thr) while 
O. hoffmanni, O. mantchurica, O. dauurica and O. rufescens present the 
mammalian conserved Met. O. hyperborea has the two alleles. In O. pusilla, 
CCL14 is a pseudogene due to a 7 base pair insertion. Our results suggest that, 
in mammals, CCL14 is evolving under positive selection. Like CCL3, CCL4 and 
CCL5, CCL14 is functional in all leporids but in the Ochotonidae family it 
underwent a pseudogenization process, suggesting that CCL14 has an 
important biological role in other mammals that apparently has been lost in the 
Ochotonidae family.  
Keywords: Chemokine ligands, CCL14, Evolution, Ochotonidae, 
Pseudogenization 
 
2. INTRODUCTION 
Chemokines are proteins that have several functions in the immune 
system and are found only in vertebrates (Nomiyama et al., 2010). These 
proteins are encoded by a multigene family that emerged by gene duplication 
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events (Nomiyama et al., 2010). Gene duplication is considered a powerful 
force in the adaptive evolution of genes in which one gene gives rise to new 
copies (Ding et al., 2012; Levasseur and Pontarotti, 2011; Nomiyama et al., 
2013). These new copies can evolve by pseudogenization, neofunctionalization 
or subfunctionalization (Kaessmann, 2010; Levasseur and Pontarotti, 2011; 
Zhang, 2003). Pseudogenization is the process in which a redundant functional 
copy passes through mutational decay and loses its ability to produce a 
functional protein (Clark, 1994; Zhang, 2003). In the remaining processes, both 
copies escape to mutation as either one copy emerges into new functions 
(neofunctionalization) or either divides the functions with the other copy 
(subfunctionalization) (Kaessmann, 2010; Levasseur and Pontarotti, 2011; 
Lynch and Force, 2000). 
Chemokines can only exert their functions through the binding to specific 
receptors, having the ability to bind and activate different receptors; for 
example, CCL14 binds with high affinity to the chemokine receptors CCR1, 
CCR3 and CCR5 (Zlotnik and Yoshie, 2012). CCR5 is used as co-receptor by 
human immunodeficiency virus type-1 (HIV-1) for infection and, despite 
controversy, it has been also associated with myxoma virus infection in rabbits 
(Abrantes et al., 2008; Blain et al., 2007; Detheux et al., 2000; Lalani et al., 
1999; Lederman and Sieg, 2007; Masters et al., 2001; Munch et al., 2002; van 
der Loo et al., 2012). In some mammalian species, CCR5 underwent gene 
conversion with CCR2 (Abrantes et al., 2011; Carmo et al., 2006; Esteves et al., 
2007; Perelygin et al., 2008; Shields, 2000; Vazquez-Salat et al., 2007). Several 
studies have been conducted in the CCR5 ligands to determine the 
consequences of the CCR5-CCR2 gene conversion and its putative association 
with the myxoma virus infection. Indeed, the study of CCL8, a potential CCR5 
ligand, revealed that in some leporid species, such as Oryctolagus and 
Bunolagus, this ligand is pseudogenized whilst in Lepus and Sylvilagus is intact 
(van der Loo et al., 2012). A study on CCL3, CCL4 and CCL5 showed that, 
unlike CCL8, these genes are all functional in leporids (de Matos et al., 2014). 
Although mouse CCL12 is the true ortholog to human CCL8 (Islam et al., 2011), 
in leporids, the gene identified as CCL8 is the true ortholog as supported by 
their phylogenetic position within the mammalian CCL8 cluster (van der Loo et 
al., 2012). 
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In leporids, other CCR5 ligands remain to be studied, including CCL14. 
CCL14, also known as Hemofiltrate CC-Chemokine 1 (HCC-1), is found in high 
concentrations in blood plasma and acts as an inflammatory chemokine after N-
terminus cleavage (Blain et al., 2007; Richter et al., 2009; Schulz-Knappe et al., 
1996). In humans, this protein is located in the Macrophage Inflammatory 
protein (MIP) region of C-C chemokine genes (Nomiyama et al., 2010; Shibata 
et al., 2013) and is expressed in numerous tissues (Blain et al., 2007; 
D'Ambrosio et al., 2003; Richter et al., 2009; Zlotnik and Yoshie, 2012). In 
humans, CCL14 encodes a protein with 93 amino acids (aa) with 3 predicted 
cleavage sites (Thr25, Glu31, and Ser33) that are necessary for the protein to 
become active (Tsou et al., 1998). There are two described variants: one 
encoded by 3 exons in which the active CCL14 consists in a 74 aa protein after 
the signal peptide cleavage, and another variant encoded by 4 exons, which 
has an insertion of 48 nucleotides between exons 1 and 2 encoding 16 aa 
(Blain et al., 2007; Detheux et al., 2000; Nomiyama et al., 2010; Richter et al., 
2009). These forms have no effect against HIV-1 infection, however the cleaved 
form CCL14 (9-74) has the ability to block HIV-1 entry and replication (Munch et 
al., 2002). CCL14 (9-74) is an agonist of CCR1, CCR3 and CCR5 which 
promotes calcium influx and migration of T lymphocytes, monocytes and 
eosinophils; through the interaction with the second external loop of CCR5, it 
has also the ability to inhibit this receptor (Blain et al., 2007; Detheux et al., 
2000; Munch et al., 2002; Richter et al., 2009). In C-C chemokines there are 2 
main interactions important for receptor binding and activation, both located in 
the N-terminus close to the CC motif. In CCL14, the first interaction corresponds 
to the high affinity binding to the receptor and includes residues located after 
the CC motif, and the second interaction comprises the residues located before 
the CC motif and that are essential for the receptor activation (Blain et al., 2007; 
Lolis and Murphy, 2007; Pakianathan et al., 1997; Rajagopalan and 
Rajarathnam, 2006; Steen et al., 2014). The N-terminus is also important for 
CCL14 degradation (Savino et al., 2009). Degradation occurs following the 
binding of D6 to the N-terminus of CCL14 and then, through the interaction with 
the residue Pro53 of CCL14 (Nibbs et al., 1997; Savino et al., 2009). 
The order Lagomorpha includes two families, Ochotonidae (pikas) and 
Leporidae (hares and rabbits) that diverged ~35 million years ago (Matthee et 
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al., 2004). The Ochotonidae family is composed of only one genus, Ochotona, 
which is divided into four subgenera, Pika, Ochotona, Conothoa and Lagotona 
(Lissovsky, 2014). The Leporidae family is divided in eleven genera (Matthee et 
al., 2004). Rodents and lagomorphs form the superorder Glires that is 
considered a sister group of the superorder Euarchonta that includes primates 
(Horner et al., 2007; Murphy et al., 2001). In rodents, CCL14 was shown to be 
absent in mouse and rat, while present in squirrel and guinea pig (Shibata et al., 
2013); in lagomorphs, information is only available for the European rabbit 
(Oryctolagus cuniculus) where a functional gene exists.  
By comparing the O. princeps CCL14 CDS available in 
GenBank/Ensembl with the remaining mammalian species (Figure 4.1) it was 
possible to observe that the initiation codon typically present in mammals is 
mutated into a Thr (ACG). Following this observation, and considering the 
apparent “random” absence of CCL14 in rodents and its role as a ligand for 
CCR5 which in some lagomorphs underwent gene conversion with CCR2, we 
aimed at determining the presence and function conservation of CCL14 in 
lagomorphs.  In addition, we studied the evolution of CCL14 in mammals by 
identifying codons that are evolving under positive selection.  
 
3. MATERIALS AND METHODS 
Mammalian CCL14 sequences were retrieved from public databases 
(accession numbers are given in Figure 4.1). Sequences were aligned using 
MUltiple Sequence Comparison by Log-Expectation (MUSCLE) available at 
http://www.ebi.ac.uk/ (Edgar, 2004). Similar results were obtained using 
Multiple Alignment using Fast Fourier Transform (MAFFT), however, MUSCLE 
alignment introduced less gaps, leading to a more conserved alignment.  
In order to determine the impact of positive selection on CCL14 
sequence evolution, we estimated ω, i.e, the ratio of nonsynonymous (dN) to 
synonymous (dS) differences in functional CCL14 orthologs (final dataset of 55 
sequences). The codon-based Maximum Likelihood (ML) method (CODEML) 
implemented in PAML v4.4 was used (Yang, 2007). An unrooted neighbour-
joining tree was constructed using MEGA6 (Tamura et al., 2013), with p-
distance as substitution model and the pairwise deletion option for gaps/missing 
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data. The topology of the phylogenetic tree obtained is in accordance with the 
accepted mammalian phylogeny. Two pairs of site-based models were 
compared: M1 (nearly neutral) vs. M2 (selection) and M7 (neutral, beta) vs. M8 
(selection, beta and ω), where M1 and M7 correspond to the null hypothesis 
and M2 and M8 to the alternative hypothesis by allowing positive selection. A 
likelihood ratio test (LRT) with 2 degrees of freedom determined if a selection 
model fitted better the data than a neutral model (Yang, 2002; Yang et al., 
2000). Codons under positive selection were identified by using a Bayes 
Empirical Bayes (BEB) approach with probability > 95%. Codon-based ML 
methods available in the HYPHY package implemented in the DataMonkey 
webserver were also used (Delport et al., 2010; Poon et al., 2009): Single 
Likelihood Ancestor Counting (SLAC), Fixed-Eﬀect Likelihood (FEL), Internal 
Branch Fel (iFEL), Mixed Effects Model of Evolution (MEME), Random Eﬀect 
Likelihood (REL) and Fast Unconstrained Bayesian AppRoximation (FUBAR) 
(Murrell et al., 2013; Murrell et al., 2012; Poon et al., 2009). For the first 4 
methods the p-value was set to ≤0.05; for FUBAR we used a p-value ≥0.95 and 
for REL we used a Bayes factor ˃95. The best fitting-model for nucleotide 
substitution was determined by the automatic model selection available in the 
webserver. As done previously for other immunity genes (Areal et al., 2011; 
Lemos de Matos et al., 2014; Neves et al., 2014b; Pinheiro et al., 2013; 
Pinheiro et al., 2014), only the codons detected by more than one method were 
considered as being under positive selection.  
Samples from pikas (Ochotona alpina, O. dauurica, O. hyperborea, O. 
hoffmanni, O. mantchurica, O. pallasi, O. princeps, O. pusilla, O. rufescens and 
O. turuchanensis) were obtained from the Zoological Museum of Moscow 
University collection and samples of O. cuniculus (subspecies O. c. cuniculus 
and O. c. algirus), Brachylagus idahoensis, Pentalagus furnessi, Sylvilagus 
bachmani, Sylvilagus floridanus, Lepus europaeus, Romerolagus diazi, and 
Ochotona princeps were provided by the CIBIO Lagomorph tissue collection. 
For RNA extraction, a liver sample of O. princeps was kindly provided by Jay 
Storz from School of Biological Sciences, University of Nebraska, USA. 
Genomic DNA was extracted using the EasySpin Genomic DNA Minipreps 
Tissue Kit (Citomed) according to manufacturer’s instructions. Total RNA was 
extracted for one specimen of Oryctolagus cuniculus cuniculus, O. c. algirus, 
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Lepus europaeus, S. floridanus and O. princeps by using RNeasy Mini Kit 
according to the manufacturer’s instructions (Qiagen). cDNA was synthesized 
using oligo(dT) as primers and SuperScript III reverse transcriptase (Invitrogen). 
CCL14 was PCR-amplified and sequenced; sequences were submitted to 
GenBank under the following accession numbers: KP407602-KP407627 and 
KP641178. The European rabbit (Oryctolagus cuniculus) and Pika (Ochotona 
princeps) CCL14 sequences available in GenBank were used as templates for 
primer design. For amplification of CCL14 from gDNA, amplification was 
partitioned and amplified with Multiplex PCR Kit (Qiagen). Primers and 
conditions are listed in Table 4.1. Sequencing was performed on an ABI PRISM 
310 Genetic Analyser (PE Applied Biosystems) and PCR products were 
sequenced in both directions. 
 
Table 4. 1. Primers and conditions used in CCL14 PCR amplification. 
 
The program PHASE, built into the software DnaSP (Librado and Rozas, 
2009), was used to reconstruct the haplotype phases of the obtained 
sequences. These sequences were aligned and translated using BioEdit (Hall, 
1999). 
The Tajima’s Relative Rate Test was conducted in order to check the 
evolutionary rate of CCL14 between lagomorphs using MEGA6 (Tajima, 1993; 
Tamura et al., 2013). 
Species 
amplified Primers sequence (5’- 3’) Primer name 
Exons 
amplified PCR conditions 
Fragment 
length 
Leporids 
CAGCTCTCCTGCAGCAGC CCL14OrcuF1 
Exon1 
Initial denaturation - 95ºC (15min) 
40 cycles  ( 95ºC (45s), 58ºC 
(20s), 72ºC(10s) 
Final extension - 60ºC (10min) 
~182bp 
GGAGTTGGATAGCTGAGAG CCL14OrcuR1 
CAGAAGCAGCCAGCAATC CCL14OrcuF2 Exon 2 
 + 
 exon 3 
Initial denaturation - 95ºC (15min) 
40 cycles  ( 95ºC (45s), 58ºC 
(20s), 72ºC(45s) 
Final extension - 60ºC (10min) 
~732bp 
CAAAGGCACAGCTCAGAG CCL14OrcuR2 
Ochotona 
CTCAGCACATCCTTACCCAG CCL14OcprF1 
Exon1 
Initial denaturation - 95ºC (15min) 
40 cycles  ( 95ºC (45s), 60ºC 
(20s), 72ºC(10s) 
Final extension - 60ºC (10min) 
~200bp 
CTTCTAGCCTCGTCTCCAG CCL14OcprR1 
CAGCAATCATGTCTCACCAG CCL14OcprF2 
Exon 2 
 + 
 exon 3 
Initial denaturation - 95ºC (15min) 
40 cycles  ( 95ºC (45s), 62ºC 
(20s), 72ºC(45s) 
Final extension - 60ºC (10min) 
~612bp 
GAAGGCACAGTTCACAGACC CCL14OcprR2 
CCAGGGTAGCAGAAGCAGC CCL14OcprF2a Initial denaturation - 95ºC (15min) 
40 cycles  ( 95ºC (45s), 60ºC 
(20s), 72ºC(45s) 
Final extension - 60ºC (10min) 
~692bp 
CTATGCCAGGAATTGCTCTG CCL14OcprR2a 
GTTCCTCTAACACCTCTCTGG CCL14OcprF2b Initial denaturation - 95ºC (15min) 
40 cycles  ( 95ºC (45s), 62ºC 
(20s), 72ºC(1min) 
Final extension - 60ºC (10min) 
~801bp 
CTTGTGCACCTCACTGAG CCL14OcprR2b 
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Figure 4. 1. a) Alignment of CCL14 for the different mammalian species (GenBank, Ensembl and Uniprot 
accession numbers are indicated for the retrieved sequences). Positively selected amino acids are boxed 
and the 3 possible cleavage sites are shaded in dark grey. (*) represent stop codons; (-) represent 
deletions; *1 and *2 represent alleles. b) Alignment of CCL14 for the different Ochotona species studied. 
The characteristic mammalian initiation codon is boxed. c) Alignment of the CCL14 for O. princeps and O. 
pusilla with the insertion of the 7 base pairs shaded in grey. 
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4. RESULTS AND DISCUSSION 
In our study, 6 amino acids were identified as being under positive 
selection: Ala22, Thr25, Thr62, Lys67, Met74 and His96 (amino acid residues 
were numbered from the ﬁrst methionine residue in human CCL14. The signal 
peptide and indels, indicated as (-), were included in the numbering; Figure 4.1). 
Ala22 and Thr25 are located in the pre peptide which is cleaved in order for the 
protein to become active (Detheux et al., 2000); however, the modifications 
observed at residue 22 are not expected to alter the CCL14 protein. In contrast, 
Thr25 is located within the region where CCL14 cleavage occurs. Since 
cleavage is required for protein activation, alterations in this site might 
negatively affect the CCL14 protein. Thr62 and Lys67 are in the region reported 
as to be essential to the binding of CCL14 to the several receptors (Blain et al., 
2007; Lolis and Murphy, 2007; Pakianathan et al., 1997; Rajagopalan and 
Rajarathnam, 2006; Steen et al., 2014); thus, changes in this region may affect 
both the ligand-receptor binding, but also CCL14 degradation (Nibbs et al., 
1997; Savino et al., 2009). Met74 and His96 are located in the β1 and β3 
sheets, respectively. Alterations in these sites may lead to alterations in the 
protein conformation.  
The comparison of the O. princeps CCL14 CDS available in GenBank 
and Ensembl with the remaining mammalian species (Figure 4.1a) showed that 
in O. princeps the initiation codon, in contrast to the other mammalian 
sequences, is mutated into a Thr (ACG). Following this observation, we 
attempted the amplification of CCL14 from gDNA of O. princeps. Our results 
indicated that, as for the sequences publicly available, the amplified fragment 
also presents the ACG mutation. Next, we attempted to amplify CCL14 from 
cDNA of O. princeps. Despite having used different Taq polymerases and 
different PCR conditions (e.g. including the addition of DMSO in the reaction, 
increasing extension times) and different pairs of primers designed according to 
the O. princeps CDS, and having previously successfully amplified other CDS of 
other genes from the same sample (Neves et al., 2014a), we were unable to 
amplify the CCL14. This may suggest that CCL14 is a pseudogene in O. 
princeps. We amplified and sequenced the CCL14 gene for 8 leporid species: 
O. cuniculus cuniculus and O. c. algirus, Brachylagus idahoensis, Pentalagus 
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furnessi, Sylvilagus bachmani and S. floridanus, Lepus europaeus and 
Romerolagus diazi.  
To support the putative pseudogenization of CCL14 in O. princeps we 
performed a Tajima’s Relative Rate Test in order to determine the rates of 
evolution of CCL14 in lagomorphs. This test determines if two genes (paralogs 
or orthologs) are evolving at similar rates, i.e. it determines statistically if the two 
sequences follow the molecular clock hypothesis of similar constant rates of 
evolution (null hypothesis) or if one sequence evolved at an accelerated or 
decelerated rate (alternative hypothesis) (Tajima, 1993). By comparing the O. c. 
cuniculus CCL14 gene with the O. princeps orthologs, and using as an outgroup 
each of the different leporids studied, the p-values of the chi-square were 
always statistically significant. This rejects the null hypothesis and favors the 
hypothesis of an acceleration of the mutation rate in Ochotona princeps. Thus, 
our results (Table 4.2) support a significant bias to neutrality between leporids 
and O. princeps, compatible with a pseudogenization process in this species. 
 
Table 4. 2. Results obtained in Tajima’s Relative Rate Test. 
1 Chi-square is a statistical test used to determine the substitution rates between species  
2 A p-value < 0.05 is used to reject the null hypothesis of equal rates between lineages. 
 
We attempted to amplify the CCL14 gene from gDNA of several pika 
species that encompass the different Ochotona subgenera: O. alpina, O. 
dauurica, O. hyperborea, O. hoffmanni, O. mantchurica, O. pallasi, O. pusilla, 
Outgroup 
Nr. divergent 
sites in the three 
sequences  
Nr. differences in 
O. c. cuniculus 
Nr. differences 
in O. princeps 
Chi-
square 1 
p-value2 
Sylvilagus bachmani 1 5 37 24.38 0.00000 
Sylvilagus floridanus 2 7 34 17.78 0.00002 
Brachylagus idahoensis 2 4 37 26.56 0.00000 
Lepus europaeus 1 6 36 21.43 0.00000 
Pentalagus furnessi 3 2 38 32.40 0.00000 
Romerolagus diazi 1 9 33 13.71 0.00021 
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O. rufescens and O. turuchanensis. Interestingly, we found different results 
within the Ochotonidae family (Figure 4.1. b and c). Indeed, O. alpina, O. pallasi 
and O. turuchanensis, share the ATG>ACG mutation with O. princeps; in 
contrast, in O. dauurica, O. hoffmanni, O. mantchurica and O. rufescens, as in 
all the other mammals examined, the putative initiation codon is conserved. In 
addition, in O. hyperborea, we could define 2 alleles, one with the putative 
initiation codon and the other with ACG. In O. pusilla, despite presenting the 
putative start codon, CCL14 seems to be a pseudogene due to an insertion of 7 
bp (base pairs 43-49) that leads to a frameshift that disrupts the CDS (Figure 
4.1c). Our results seem to indicate that in the Ochotonidae family subgenus 
Pika CCL14 is under a process of pseudogenization with inactivation of the 
gene in some, but not all species; this pseudogenization, however, does not 
reflect the taxonomic relationships in the Ochotona genus (Figure 4.2). Indeed, 
the subgenus Pika where the mutation in the start codon emerged 
encompasses species from different lineages that present both the ATG and the 
ACG (Lissovsky, 2014; Melo-Ferreira et al., 2015). O. pusilla is the only species 
studied where CCL14 is obviously a pseudogene (Figure 4.1c), and belongs to 
a different subgenus (Lagotona) (Fostowicz-Frelik and Frelik, 2010; Fostowicz-
Frelik et al., 2010; Lanier and Olson, 2009; Lissovsky, 2014; Melo-Ferreira et 
al., 2015). 
Taking in account the CCL14 alterations described in the Ochotona 
species, we also determined if those alterations could have had any influence in 
the receptors. For this we sequenced the CCR5 and the CCR1 genes (data not 
shown). However, these sequences did not reveal alterations that could explain 
the pseudogenization of CCL14. 
In the human genome, pseudogenes are quite common, with high 
prevalence in multigene families such as chemokines (Ondrej and Jianzhi, 
2010), but little is known for other mammals. For CCL14, it was previously 
shown that in Rodentia, CCL14 is absent in rat and mouse of the Muridae family 
(Shibata et al., 2013), but is a functional gene in the families Dipodidae (Jaculus 
jaculus), Spalacidae (Nannospalax galili), Sciuridae (Spermophilus 
tridecemlineatus), Bathyergidae (Heterocephalus glaber), Chinchillidae 
(Chinchilla laniger) and Caviidae (Cavia porcellus). In addition, in the 
Trichechus manatus latirostris (Florida manatee) that belongs to the superorder 
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Afrotheria, the CCL14 predicted sequence available in GenBank (accession 
number XM_004385435.1) seems to be a pseudogene due to an early stop 
codon while for the other species within this order for which the CCL14 
sequences are available (Loxodonta africana and Echinops telfairi), the gene 
seems to encode a functional protein. This indicates that although CCL14 is 
present as a functional gene in the common ancestor of these species, it was 
later inactivated or deleted in some species, even within the same clade. This 
suggests that CCL14 might have functions that overlap with the function of 
other genes making its presence unnecessary and leading to its 
pseudogenization.  
 
 
Figure 4. 2. Evolutionary topology showing the molecular phylogeny within the Ochotonidae family 
(adapted from Melo-Ferreira et al., 2015). In the AYG found in O. hyperborea, Y is a pyrimidine indicative 
that this species has 2 alleles, one with ATG and other with ACG. 
 
5. CONCLUSIONS 
In most of the mammals we observed that CCL14 encodes a functional 
gene that is evolving under positive selection, with positively selected codons 
located in regions important for ligand-receptor binding. In contrast, in two of the 
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Ochotonidae family subgenera (Pika and Lagotona) CCL14 is a pseudogene 
due to distinct disabling mutations and the detection of an acceleration of the 
mutation rates. While in some mammals CCL14 retained its biological 
significance in the Ochotonidae family (subgenera Pika and Lagotona) it seems 
to have been lost. 
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EVOLUTION OF CCL11: GENETIC CHARACTERIZATION IN LAGOMORPHS 
AND EVIDENCE OF POSITIVE AND PURIFYING SELECTION IN MAMMALS 
 
Fabiana Neves, Joana Abrantes, Pedro J Esteves 
 
 
1. ABSTRACT 
The interactions between chemokines and their receptors are crucial for 
differentiation and activation of inflammatory cells. CCL11 binds to CCR3 and to 
CCR5 that in leporids underwent gene conversion with CCR2. Here, we 
genetically characterized CCL11 in lagomorphs (leporids and pikas). All 
lagomorphs have a potentially functional CCL11, and the pygmy rabbit has a 
mutation in the stop codon that leads to a longer protein. Other mammals also 
have mutations at the stop codon that result in proteins with different lengths. 
By employing Maximum Likelihood methods, we observed that in mammals 
CCL11 exhibits both signatures of purifying and positive selection. Signatures of 
purifying selection were detected in sites important for receptor binding and 
activation. Of the three sites detected as under positive selection, two were 
located close to the stop codon. Our results suggest that CCL11 is functional in 
all lagomorphs, and that the signatures of purifying and positive selection in 
mammalian CCL11 probably reflect the protein’s biological roles.  
 
Keywords: CCL11, purifying selection, positive selection, lagomorphs, 
mammals 
 
2. INTRODUCTION 
C-C chemokine ligand 11 (CCL11), also known as Eotaxin-1, is a 
chemoattractant for eosinophils with an important role in allergic and parasitic 
inflammation (Pease and Williams, 2001; Puxeddu et al., 2006; Stevenson et 
al., 2009). First isolated in a guinea pig model of asthma (Jose et al., 1994), this 
protein is located in the monocyte chemoattractant protein (MCP) region of the 
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CC cluster of several mammals, including human, mouse, rat, rabbit, horse and 
cow (Nomiyama et al., 2010; Shibata et al., 2013). In the European rabbit 
(Oryctolagus cuniculus) genome, CCL11 has been mapped to chromosome 
19:23,739,202-23,742,061 on the forward strand with an Ensembl gene 
designation ENSOCU00000005935. CCL11 can exert its functions through the 
interaction between residues located in its extracellular loops and NH2-terminus 
and the N-terminus of two receptors, CCR3 and CCR5 (Allen et al., 2007; 
D'Ambrosio et al., 2003; Millard et al., 2014). 
An extensive gene conversion in the CCR5 transmembrane domain has 
been reported for several species (Abrantes et al., 2011; Carmo et al., 2006; 
Esteves et al., 2007; Perelygin et al., 2008; Shields, 2000; Vazquez-Salat et al., 
2007). In contrast, in some leporids, CCR5 suffered a dramatic change at the 
second extracellular loop, resulting from a gene conversion event with the 
paralogous CCR2. This alteration was confirmed in the European rabbit, 
riverine rabbit (Bunolagus monticularis) and Amami rabbit (Pentalagus 
furnessi), but it was not observed in the Eastern cottontail (Sylvilagus 
floridanus) or in European and Iberian hares (Lepus europaeus and L. 
granatensis) (Abrantes et al., 2011; Carmo et al., 2006). In the other 
Lagomorpha family, Ochotonidae (pikas), this gene conversion is also absent 
(Pinheiro et al., 2016). The most likely evolutionary scenario that could explain 
this pattern is that the gene conversion event occurred in the ancestor of 
Oryctolagus, Bunolagus and Pentalagus genera at ~8 million years ago, 
probably conferring some selective advantage, and thus became fixed in the 
ancestral population (Pinheiro et al., 2016). 
This CCR5 evolutionary pattern led to the study of the CCR5 ligands in 
lagomorphs. The study of CCL3, CCL4 and CCL5 revealed that these genes 
are all functional in leporids and showed evidence of strong purifying selection 
(de Matos et al., 2014). CCL14 is functional in the Leporidae family. In the 
Ochotonidae family, CCL14 is suffering a pseudogenization process with an 
intact gene in some species while in others it is a pseudogene. In contrast, 
among the leporids, CCL8 is pseudogenized in the European rabbit and riverine 
rabbit, but functional in Sylvilagus and Lepus (Neves et al., 2015; van der Loo et 
al., 2012).  
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In chemokine receptors the sites located intracellularly or in the 
transmembrane domains are involved in signal transduction and dimerization 
(Metzger and Thomas, 2010). Consequently, new nucleotide changes that lead 
to amino acid (aa) alterations tend to be quickly eliminated. In contrast, the aa 
residues localized in the extracellular domains are evolving under selective 
pressure resulting from ligand-binding and pathogen interactions. Thus, in these 
regions, the proportion of non-synonymous nucleotide substitutions is expected 
to be significantly higher than synonymous substitutions. This pattern has been 
observed in chemokine receptors such as CCR2 and CCR3 (Metzger and 
Thomas, 2010). The interactions between chemokine ligands and their 
receptors suggest that the chemokine ligands might also exhibit signatures of 
positive and purifying selection. Here, we characterized CCL11 in lagomorphs 
and investigated the selective pressures that have been driving the evolution of 
this molecule in mammals. 
 
3. MATERIALS AND METHODS 
Tissue samples were provided by the CIBIO Lagomorpha tissue 
collection with the exception of brush rabbit (Sylvilagus bachmani) tissue 
samples which were kindly provided by Jeff Wilcox and Dr. Michael Hamilton 
from Blue Oak Ranch Reserve, University of California, Berkeley. Genomic 
DNA (gDNA) was extracted from three tissue samples of pygmy rabbit 
(Brachylagus idahoensis) and from one sample from each European rabbit 
subspecies (Oryctolagus cuniculus cuniculus and Oryctolagus cuniculus 
algirus), and one sample of European brown hare (Lepus europaeus), pygmy 
rabbit (Brachylagus idahoensis),brush rabbit (Sylvilagus bachmani), volcano 
rabbit (Romerolagus diazi) and American pika (Ochotona princeps) using the 
EasySpin Genomic DNA Minipreps Tissue Kit (Citomed, Torun, Poland) 
according to manufacturer’s instructions. Total RNA was extracted using the 
RNeasy Mini Kit according to the manufacturer’s instructions (Qiagen, Hilden, 
Germany) from samples of European rabbit (subspecies cuniculus) and 
European brown hare. cDNA was synthesized using oligo(dT) as primers and 
SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA). The 
European rabbit and American pika sequences available in public databases 
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were used for primer design. PCR amplification was performed with the 
Multiplex PCR Kit (Qiagen) according to the manufacturer’s protocol (Table 
4.3). Sequencing was performed on an ABI PRISM 310 Genetic Analyser (PE 
Applied Biosystems) and PCR products were sequenced in both directions. 
Sequences were submitted to GenBank under the following accession 
numbers: KU987806-KU987816. 
 
Table 4. 3. Primers and conditions used for PCR amplification and sequencing of CCL11 from lagomorphs’ 
gDNA samples. 
 
Sequences were aligned using Multiple Sequence Comparison by Log-
Expectation (MUSCLE) available at http://www.ebi.ac.uk/ (Edgar, 2004). The 
program PHASE, built into the software DnaSP (Librado and Rozas, 2009), was 
used to reconstruct the haplotype phases of the obtained sequences. 
Haplotypes were translated using BioEdit (Hall, 1999). 
In order to identify which codons of CCL11 are under selection (purifying 
and positive), we estimated ω, i.e, the ratio of nonsynonymous (dN) to 
synonymous (dS) substitutions in CCL11 orthologs (final dataset of 68 
sequences) by employing codon-based Maximum Likelihood (ML) methods 
available in the HYPHY package implemented in the DataMonkey webserver 
(Delport et al., 2010; Poon et al., 2009): Single Likelihood Ancestor Counting 
(SLAC), Fixed-Effect Likelihood (FEL), Internal Branch Fel (iFEL), Random-
Effect Likelihood (REL) and Fast Unconstrained Bayesian AppRoximation 
(FUBAR) (Murrell et al., 2013; Murrell et al., 2012; Poon et al., 2009). For the 
first 3 methods the p-value was set to ≤0.05; for FUBAR we used a p-value 
Species amplified Primers sequence (5’- 3’) Primer name Exons amplified PCR conditions 
Fragment 
length 
Leporids 
GATCAATCCAGAAGCCTCC CCL11OrcuF1* 
Exon1 
95ºC (15min) 
40 cycles: 95ºC (45s), 
58ºC (20s), 72ºC (20s) 
60ºC (10min) 
~185bp 
CAGGTCAGCAAGTGTCTTC CCL11OrcuR1 
European rabbit 
Brush rabbit 
CTACCTCTGACACATCCTC CCL11OrcuF2 
Exon 2 
+ 
Exon 3 
95ºC (15min) 
40 cycles: 95ºC (45s), 
58ºC (20s), 72ºC (50s) 
60ºC (10min) 
~805bp 
CCTTCTCAAGATGCGTTCTG CCL11OrcuR2* 
European brown hare 
Pygmy rabbit 
Volcano rabbit 
CTGTGTATCATTAGTAGCTC CCL11OrcuF2a 95ºC (15min) 40 cycles: 95ºC (45s), 
56ºC (20s), 72ºC (45s) 
60ºC (10min) 
~778bp 
GTGAGCTAAGCCTCACCTG CCL11OrcuR2a 
Ochotona princeps 
GCAGGCAGAACAATCAAATAC CCL11OcprF1a* Exon1 
+ 
Exon 2 
+ 
Exon 3 
95ºC (15min) 
40 cycles: 95ºC (45s), 
64ºC (20s), 72ºC 
(1min40s) 
60ºC (10min) 
~1637bp GTTATTGCTGGTCGCTCAG CCL11OcprR1a* 
CCTCTTGATGAGCATGTTC CCL11OcprFint1 
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≥0.95 and for REL we used a Bayes factor ˃95. The best fitting-model for 
nucleotide substitution was determined by the automatic model selection tool 
available in the webserver. We further used the codon-based ML method 
(CODEML) implemented in PAML v4.4 (Yang, 2007). An unrooted neighbor-
joining tree was constructed using MEGA6 (Tamura et al., 2013), with p-
distance as substitution model and the pairwise deletion option for gaps/missing 
data. The topology of the phylogenetic tree obtained follows the accepted 
mammalian phylogeny for the major groups. Two pairs of site-based models 
were compared: M1 (nearly neutral) vs. M2 (selection) and M7 (neutral, β) vs. 
M8 (selection, β and ω), where M1 and M7 correspond to the null hypothesis 
and M2 and M8 to the alternative hypothesis by allowing positive selection. A 
likelihood ratio test (LRT) with 2 degrees of freedom determined whether a 
selection model fit the data better than a neutral model (Yang, 2002; Yang et 
al., 2000). Codons under positive selection were identified by using a Bayes 
Empirical Bayes (BEB) approach with probability > 95%. As done previously for 
other immunity genes (Areal et al., 2011; Lemos de Matos et al., 2013, 2014; 
Neves et al., 2014; Pinheiro et al., 2013; Pinheiro et al., 2014), only the codons 
detected by more than one method were considered as being under selection.  
The three-dimensional (3D) structure displaying the interaction of Human 
CCL11 with CCR3 was downloaded from the Protein Data Bank in Europe 
(PDBeurope) available in http://www.ebi.ac.uk/pdbe/entry/pdb/2MPM, and 
Discovery Studio 3.5 software (BIOVIA, San Diego, CA, USA) was used to map 
the sites under selection.  
The secondary structures of human, European rabbit and pygmy rabbit 
CCL11 were predicted by using PsiPred (http://bioinf.cs.ucl.ac.uk/psipred/) . 
This software calculates the protein cysteines that create disulfide bonds by 
using Position Specific Iterated – BLAST (PSI-BLAST) to obtain evolutionary 
information that is used to predict the secondary structure of the query protein. 
 
4. RESULTS AND DISCUSSION 
We amplified and sequenced the CCL11 gene for six lagomorph species: 
both subspecies of European rabbit, European brown hare, brush rabbit, pygmy 
rabbit, volcano rabbit and American pika. These sequences were further 
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compared with CCL11 sequences available for other mammals and some 
differences were observed (Figure 4.3). Indeed, at position 40, where human 
has an Asn, all leporids have a deletion and the American pika has a Lys. There 
are also some amino acid changes that are only present in some lagomorph 
species: Val12 and Met43 in the European rabbit; Thr10 (pygmy rabbit); His44 
(volcano, pygmy and brush rabbits and European brown hare); Phe70 (volcano 
rabbit) and Met2, Ser5, Asn53, Leu66, Ser89 (American pika). In addition, we 
found a Met65 in all CCL11 sequences from the leporids amplified in this work, 
while the sequence from the European rabbit available in public databases 
(ENSOCUG00000005935) has an isoleucine. Additionally, and despite the 
identification of two different transcripts in the American pika sequence 
available online (XM_004593867.1 and XM_004593868.1 – deletion/insertion of 
two aa Asp26 and Ser27, respectively), we were only able to detect the first 
transcript. The listed amino acid alterations lead to changes in charge and 
polarity (Supplementary material table 4.5) which can induce modifications in 
protein structure and conformation and even alter the protein functions 
(Majewski and Ott, 2003).  
Strikingly, within leporids, the pygmy rabbit has a mutation in the stop 
codon leading to an extension of 8 amino acids (Gln100-Asn107) resulting in a 
protein with 104 amino acids. This mutation was detected in three different 
individuals confirming that this was not a PCR artifact. Other mammals also 
code for longer proteins due to mutations in the stop codon (Figure 4.3), leading 
to CCL11 proteins ranging from 100 to 108 amino acids. The protein length is 
important for the three-dimensional structure and different sizes may imply 
different folding patterns which may affect protein functions (Tiessen et al., 
2012). The implications of these mutations in the protein structure are unknown, 
however PsiPred results do not predict any differences in the secondary 
structure of these species when compared with human.  
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Disulfide bonds between cysteine residues are important for protein 
structure and function, being involved in an array of biological processes (Fass, 
2012; Helenius and Aebi, 2004; Rudd et al., 2001). For CCL11, the cysteine 
residues and the predicted disulfide bonds are highly conserved between all the 
mammals studied (Cys34-Cys59 and Cys35-Cys75). However, some extra 
cysteines were detected: cattle, sheep, domestic goat and chiru have Cys17 
and the lesser hedgehog tenrec has Cys18. In addition, most mammals, with 
the exception of primates, American pika, mouse, rat, spalax mole-rat and 
Chinese hamster, have an extra cysteine at position 9. Their location in the 
signal peptide suggests no role in establishing extra disulfide bonds. In contrast, 
the Baiji sequence has an extra cysteine at position 50 that can potentially 
establish a disulfide bond. 
Chemokines exert important roles in the immune response. In order to 
maintain their conformation and biological role, chemokines are expected to 
have signatures of purifying selection; however, if we consider that these 
proteins are targets for several types of molecules (such as pathogens, drugs, 
receptors) it should be expected that chemokines also have signatures of 
positive selection (Metzger and Thomas, 2010). The results obtained indicate 
that mammalian CCL11 has 21 codons negatively selected and 3 codons 
positively selected (Table 4.4). CCL11 interacts with both CCR3 and CCR5 
receptors, with CCR3 being the higher affinity receptor (Manns et al., 2007). 
The most crucial region for receptor binding and activation is the N-terminus 
preceding the disulfide bonds. The first 20 amino acids (following the signal 
peptide) and the N-loop located after the disulfide bonds are also described to 
be important for receptor binding (Crump et al., 1998; Millard et al., 2014; Ye et 
al., 2000; Zhang and LiWang, 2014). Thirteen of the twenty-one sites identified 
as under purifying selection are located in close vicinity with these regions 
(Figure 4.3): Ala14, Leu22, Phe36, Leu48, Thr55, Cys59, Pro60, Ala63, Lys72, 
Cys75, Asp77, Lys81 and Val83. A similar pattern was observed for CCL3, 
CCL4 and CCL5 in leporids, where these CCR5 ligands have sites under 
purifying selection probably due to functional binding constraints (de Matos et 
al., 2014).  
Secretory proteins such as CCL11 only become functional after crossing 
the membrane and arriving to the appropriate cellular compartment and 
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consequently being cleaved by signal peptidases (Singh et al., 2013; Thakur et 
al., 2013). The signal peptide plays important roles in targeting and membrane 
insertion and after being cleaved can also exert other functions such as 
protecting cells from being killed by other cells (Hegde, 2002; Li et al., 2009; 
Singh et al., 2013; Thakur et al., 2013). Before cleavage, the signal peptide may 
have also important functions in protein folding and maturation (Hegde, 2002). 
Therefore, mutations in the signal peptide may interfere with such functions. 
Indeed, from the 23 amino acids that compose the CCL11 signal peptide, five 
were found to be under purifying selection confirming the importance of their 
maintenance (Ser4, Ala6, Leu11, Ala14 and Leu22).  
 
 
Figure 4. 4. 3D structure of the CCL11-CCR3 complex. CCL11 appears in blue while CCR3 appears in 
dark grey. The purifying selected amino acids identified in this study and located near important sites for 
ligand-receptor binding and interaction are marked in yellow; the positively selected sites are highlighted in 
light grey. 
 
Signatures of positive selection in immune system genes tend to be 
associated with regions where the binding with other molecules occurs 
(proteins, receptors) and that can alter the proteins’ activity and consequently 
their biological roles (Hage et al., 1999; Koyanagi et al., 2010; LaPorte et al., 
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2008; Zhang et al., 2002). For CCL11, these regions had not been described, 
but the amino acids changes observed as positively selected show different 
polarity and charge that can cause changes in the protein. In addition, two of 
the positively selected sites (Pro95 and Pro99) are located in close vicinity to 
the stop codon that is mutated in several mammalian species, leading to 
proteins with different sizes.  
Since the CCL11 predicted secondary structures of Human and the 
European rabbit obtained in PsiPred were similar (data not shown), we used the 
Human 3D structure available online (CCL11-CCR3 interaction) to locate the 
sites under selection (Figure 4.4). This confirmed their relevance for receptor 
binding. A previous study in lagomorphs identified one site under positive 
selection in chemokine ligand CCL5 (de Matos et al., 2014), but this was 
located in the signal peptide that is cleaved in protein maturation. 
 
5. CONCLUSIONS 
This work describes the detection of codons under positive and purifying 
selection in CCL11. Purifying selection may result from the proteins’ functional 
constraints, while an increase in diversity, probably as such mutations are 
advantageous in the host response against several agents, suggests positive 
selection. Our results identified 21 codons under purifying selection in sites 
located in regions important for ligand-receptor binding and activation and in the 
signal peptide and 3 sites under positive selection near signal peptide and the 
stop codon. We observed that CCL11 is functional in lagomorphs, with pygmy 
rabbit having a longer protein due to a mutation in the stop codon. Further 
functional studies should evaluate the biological implications of this extension.  
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7. SUPLEMENTARY MATERIAL 
Table 4. 5. Characterization of the CCL11 amino acids differences between lagomorphs and other 
mammals 
Human 
amino 
acid 
position 
  Amino acids 
 Lagomorphs   
 Leporids   
European 
rabbit 
European 
brown 
hare 
Brush 
rabbit 
Volcano 
rabbit 
Pygmy 
rabbit 
American 
pika Other mammals 
2K*+ K*+ M# K*+, Q*, R*+ 
5A# A# S* A#, T*, M#, G# 
6A# A# T* A#, V#, M#, T*, E*-, G# 
9W# C* G# F#, C*, W#, S*, G# 
10L# M# V# M# V# T* L# V#, M#, L# 
12L# V# L# I#, F# 
13I# T* I# T*, L#, S*, I#, V#, A#, W# 
16A# V# T* S*, A#, L#, V#, T*, I# 
19P# S* T*, I#, S*, P#, N*, A# 
21G# V# G#, I#, V#, A# 
24G# Q* H*+, Q*, L#, E*-, G# 
29S* F# F#, S*, L#, K*+, A#, T*, V# 
32T* T* A# T*, R*+, S*, A#, K*+, N*, I# 
37N* S* N*, V#, S*, I#, T*, A#, R*+ 
38L# M# V#, L#, M# 
40N* - - - - - K*+ S*, K*+, G#, R*+, N*, P#, T*, A# 
41R*+ K*+ R*+, K*+ 
43I# M# I# I# 
44P# P# H*+ P# S*, L#, P# 
45L# L# I# L# I# L# T* L#, T*, N*, F#, I#, V#, K*+, M# 
53R*+ R*+ N* R*+, K*+, Q*, I#, T* 
55T* S* T*, S*, N*, I#, K*+ 
56S* G# S* N*, S*, G#, D*-, A# 
57G# S* N*, S*, T*, G# 
65I# I#, M# M# I#, S* I#, V#, L# 
66F# F# L# F# 
70L# L# F# L# L#, Q*, R*+, A#, S*, M#, P# 
73D*- E*- K*+, E*-, D*-, M# 
76A# A# V# A#, V#, T* 
80K*+ E*- K*+, E*-, Q*, A#, N*, V# 
85D*- D*-, N* D*- D*-, N*, E*-, A# 
87M# I# I#, T*, M#, V#, L#, K*+ 
89Y* Y* S* Y*, H*+ 
95P# K*+ R*+ P#, Q*, R*+, K*+, S*, T*, L#, H*+ 
97P# S* P#, T*, L#, S*, Q*, V#, A# 
99P# P# S* P#, Y*, S*, H*+, K*+, L#, I# 
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EVOLUTION OF CCL16 IN GLIRES (RODENTIA AND LAGOMORPHA) SHOWS 
AN UNUSUAL RANDOM PSEUDOGENIZATION PATTERN 
 
Fabiana Neves, Joana Abrantes, Ana M Lopes, Maria J Magalhães,Wessel van der 
Loo, Pedro J Esteves  
 
1. ABSTRACT 
The chemokine ligand CCL16 is a strong pro-inflammatory chemokine 
and a chemoattractant for monocytes and lymphocytes. It is present at high 
concentrations in normal plasma and elicits its effects on cells by interacting 
with cell surface chemokine receptors.  
The CCL16 gene was identified as a pseudogene in the European rabbit 
and in some rodents such as mouse, rat and guinea pig, while in squirrel it 
seems to be functional. To elucidate the evolution of this gene in the superorder 
Glires, composed by rodents and lagomorphs, we sequenced eleven leporids 
and seven Ochotona species. Additionally, we retrieved the CCL16 sequences 
of twelve rodents available in public databases. Sequencing of CCL16 showed 
that similarly to the European rabbit, all leporid species showed 
pseudogenization of CCL16. In contrast, in Ochotona species CCL16 seems 
functional, except for Hoffmann’s pika where one allele is a pseudogene. 
Pseudogenization of CCL16 in leporids is due to a mutation in the typical CC 
motif leading to a premature stop codon. In Sylvilagus spp. this motif is also 
mutated, but it codes for a Lysine residue. In addition, in the Mexican cottontail, 
CCL16 is a pseudogene due to a 95-base pair deletion that leads to a 
frameshift. Furthermore, we were not able to amplify this gene from Eastern 
cottontail (S. floridanus) cDNA, supporting that in this species CCL16 is a 
pseudogene. In rodents, the same pattern was observed with species 
presenting a functional CCL16 while in others it is a pseudogene. This 
pseudogenization is due to species-specific mutations. Our results suggest that 
despite being functional in the Glires ancestor, CCL16 underwent 
pseudogenization in some species. This process occurred stochastically or in 
206 
 
specific lineages at different moments in the evolution of Glires. In addition, in 
cottontails, although they do not present the same inactivating mutations as in 
the remaining leporids, CCL16 remains non-functional. 
 
Keywords: Chemokine ligands, CCL16, Evolution, Glires, Pseudogenization 
 
2. INTRODUCTION 
Chemokines are small pleiotropic proteins of low-molecular weight with 
important roles in inflammation, homeostasis and immune response (Ono et al., 
2003; Zlotnik and Yoshie, 2012). Chemokines are only found in vertebrates and 
are classified according to their conserved N-terminal Cysteines residues into 
CC, CXC, XC, CX3C and CX (only identified in zebrafish) (Nomiyama et al., 
2008; Nomiyama et al., 2013). In C-C chemokines, both N-terminus Cysteines 
are juxtaposed. These proteins are able to exert their function trough the 
interaction between the residues located in both the extracellular loops and the 
NH2-terminus and the chemokine receptors (Crump et al., 1999; Teran, 2000; 
Van Coillie et al., 1999). 
Chemokines originated through gene duplication from an ancestral gene 
(Juan et al., 2009; Nomiyama et al., 2010) and can evolve by pseudogenization, 
neofunctionalization or subfunctionalization. In the pseudogenization process, 
disruption of the coding sequence leads to the loss of function. In the 
neofunctionalization and subfunctionalization, the genes are maintained in the 
either by acquiring new functions or maintaining functions with the other copy, 
respectively (Ding et al., 2012; Levasseur and Pontarotti, 2011; Zhang, 2003).  
CCL16, also known as liver-expressed chemokine (LEC) or human C-C 
chemokine (HCC)-4, is located in the macrophage inflammatory protein (MIP) 
region of the CC cluster. CCL16 is a strong pro-inflammatory chemokine and a 
chemoattractant for monocytes and lymphocytes, enhancing their adhesive 
properties (Nomiyama et al., 2001; Youn et al., 1998). Commonly present at 
high concentrations in normal plasma, CCL16 elicits its effects on cells by 
interacting with cell surface chemokine receptors such as CCR1, CCR2, 
CCR5 and CCR8 (Zlotnik and Yoshie, 2012). In some mammalian species, 
including some leporids, CCR5 evolved under gene conversion with CCR2 
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(Abrantes et al., 2011; Carmo et al., 2006; Esteves et al., 2007; Perelygin et al., 
2008; Shields, 2000; Vazquez-Salat et al., 2007). Thus, leporids are a good 
model to study the co-evolution of chemokine receptors and their ligands. 
Indeed, in the leporids European rabbit (Oryctolagus cuniculus), Amami rabbit 
(Pentalagus furnessi) and riverine rabbit (Bunolagus monticularis) CCR5 
suffered a gene conversion with CCR2 in the second external cellular loop, 
while cottontail rabbits (Sylvilagus spp.) and hares (Lepus spp.) have a normal 
CCR5. In order to determine the consequences of this CCR5-CCR2 gene 
conversion, the CCR5 chemokine ligands have been studied in leporids. CCL3, 
CCL4, CCL5 and CCL11 genes are functional in leporids (de Matos et al., 2014; 
Neves et al., 2016). In rabbit, mouse and rat there is only one copy of CCL3 and 
CCL4, but in other rodents such as squirrel and guinea pig there are several 
copies that may be either functional or inactivated (Shibata et al., 2013; Zlotnik 
et al., 2006). The study of CCL8 in leporids showed that this gene is 
pseudogenized in the European rabbit, riverine rabbit and Amami rabbit, while 
intact in hares and Eastern cottontail (S. floridanus) (van der Loo et al., 2012; 
van der Loo et al., 2016). CCL14 is functional in the Leporidae family while in 
the Ochotonidae family it is suffering a pseudogenization process with some 
species presenting an intact CCL14 while in others it is disrupted (Neves et al., 
2015b). Interestingly, mouse and rat lack the CCL14 gene (Shibata et al., 
2013). 
The superorder Glires includes two orders, Rodentia (rodents) and 
Lagomorpha (rabbits, hares and pikas) that diverged at approximately 82 million 
years ago (mya) (Hedges et al., 2015). Rodentia is the most diverse order from 
placental mammals with 2.277 species within 33 families (Blanga-Kanfi et al., 
2009). Several phylogenies proposed for rodents. According to Blanga-Kanfi et 
al., (2009) there are two main groups of rodents that diverged ~ 73 mya. The 
first group is composed by the Octodontoidea (degu), Chinchilloideia (long 
tailed chinchilla), Cavioidea (guinea pig) and Bathyergidae (naked mole-rat and 
damaraland mole-rat) families that were separated ~ 43 mya. The second group 
includes the Heteromyidae (ord’s kangaroo rat), Dipodidae (lesser Egyptian 
jerboa), Cricetidae (Chinese and golden hamsters) and Muridae (mouse and 
rat) families that diverged ~70 mya (Blanga-Kanfi et al., 2009). Lagomorpha 
includes only two families, Ochotonidae (pikas) and Leporidae (rabbits and 
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hares), that diverged at ~ 9.2 mya (Matthee et al., 2004). The Ochotonidae 
family is composed of only one genus, Ochotona, which is divided into four 
subgenera, Pika, Ochotona, Conothoa and Lagotona (Lissovsky, 2014). The 
Leporidae family comprises eleven genera Poelagus, Pronolagus, Nesolagus, 
Oryctolagus, Caprolagus, Bunolagus, Pentalagus, Brachylagus, Sylvilagus, 
Lepus and Romerolagus. From these, Oryctolagus is most closely related with 
Bunolagus and Pentalagus, while Brachylagus and Sylvilagus are closest to 
each other (Matthee et al., 2004). 
CCL16 is a pseudogene in the European rabbit and in some rodents 
such as mouse, rat and guinea pig, while in squirrel it seems to be functional 
(Shibata et al., 2013). Here, we genetically characterized CCL16 in lagomorphs. 
We further included the sequences available for several rodent species aiming 
at determine the evolution of this gene in the superorder Glires. With the 
exception of cottontails, in the remaining leporids CCL16 is a pseudogene due 
to a mutation in the juxtaposed Cysteines that leads to a stop codon. Cottontail 
rabbits also present a mutation in this motif, but it leads to a Lysine. In addition, 
Mexican cottontails possess a frameshift mutation in the first exon making it 
also a pseudogene. In the Ochotonidae family, with the exception of Hoffmann’s 
pika, CCL16 seems functional. In Hoffmann’s pika, CCL16 presents two alleles, 
one functional and the other with the same mutation in the CC motif observed in 
leporids. Interestingly, in rodents there are also some species where CCL16 is a 
pseudogene while in others it is functional, however due to mutations different 
than those described for lagomorphs. 
  
3. MATERIALS AND METHODS 
Genomic DNA was extracted using the EasySpin Genomic DNA 
Minipreps Tissue Kit (Citomed, Torun, Poland) from tissue samples of  
European rabbit (Oryctolagus cuniculus cuniculus and Oryctolagus cuniculus 
algirus), riverine rabbit (Bunolagus monticularis), Amami rabbit (Pentalagus 
furnessi), pygmy rabbit (Brachylagus idahoensis), Mexican cottontail (Sylvilagus 
cunicularis), forest cottontail (Sylvilagus brasiliensis), Eastern cottontail 
(Sylvilagus floridanus),  European brown hare (Lepus europaeus), Iberian hare 
(Lepus granatensis), volcano rabbit (Romerolagus diazi),  American pika 
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(Ochotona princeps), Northern pika (O. hyperborea), manchurian pika (O. 
mantchurica), steppe pika (O. pusilla), Hoffmann’s pika (O. hoffmanni), Palla’s 
pika (O. pallasi) and turuchan pika (O. turuchanensis) according to 
manufacturer’s instructions. Total RNA was extracted from one specimen of 
American pika and three of Eastern cottontail by using the RNeasy Mini Kit 
according to the manufacturer’s instructions (Qiagen, Hilden, Germany). cDNA 
was synthesized using oligo(dT) as primers and SuperScriptIII reverse 
transcriptase (Invitrogen, Carlsbad, CA, USA). The European rabbit and 
American pika sequences available in GenBank were used for primer design. 
PCR amplification from gDNA was performed by amplification of several 
overlapping fragments with Multiplex PCR Kit (Qiagen, Hilden, Germany), 
according to the manufacturer’s protocol (PCR conditions are available upon 
request). Sequencing was performed on an ABI PRISM 310 Genetic Analyser 
(PE Applied Biosystems) and PCR products were sequenced in both directions. 
Sequences were submitted to GenBank under the following accession 
numbers: xxxxxx. 
The sequences obtained in this work were aligned with other CCL16 
sequences available in Genbank. For Rodentia all sequences available in 
Genbanl were collected. Additionally we added CCL16 for the most 
representative Primates, Artyodactyla, Carnivores, etc. Sequences were aligned 
using MUltiple Sequence Comparison by Log-Expectation (MUSCLE) available 
at http://www.ebi.ac.uk/ (Edgar, 2004) and translated using BioEdit (Hall, 1999).  
Furthermore, we retrieved sequences available for all the 28 chemokine ligands 
for Primates, Lagomorpha, Rodentia, Arctiodactyla and Carnivora and 
performed a phylogenetic analysis. The Maximum Likelihood tree was 
estimated in MEGA6 by using the best-ﬁt nucleotide substitution model 
predicted by the same software and 1000 bootstrap replicates (Tamura et al., 
2013). 
Splicing sites were predicted by using the NetGene2 server available at 
http://www.cbs.dtu.dk/services/NetGene2/ (Brunak et al., 1991; Hebsgaard et 
al., 1996).  
 
 
210 
 
4. RESULTS AND DISCUSSION 
In both the European rabbit and mouse, CCL16 is described as being a 
pseudogene located in the MIP region of chromosomes 19 and 11, respectively. 
In this study we amplified and sequenced the CCL16 gene for eleven leporids: 
both subspecies of European rabbit (Oryctolagus cuniculus cuniculus and 
Oryctolagus cuniculus algirus), riverine rabbit (Bunolagus monticularis), Amami 
rabbit (Pentalagus furnessi), pygmy rabbit (Brachylagus idahoensis), Mexican 
cottontail (Sylvilagus cunicularis), forest cottontail (Sylvilagus brasiliensis), 
Eastern cottontail (Sylvilagus floridanus), European brown hare (Lepus 
europaeus), Iberian hare (Lepus granatensis) and volcano rabbit (Romerolagus 
diazi). In addition, we sequenced the CCL16 gene for seven pika species: 
American pika (Ochotona princeps), Northern pika (O. hyperborea), manchurian 
pika (O. mantchurica), steppe pika (O. pusilla), Hoffmann’s pika (O. hoffmanni), 
palla’s pika (O. pallasi) and turuchan pika (O. turuchanensis).  
An amino acid alignment of the CCL16 sequences for lagomorphs, 
rodents and other mammalian groups (Artiodactyla, Carnivores, Chiroptera, 
Primates, etc.) is depicted in Figure 4.5. The CCL16 sequences obtained for 
leporids were quite different from those from the remaining mammals. Indeed, 
when comparing the cottontails’ CCL16 sequences with the human sequence 
they only share 48 amino acids. However, C-C chemokines are similar between 
themselves. Thus, we performed a phylogenetic analysis of the sequences 
obtained along with all the C-C chemokine ligand sequences available for 
Primates, Lagomorpha, Rodentia, Arctiodactyla and Carnivora. In the 
phylogenetic analysis our CCL16 sequences clustered with the other CCL16 
sequences with good bootstrap values (Figure 4.6).  
  
Leporidae 
Our results further (Figure 4.7) showed that, like in the European rabbit, 
in the riverine rabbit, Amami rabbit, pygmy rabbit, European brown hare, Iberian 
hare and volcano rabbit, CCL16 is a pseudogene. In all these leporids, a non-
synonymous mutation (C>A) at codon 45 leads to a premature stop codon 
(TGC>TGA) and disrupts the typical C-C chemokines juxtaposed Cysteines 
(Cys45-Cys46). Interestingly, in the Mexican, forest and Eastern cottontail 
rabbits, the Cys45 also suffered a mutation, but it encodes a Lysine (K).  
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Figure 4. 6. Maximum likelihood (ML) tree of the mammalian C-C chemokine ligands CCL1-CCL28. The 
clade composed of CCL16 sequences is shown in detail. Only bootstrap values ≥ 75% are shown. 
 
In addition, in the Mexican cottontail, the CCL16 gene presents a deletion 
of 95-base pairs (bp) between nucleotides 22 and 117 (see Figure 4.7) that 
further leads to a frameshift.  
To assess whether the CCL16 gene was expressed in cottontails, we 
attempted its amplification from cDNA of three samples of Eastern cottontail. 
These cDNA samples had been previously successfully amplified for other 
genes of the innate and adaptive immune system (Lavazza et al., 2015; Neves 
et al., 2015a; Neves et al., 2015b; Pinheiro et al., 2014). Despite all attempts, 
amplification failed, suggesting that CCL16 is not expressed in the Eastern 
cottontail although no disrupting mutations were detected.  
The exchange of one of the Cysteines for a Lysine might have suggested 
the possibility that the protein acquired a new function. However, the 
unsuccessful amplification from cDNA of the Eastern cottontail along with the 
frameshift observed in the Mexican cottontail may indicate that CCL16 is not 
functional and is probably undergoing a pseudogenization process in 
cottontails. We hypothesize that the Cys>stop codon mutation was already 
present in the ancestor of leporids and that, for some unknown reason, was 
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“restored” into a Lysine in the cottontail branch at ~9.2 mya. In addition, in the 
cottontail lineage two distinct scenarios are possible: some species possess an 
intact CCL16 gene, however it is not expressed at the mRNA level, while in 
others it is not functional due to other pseudogenization mutations. Thus, we 
suggest that although the CCL16 gene suffered mutations that could make it 
functional, in cottontails it “remains” nonfunctional. 
Other species-specific mutations that can lead to pseudogenization were 
also observed. Indeed, Lepus spp., riverine rabbit, Amami rabbit and volcano 
rabbit have a bp deletion at nucleotide positions 4, 100, 142 and 275, 
respectively (Figure 4.7). In addition, Lepus, volcano rabbit and pygmy rabbit 
also present deletions of 4, 10 and 29 bp, respectively. Furthermore, pygmy 
rabbit and riverine rabbit present other mutations that lead to stop codons. 
These mutations occur in the pygmy rabbit at nucleotide position 148 (GAG 
(Glu) ˃ TGA) and in the riverine rabbit in position 184 (AGA (Arg) ˃ TGA). In 
addition, amplification of CCL16 from gDNA of the Amami rabbit revealed an 
insertion of 24 nucleotides at the end of the first exon (from position 206 to 234). 
All these deletions were probably due to independent events that occurred in 
different moments in the evolution of leporids, likely being lineage-specific.  
 
Ochotonidae 
We successfully amplified the American pika CCL16 from both cDNA and 
gDNA. The American pika sequence obtained from cDNA presented some 
differences when comparing with the sequence available in Ensembl 
(ENSOPRG00000012019) (Figure 4.8a). The sequence available in Ensembl 
presents several indels and misses the stop codon suggesting a non-functional 
CCL16. However, our sequences (gDNA and cDNA) seem to be functional and 
present an insertion of twenty one nucleotides that correspond to an insertion of 
seven amino acids in the beginning of exon 2. The complete sequence of the 
CCL16 gene (three exons and the two introns) showed that this insertion 
derives from intron 1 (Figure 4.8b). This insertion might have resulted from the 
appearance of an alternative splicing site in the American pika CCL16 gene. 
This alternative splicing site occurs in a CA motif located in the intron 21 bp 
upstream of the CA motif that in human CCL16 gene immediately flanks the 
exon 2. These results were further confirmed by comparing the human and 
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American pika CCL16 sequences in NetGene2. Indeed, for the American pika, 
NetGene2 predicted that the splicing occurs at nucleotide position 15 while in 
human it corresponds to nucleotide position 36 (according to the American pika 
sequence; Figure 4b). Studies on other chemokines showed that human 
CXCL12, CCL4, CCL20, CCL23 and CCL27 also exhibit alternative splicing, 
leading to novel and functional proteins (Colobran et al., 2007). Alternative 
splicing is a crucial step in the mature mRNA production (Shakola et al., 2015). 
This process leads to protein diversity and can occur by exon skipping (38%); 
alternative 5’ or 3’ spliced sites (26%); intron retention (3%); mutually exclusive 
exons, alternative promoters or multiple polyadenylation sites (33%) (Keren et 
al., 2010; Sahoo and Im, 2010). In the American pika CCL16 gene, alternative 
splicing occurred by intron retention (seven amino acids). 
For pikas, we observed that, with the exception of Hoffmann’s pika, the 
CCL16 gene seems to encode a functional protein. Interestingly, in Hoffmann’s 
pika we identified two alleles, one coding for an intact gene and the other, 
similar to leporids, presenting a mutation in the Cys45 that leads to a premature 
stop codon. This stop codon has the same location as found for leporids 
suggesting that this region may be prone to suffer mutations which is at odd as 
this site is important for disulfide bond formation, and thus alterations in this 
motif may alter protein structure and consequently, its function.  
C-C chemokines are characterized by two juxtaposed Cysteines that in 
CCL16 correspond to amino acids 45 and 46. The loss of one of these 
Cysteines due to a mutation that encodes a premature stop codon leads to 
pseudogenization of this chemokine. Moreover, the mutation into an amino acid 
different than a Cys impairs the protein to exert its functions. This is the case for 
almost all leporids studied and one allele of Hoffmann’s pika. The presence of 
the same mutation in the two families of the order Lagomorpha might be 
explained by parallel evolution in two different lineages, leporids and 
Hoffmann’s pika, such that the same mutation occurred independently at 
different moment in the lagomorphs’ evolution. Alternatively, this Cys-stop 
codon mutation was already present in the lagomorphs’ ancestor and was later 
“distributed” stochastically with some species presenting the stop mutation 
whilst others do not.  
216 
 
 
 
 
 
 
 
 
 
Figure 4. 7. Detail of the nucleotide alignment for the different CCL16 pseudogenes. Insertions in the coding 
sequence are shaded in light grey while frameshifts mutations are shaded in dark grey. A black dashed box 
represents the extra stop codons; (*) represent normal stop codons; (-) represent indels; *1, *2 and *3 represent 
different alleles. Human (Homo sapiens), European rabbit (Oryctolagus cuniculus cuniculus and Oryctolagus 
cuniculus algirus), riverine rabbit (Bunolagus monticularis), Amami rabbit (Pentalagus furnessi), pygmy rabbit 
(Brachylagus idahoensis), Mexican cottontail (Sylvilagus cunicularis), Hoffmann’s pika (O. hoffmanni), ord’s 
kangaroo rat (Dipodomys ordii), guinea pig (Cavia porcellus), mouse (Mus musculus). Numbering used in the text is 
according to human CCL16 sequence, with signal peptide and indels (indicated as (-)) being included in the 
numbering. 
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Figure 4. 9. Phylogenetic relationships within the clade Glires. Divergence times (in million years) are 
indicated in the nodes. Relationships within the Leporidae family are based on a molecular super matrix 
(adapted from Mathee et al. 2015, while for the Ochotonidae family it is based in a multilocus coalescent 
approach (adapted from (Melo-Ferreira et al., 2015). Within Rodentia, relationships are according to 
(Hedges et al., 2015). ψ indicate the pseudogenes. 
 
Rodentia 
Considering that in rodents some species have a functional CCL16 while 
in others CCL16 is a pseudogene (Shibata et al., 2013), we retrieved twelve 
rodent CCL16 sequences available in public databases (NCBI, Ensembl and 
UNIPROT). We observed that besides mouse, rat and guinea pig, CCL16 is 
also a pseudogene in the ord’s kangaroo rat (Figure 4.10). In these species, 
CCL16 is a pseudogene due to different mutations. Mouse CCL16 has been 
reported as a pseudogene due to mutations that lead to the loss of the 
characteristic juxtaposed conserved Cysteines and  an insertion of a Long 
Interspersed Element–1 (L1) in the third exon (Fukuda et al., 1999). Rat CCL16 
is also a pseudogene (Nomiyama et al., 2010; Shibata et al., 2013), but there is 
no further information on what led to its pseudogenization and no sequence is 
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available in the public databases. For the ord’s kangaroo rat and guinea pig, 
CCL16 is a pseudogene due to a premature stop codon at positions 145 and 
277, respectively. In the remaining sequences available, CCL16 seems to 
encode a functional protein.  
The different mutations observed in different lineages in rodents may 
indicate that the CCL16 gene was functional in the rodents’ ancestor and 
became posteriorly pseudogenized (Figure 4.10). Indeed, we observed that 
Muridae (mouse and rat), Heteromyidae (ord’s kangaroo rat) and Cavioidea 
(guinea pig) have a pseudogenized CCL16 gene while in members of the 
Sciuroidea (thirteen lined ground squirrel and alpine marmot), Cricetidae 
(Chinese and golden hamsters), Dipodidae (lesser Egyptian jerboa), 
Bathyergidae (naked mole-rat and damaraland mole-rat), Chinchilloidea (long 
tailed chinchilla), and Octodontoidea (degu), CCL16 is intact. Thus, the CCL16 
pseudogenization occurs stochastically along the Rodentia order. 
 
5. CONCLUSIONS 
Overall these results suggest that in Glires (rodents and lagomorhps), CCL16 
suffered several independent pseudogenization events, with some species 
presenting one or both alleles disrupted. Thus, in Glires, we observe distinct 
scenarios for CCL16: in the order Lagomorpha, some species present an intact 
CCL16 while in others it is a pseudogene. The same occurs in the Rodentia 
order, where some members of the Muridae, Heteromyidae and Cavioidea have 
a pseudogenized CCL16 gene while in members of the Sciuroidea, Cricetidae, 
Dipodidae, Bathyergidae, Chinchilloidea, and Octodontoidea, CCL16 is intact. 
This may indicate that although CCL16 was present and functional in the 
ancestor of the Glires clade, it was later inactivated in some species. This may 
have occurred stochastically or in specific lineages at different moments in the 
CCL16 evolution. 
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1. GENERAL DISCUSSION 
The major goal of this dissertation was to contribute to the current 
knowledge on the lagomorphs’ immune system. The European rabbit has been 
widely used as a laboratory model in immunological studies. Since the 1950s, 
the European rabbit population has decreased abruptly, mostly due to the 
arrival of two viral diseases, myxomatosis and rabbit hemorrhagic disease 
(RHD). The emergence of these diseases has lead to the co-evolution between 
the host and the respective pathogens. Myxomatosis is caused by a poxvirus, 
the myxoma virus (MYXV), which has its natural host in the forest cottontail 
(Sylvilagus brasiliensis) where it only causes a cutaneous lesion at the 
inoculation site, while in the European rabbit it is fatal (Kerr et al., 2015; 
Spiesschaert et al., 2011). Myxomatosis is caused by a poxvirus, the MYXV, 
responsible for high mortality in the European rabbit, being useful as a model to 
study host-pathogen interactions. RHD is caused by a calicivirus, the rabbit 
hemorrhagic disease virus (RHDV), which is also responsible for high mortality 
in the European rabbit. RHDV and RHD were also used as a model to better 
understand acute liver failure, a human critical illness with high mortality rates 
(Garcia-Lastra et al., 2010; San-Miguel et al., 2014; Tunon et al., 2011a; Tunon 
et al., 2011b; Vallejo et al., 2014). With larger incidence in humans with no pre-
existing liver diseases, the acute liver failure leads to a rapid deterioration of the 
liver functions (Bernal and Wendon, 2013). Thus, the European rabbit and its 
viral diseases are important models to further understand similar human 
diseases. However, most of these studies focused on the pathogens rather than 
in the host. Genes of the innate and adaptive host immune system are 
candidate genes to explore the processes involving the host-pathogen co-
evolution. In order to further improve our current knowledge on the host immune 
system genes that may have important roles against these viral pathogens, we 
investigated the evolutionary and genetic aspects of some of these genes. Our 
results on the C-C chemokine ligands (CCLs) 11, 14 and 16 and interleukins 
(ILs) identified unique characteristics in lagomorphs. These findings should be 
further complemented with functional studies to determine their biological 
relevance.  
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Innate Immune System 
 The innate immune system is the first line of defense against pathogens 
and includes, among others, the Toll-like receptors (TLRs), peptidoglycan 
recognition proteins, NOD-like receptors, cytokines and chemokines (Owen et 
al., 2013). Previous studies on lagomorphs’ innate immune system genes 
included TLRs (Abrantes et al., 2013; Chen et al., 2014; Elfeil et al., 2016; 
Vaure and Liu, 2014), cytokines (Gertz et al., 2011; Godornes et al., 2007; Kerr 
et al., 2004; Liu et al., 2009; Mage and Mage, 2012; Perkins et al., 2000; 
Schnupf and Sansonetti, 2012; Siewe et al., 2010; Trzeciak-Ryczek et al., 2016) 
and chemokines receptors (Abrantes et al., 2011; Abrantes et al., 2008; Carmo 
et al., 2006; de Matos et al., 2014; Schnupf and Sansonetti, 2012; van der Loo 
et al., 2012; van der Loo et al., 2016).  
CCR5-CCR2 gene conversion is well documented in lagomorphs, where 
a characteristic motif of the second extracellular loop of CCR2 (HTIMRN) 
replaces the CCR5 sequence motif QTLKMT (Carmo et al., 2006), 
characterized as crucial for ligand specificity (Samson et al., 1997). 
Interestingly, this event was not observed in Sylvilagus or Lepus species 
(Abrantes et al., 2011; Carmo et al., 2006). This gene conversion event 
prompted the study of the CCR5 ligands (Zlotnik and Yoshie, 2012). Previous 
studies revealed that CCL3, CCL4 and CCL5 genes are functional in leporids 
and under strong purifying selection (de Matos et al., 2014) while CCL8 is 
pseudogenized in the European rabbit, riverine rabbit and Amami rabbit, while 
intact in hares and Eastern cottontails (van der Loo et al., 2012; van der Loo et 
al., 2016). Thereby, our main goal was to genetically characterize the remaining 
CCR5 ligands in lagomorphs, expecting to better understand the implications of 
the CCR5-CCR2 gene conversion in Oryctolagus, Sylvilagus and Lepus. 
Considering the role of interleukins in RHDV (IL1, IL2, IL6, IL8, and IL10) 
(Garcia-Lastra et al., 2010; Marques et al., 2012; Marques et al., 2014; Teixeira 
et al., 2012; Trzeciak-Ryczek et al., 2016); MYXV (IL4, IL12, IL15 and IL18) 
(Johnston and McFadden, 2004; Kerr et al., 2004; Liu et al., 2009; Stanford and 
McFadden, 2005; Tosic et al., 2014; Vande Walle and Lamkanfi, 2011) and 
bacterial (IL17 and IL22) infections (Schnupf and Sansonetti, 2012; Skyberg et 
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al., 2013), we performed a genomic characterization of these interleukins in 
several lagomorph species. 
A dynamic immune system requires an efficient recognition of the 
invading pathogens. For this, a wide array of antigens must be efficiently 
recognized and cells of the immune system must be able to quickly adapt and 
respond to changes in the normal conditions. Therefore, such an intricate 
system involves highly complex networks and relies heavily on several 
mechanisms of gene regulation to succeed by obtaining the required diversity 
and flexibility. The immune system genes studied here revealed some of the 
mechanisms that ensure the plasticity of the immune system and that ultimately 
leads to successfully eradicate the invading pathogens. 
 
Evolutionary forces 
Genes of the immune system are constantly under pressure from 
invading microorganisms. In vertebrates, the innate immune response precedes 
and shapes the adaptive immunity. Therefore, alterations in the vertebrate 
innate immunity genes may have crucial consequences in the development of 
an appropriate adaptive immune response (Quintana-Murci and Clark, 2013). 
There is some controversy regarding the selective pressures acting in the 
immune system. It is well-known that genes associated with the immune system 
present high evolutionary rates and signatures of positive selection are 
commonly detected due to adverse environmental conditions and the arms race 
established between pathogens and the host (Barreiro and Quintana-Murci, 
2010; Ferrer-Admetlla et al., 2008). Nevertheless, in order to maintain their 
conformation and biological role, immune system genes are also under purifying 
selection (Metzger and Thomas, 2010). Previous studies on human innate 
immunity genes evidenced signals of both positive (Vallender and Lahn, 2004) 
and purifying selection (Mukherjee et al., 2009). Our results show that in 
lagomorphs, the interleukins studied and CCL14 are also under strong positive 
selection. On the other hand, and as observed for other chemokine ligands (de 
Matos et al., 2014), CCL11 is under both positive and purifying selection. 
Interestingly, we detected both selective pressures in regions responsible for 
the interaction with other proteins such as receptors and binding proteins.    
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Mutations in immune system genes 
Gene mutation is a permanent change in the DNA sequence that can be 
inherited or acquired due to distinct selective pressures or owing to errors 
during DNA replication. Studies in different mammals, particularly in humans, 
showed that mutations in immune system genes might be responsible for the 
development of diseases (Buckley, 2005; Carvalho et al., 2010; Ochs et al., 
2014). For example, mutations in human IL2 are associated with an increase of 
Mendelian susceptibility to mycobacterial disease (MSMD), while mutations in 
the C-terminal of CXCR4 are associated with Myelokathexis (Rosenzweig and 
Holland, 2011). In this work, several different mutations that lead to different 
alterations in innate immune system genes of lagomorphs were detected. 
Indeed, CCL11 is functional in lagomorphs, but the pygmy rabbit presents a 
longer protein due to a mutation in the stop codon. Despite being functional in 
leporids, in some Ochotona species (O. princeps, O. pallasi, O. alpina and O. 
turuchanensis, O. hyperborea and O. pusilla) the CCL14 is a pseudogene due 
to distinct disrupting mutations. For CCL16, some lagomorphs (the European 
rabbit, riverine rabbit, Amami rabbit, pygmy rabbit, European brown hare, 
Iberian hare, volcano rabbit and Hoffmann’s pika) present a mutation in the 
characteristic juxtaposed cysteines leading to a premature stop codon. 
Interestingly, the only leporids that present a possible functional CCL16 are the 
cottontails (with the exception of the Mexican cottontail) where this mutation 
codes for a Lysine. Nevertheless, and despite all the attempts, CCL16 could not 
be amplified from Eastern cottontail cDNA, suggesting that the CCL16 may not 
be expressed. For IL6, the European rabbit and the Amami rabbit, when 
compared with other mammals, present a mutation that leads to longer proteins 
with extra 27 and 17 amino acids, respectively.  
 
Alternative Splicing 
Alternative splicing is an important feature of gene regulation being 
responsible for tissue and species-specific differentiation patterns (Keren et al., 
2010; Kornblihtt et al., 2013). Alternative splicing includes the recognition and 
removal of introns and the attachment of different exons by several splicing 
proteins to form the mature mRNA (Keren et al., 2010). This mechanism can 
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increase protein diversity by producing distinct mature transcripts that translate 
into different proteins. Over 90% of human genes are subject to alternative 
splicing (Wang et al., 2008). Alternative splicing may also result in proteins with 
different biological roles and with different outcomes within cells, alterations in 
the biochemical properties of the proteins and ultimately, in the loss of function 
(Shakola et al., 2015; Yabas et al., 2015). Only a few studies have focused on 
the importance of alternative splicing in regulating the functions of the immune 
system and there are still many unanswered questions. Thus, in order to fully 
comprehend immunity-related diseases, it is crucial to understand the 
mechanisms underlining the alternative splicing and also the mechanisms that 
regulate the splicing events in the normal immune response (Martinez and 
Lynch, 2013). Indeed, some isoforms of cytokine receptors mediate antagonistic 
functions in cytokine signaling leading, to alterations in cytokine function (Sahoo 
and Im, 2010; Shakola et al., 2015). Moreover, cytokines modulate the 
expression of several genes associated with the alternative splicing machinery 
(Ortis et al., 2010). Previous studies have highlighted the existence of different 
isoforms in the European rabbit interleukins IL1Ra, which suppress the IL1 anti-
inflammatory activity (Cominelli et al., 1994; Cominelli et al., 1992); IL2, IL4 and 
IL10, where the new isoforms lack some exons (Perkins et al., 2000), and IL7II 
that may act as an antagonist of IL7 (Siewe et al., 2010). Our results further 
showed the existence of alternative splicing in the second exon of American 
pika IL8 and CCL16 that originated from the 5’ untranslated regions (UTRs). 
 
N-glycosylation 
N-glycosylation consists in the attachment of a N-glycan to a nitrogen 
atom of the amino acid residue asparagine by a N-glycosidic bond. This 
process is considered crucial for protein function being involved in several 
biological mechanisms such as protein folding, ligand binding, protease 
protection, oligomerization, intrinsic stability, leukocyte trafficking, and 
expression (Marth and Grewal, 2008; Moremen et al., 2012; Varki and Lowe, 
2009). In addition, glycans are present on the surface of mammalian cells, 
attached to the ectodomain of PRRs, being used as recognition motifs and 
therefore, are essential to mediate cell-to-cell interactions and in pathogen 
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recognition. Glycans are also responsible for most of the cell-specific inter-
variability (Lee and Lee, 1995; van Kooyk and Rabinovich, 2008; Wolfert and 
Boons, 2013). Thus, alterations in glycosylation sites are variable and 
unpredictable and changes in these regions can have different effects in 
different cells (Varki and Lowe, 2009). For example, studies showed that 
alterations in N-glycosylation sites of interferon-γ receptor 2 disrupt the ability of 
this receptor to bind to its ligands, and were also associated with Mendelian 
susceptibility to mycobacterial disease (Marth and Grewal, 2008; Vogt et al., 
2005). Furthermore, alterations in N-glycans of IL21R were linked to combined 
immunodeficiency syndrome (Kotlarz et al., 2013). In this work we detected 
alterations in N-glycosylation sites for IL1, IL6, IL10, IL12B, IL15 and IL17. 
Indeed, in some of these proteins these alterations are predicted to induce 
structural modifications, namely in the number of helixes.  
 
Disulfide bonds  
Formation of disulfide bonds is an important post-translational 
modification that can have crucial implications in the protein folding and integrity 
(Hogg, 2003). These bridges are formed between the thiol groups of cysteine 
residues being well conserved between related-proteins and species (Fass, 
2012; Li et al., 2011; Thangudu et al., 2008). Some studies indicated that 
mutations in the cysteines that form the disulfide bonds do not significantly alter 
the proteins’ structure, however, they might affect their activity and sometimes 
can lead to alterations in their function (Li et al., 2011; Thangudu et al., 2008). 
Disulfide bonds with a crucial role in the protein are usually highly conserved. 
The non-conservation of these bonds within homologous proteins can be 
related with mutations that favor other interactions or with other inconspicuous 
structural alterations that compensate this loss, being also associated with 
differentiation and specialization of the protein function (Thangudu et al., 2008). 
Nevertheless, studies on IL2 and its receptors showed that alterations in these 
proteins’ disulfide bonds lead to the lack of interaction, loss of function and were 
also associated with development of disease (Metcalfe et al., 2012; Niemela et 
al., 2000; Wang et al., 2005). Our results show that alterations in cysteines 
important for disulfide bonds lead to an extra helix in the American pika IL1β 
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and in the European rabbit IL6. Moreover, in CCL16 our results evidenced that 
in the majority of leporids and in Hoffman’s pika one of the two N-terminal 
cysteine residues that form disulfide bridges with the two C-terminal cysteines 
of the molecule is mutated into a stop codon. 
Since the 1980s the European rabbit has been used as an animal model 
and important advances were made on human health, namely for rabies and 
syphilis (Knell, 2004; Pasteur, 1885). However, the European rabbit was 
gradually replaced as an animal model for human diseases by mouse (Mus 
musculus). However, from an immunological point of view, it is now known that 
the European rabbit presents some unique characteristics such as organ’s size, 
longer lifetime which allows to study chronic aspects of a disease and are 
carriers or reservoirs of different pathogens that are able to cause zoonotic 
diseases (Fontanesi et al., 2016; Kamaruzaman et al., 2013). These specific 
features make the European rabbit a better model to study human diseases. 
Indeed several authors stated that for some immunological studies the rabbit 
may be a better model than mouse (Burkhardt and Zlotnik, 2013; Kamaruzaman 
et al., 2013; Keir and Page, 2008; Mullane and Williams, 2014; Perkins et al., 
2000; Pinheiro et al., 2016; Seok et al., 2013; Shay et al., 2015; Takao and 
Miyakawa, 2015; Webb, 2014). Our results show that for interleukins, the 
European rabbit is closer to human further supporting that the European rabbit 
might be a better animal model to study the role of human interleukins in the 
inflammatory process. 
  
2. FUTURE PERSPECTIVES 
The work developed in this thesis shed light on some aspects of the 
lagomorphs’ innate immune system. However, many questions croped up and 
remain unanswered. Future lines of research should take them into account. 
Despite the knowledge gathered with this thesis regarding different 
innate immune system genes, the biological implications of the alterations found 
in lagomorphs and in the development of an effective immune response are still 
largely speculative. Several reasons might underlie our findings, including the 
“acquisition” of speciﬁc biological functions and the maintenance of crucial 
structural features. However, the limited knowledge of the role of speciﬁc 
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codons in the functions of the proteins encoded by these genes hampers the 
complete understanding of our observations. In addition, the information 
available for the genes studied is mostly restricted to human with almost no 
information available for other mammals. Our results provide essential 
contributions to the knowledge of the innate immune response in lagomorphs 
that could have implications for the initiation and perpetuation of immune-
mediated disorders. It is clear that a multitude of apparently non-redundant 
regulatory mechanisms act in concert to fine-tune and modulate the initiation, 
duration and magnitude of the immune response. An extensive knowledge of all 
of these mechanisms can provide significant information on our understanding 
of the European rabbit diseases such as myxomatosis and RHDV and lead to 
the development of new therapeutics. 
Functional and structural studies by using mutagenesis and 
crystallographic approaches should be performed for a full comprehension of 
the role and consequences of the observed alterations. With a site-directed 
mutagenic approach we will be able to induce specific mutations into a protein 
with a known sequence (Carter, 1986; Kunkel, 1985). Crystallographic studies 
are used to obtain the structure of a protein, being also helpful to determine how 
some interactions influence the target of the protein and what structural 
changes occur upon interaction (Scapin, 2006). Thus, the application of these 
techniques to the proteins studied will allows us to determine the impact of the 
mutations described in the protein function, structure and interactions. An effort 
should also be made to integrate functional transcriptomic and proteomic 
analyses in different organs and tissues in order to link the observed mutations 
with their emerging new roles in lagomorphs. 
Several aspects of lagomorphs’ immune system remain unclear. Many 
other host immune system genes might be responsible for 
susceptibility/resistance to the different diseases and outcomes in leporid 
species. Indeed, Toll-like receptors (TLRs) are important proteins with the ability 
to detect a wide range of pathogens, being important for both innate and 
adaptive immunity. These pattern recognition receptors play a central role in 
response against danger signals (Christmas, 2010) and might be important for 
RHDV infection (Abrantes et al., unpublished observations). In lagomorphs, 
studies are only available for TLR1, TLR2, TLR3 and TLR4 (Abrantes et al., 
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2013; Chen et al., 2014; Elfeil et al., 2016; Vaure and Liu, 2014), but should be 
further extended to the other TLRs. 
Protein kinase R (PKR) is an antiviral protein that can be found in most 
vertebrates and can be induced by type I IFN. When activated this protein 
phosphorylates the α subunit of the eukaryotic initiation factor 2 (eIF2) that 
leads to the inhibition of virus replication (Elde et al., 2009; Sadler and Williams, 
2007). Interestingly, recent studies evidenced that myxoma virus variant 
MYVX156 is homologous to eIF2 and is able to inhibit the rabbit PKR (Peng et 
al., 2016). In addition, a single mutation in this variant blocks this inhibition 
(Burgess and Mohr, 2016; Peng et al., 2016). These results might be related 
with the MYXV-rabbit co-evolution. 
Immunoglobulins (Igs) are proteins able to recognize and bind to several 
different antigens as well as recruit effector functions for the pathogen removal. 
Thus, in order to successfully infect the host, pathogens evolved several 
strategies to escape from the Igs activity (Owen et al., 2013). Due to its 
important functions in the European rabbit, Igs have been widely studied, with 
the main focus in the Igs heavy chain (Esteves et al., 2006; Esteves et al., 
2005; Gertz et al., 2013; Lavinder et al., 2014; Pinheiro et al., 2011; Pinheiro et 
al., 2013; Pinheiro et al., 2014; Ros et al., 2004). There are few studies on the 
Immunoglobulin light chain, with emphasis on the kappa (κ) locus (Mage et al., 
2006; Popkov et al., 2003; Ros et al., 2005). Indeed, Gertz et al. (2013) is the 
only study performed in recent years that focus on the immunoglobulin light 
chain lambda locus (IgLλ) and summarizes the available information for the 
European rabbit. 
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